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A comparison of medicines management documents in use by NHS 
organisations in the West Midlands confirms that there are important 
differences between the primary care and hospital sectors in respect to 
medicines management interface issues. Of these, two aspects important to 
paediatric patients have been studied. These are the transfer of information 
as a patient is admitted to hospital, and access to long-term medicines for  
home-patients. National guidance provided by NICE requires medication 
reconciliation to be undertaken on admission to hospital for adults. A study of 
paediatric admissions, reported in this thesis, demonstrates that the clinical 
importance of this process is at least as important for children as for adults, 
and challenges current UK guidance. The transfer of essential medication 
information on hospital admission is central to the medication reconciliation 
process. Two surveys of PCTs in 2007 and again in 2009 demonstrate that 
very few PCTs provide guidance to GPs to support this process. Provision of 
guidance is increasing slowly but remains the exception. The provision of 
long-term medicines for children at home is hindered by this patient 
population often needing unlicensed drugs. Further studies demonstrate that 
primary care processes regularly fail to maintain access to essential drugs 
and patients and their carers frequently turn to hospitals for help. Surveys of 
hospital medical staff (single site) and hospital nurses (six UK sites) 
demonstrates the activity these healthcare workers perform to help children 
get the medicines they need. A similar survey of why carers turn to a hospital 
pharmacy department for urgent supplies (usually termed rescue-medicines) 
adds to the understanding of these problems and supports identifying service 
changes. A large survey of community pharmacies demonstrates the 
difficulties they have when dispensing hospital prescriptions and identifies 
practical solutions. This programme concludes by recommending service 
changes to support medication management for children. 
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Background  
 
Why undertake this study? There are a number of reasons, all of which are based on common 
observations of current health care arrangements in the UK. These issues build towards an 
inevitable conclusion that medicines management across the healthcare sectors for paediatric 
patients is problematic and in need of reform. These reasons include: 
 
1. Seamless care across healthcare sectors in England is not robust. 
2. Medicines management for children at the healthcare interface may be prone to additional 
problems due to the nature of long-term medicines required in paediatric practice. 
3. Some key aspects of paediatric medicines management is not well reported, including 
3.1. essential medication information on transfer to hospital (admission) is poor 
3.2.  access to long-term medicines outside hospital, as home-patients, is problematic. 
 
Chapter 6 describes the identification of medicines management issues across the healthcare 
sectors. 
 
The Department of Health states that the use of medicines is the most common therapeutic 
intervention provided by the NHS.(1) However operational systems and communication 
arrangements dealing with medication often breaks down at the interface between healthcare 
sectors (e.g. between primary and secondary care), leading to poor patient care.(2) In particular 
there are problems with transmission of essential medication information on admission to 
hospital and this issue is examined in Chapters 7 and 8. There may also be a lack of clarity over 
which sector will prescribe any long-term medication. For adults this is usually the patient‘s GP. 
But for children it may be more appropriate for the hospital consultant to retain prescribing 
responsibility due to the need for unlicensed drugs (Specials) or licensed drugs used off-label. 
The Department of Health provided guidance on this issue in 1991 in the form of an Executive 
Letter EL91(127).(3) Whilst this guidance is nearly 20 years old it continues to provide the 
current basis for professional guidance.(4) This issue is examined in Chapters 9, 10 and 11. 
 
A number of publications indicate that better communication across the health care interface will 
reduce prescribing discrepancies and reduce drug related problems for patients.(5, 6) This is 
emphasised in the care of children discussed in the National Service Framework for Children 
(1), which states: 
(5.6) Effective communication is required between hospital consultants and general 
practitioners. Children and young people and their parents or carers sometimes 
experience difficulty in accessing medicines in the community following discharge from 
hospital resulting in confusion and anxiety for parents, carers and young people. 
 
National and probably local guidance concerning medicines management as a patient moves 
from one healthcare sector to another is scant and when provided focuses on communication 
needs during discharge (5, 7-16) with little emphasis on admission. 
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However the significance of ‗interface‘ issues is beginning to be acknowledged and recent 
guidance seeks to address some of the issues. In December 2007 the National Institute for 
Health and Clinical Excellence (NICE) and the National Patient Safety Agency (NPSA) 
published a joint document concerning medicines reconciliation.(17) This guidance, the first 
‗Technical Patient Safety Solution‘, offers direction to NHS organisations admitting adult 
patients to provide medicines reconciliation services to patients on admission to hospital. The 
document comments that: 
The aim of medicines reconciliation on hospital admission is to ensure that medicines 
prescribed on admission correspond to those that the patient was taking before 
admission. 
 
It is disappointing that this guidance specifically excludes children under 16 years of age. 
 
Paediatric patients may be particularly prone to ‗interface‘ issues since many children with long-
term conditions will require unlicensed medicines. The issue of which sector should prescribe 
has already been highlighted. But the provision of a prescription may not ensure a timely supply. 
There may also be problems in obtaining unlicensed medicines from community pharmacies. 
Issues relating to the dispensing of hospital prescriptions by community pharmacists are 
examined in Chapter 12. 
 
There are a number of reasons then why continuity of agreed care for children may be 
compromised with potential for adverse clinical consequences. This study focuses on two major 
interface issues for children. Firstly the transfer of essential medication information on 
admission to hospital and secondly issues relating to access to medicines for children needing 
long-term medication when they are not in hospital. 
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1. Introduction 
 
1.1. Medicines management – what is it? 
 
As a relatively new term it is perhaps not surprising that the meaning of medicines management 
has been evolving, with a number of organisations and authors providing various definitions 
over recent years. Before the term medicines management came into vogue a number of other 
terms and phrases were used to express the beneficial application of pharmaceutical sciences 
to patient care. Two of the most familiar terms are ‗Pharmaceutical Care‘ and ‗Clinical 
Pharmacy‘. Pharmaceutical care was defined by Hepler and Strand (18) in 1990 as: 
 
‗… the responsible provision of drug therapy for the purpose of achieving definite 
outcomes which improve the patient‘s quality of life.‘ 
 
Definitions of clinical pharmacy are less easy to come by. Indeed the United Kingdom Clinical 
Pharmacy Association (UKCPA) in its document ‗Statement on Pharmaceutical Care‘ (19), 
perhaps surprisingly, does not define the term clinical pharmacy. Until 2007 UKCPA documents 
used the term ‗pharmaceutical care‘ to express the benefits their members provide. However in 
December 2006 the UKCPA announced that it intended to canvas its members on whether it 
should include the term ‗medicines management‘ within its mission statements,(20) the reasons 
cited by the then Chairman as  
“ … to reflect the use by Government and other bodies of the term „medicines 
management‟ rather than „pharmaceutical care‟ and to emphasise the need for standard 
setting.”  
 
The membership agreed to the change and the term ‗medicines management‘ was adopted. 
The current Mission Statement (21) reads: 
To promote expert practice in medicines management for the benefit of patients and the 
public by establishing standards, developing the workforce and advancing innovation in 
all health care settings. 
 
However the UKCPA does describe clinical pharmacy within its statement (19): 
Clinical pharmacy has become part of the mainstream of the pharmacist's contribution 
to patient care.  There is now widespread recognition of this development not only 
within the Health Service but also by professional bodies and by Schools of 
Pharmacy.  The term clinical pharmacy no longer implies any degree of exclusivity but 
has come to be used generally to describe the knowledge, skills and attitudes required 
by a pharmacist to contribute to patient care.  
 
In general, the terms ‗pharmaceutical care‘ and ‗clinical pharmacy‘ both tend to focus on the 
individual patient, and the delivery of patient centred clinical pharmacy services is a corner 
stone of good medicines management. This is made clear by clinical pharmacy organisations 
and is endorsed by national guidance.(5, 19, 22, 23)  
 
The Nuffield Report (24) was published in 1986. Whilst this influential document supported the 
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development of clinical pharmacy and described some aspects of what we now refer to under 
the heading of medicines management, it never actually used the term medicines management. 
Similarly the Department of Health described the concepts of medicines management in 1988, 
including the aims of clinical benefit with good financial control, in the document ‗The Way 
Forward for Hospital Pharmaceutical Services‘ (22), without actually using the phrase medicines 
management.  
 
The term medicines management began to emerge during the early 1990s and indeed was 
used as the general title of a series of articles published in The Pharmaceutical Journal during 
1996 (25-29). These articles developed a number of themes and in particular extended the 
previous definitions from purely a patient focus to population based considerations. In 1998 
Tomlin in an article in the journal Pharmacy Management (30) described (hospital) pharmacy 
activity as managing medicines and suggested that the term pharmaceutical care was perhaps 
less well understood by other health professionals. 
 
Clearly by the early years of the new millennium 2000, the term medicines management was in 
regular use – although this phrase may be more common in England and Wales, with perhaps 
other countries continuing to use the term pharmaceutical care for the same concepts.(31) In his 
article in the Pharmaceutical Journal in 2001 Simpson (31) describes medicines management 
as the wider term with pharmaceutical care a section of it. Some of the most cited definitions of 
medicines management are: 
 
Medicines management encompasses the entire way in which medicines are selected, 
procured, delivered, prescribed, administered and reviewed to optimise the contribution 
that medicines make to producing informed and desired outcomes of patient care. (32) 
 
Medicines management is a system of processes and behaviours that determines how 
medicines are used by patients and by the NHS. (33) 
 
Medicines management is all aspects of the supply and therapeutic use of medicines 
from an individual patient level to an organisation level. (34) 
 
In considering the development of medicines management the Welsh executive of the RPSGB  
(35) concluded: 
‗ … medicines management is not a new concept but an evolving concept towards 
patient focused care and the services that help deliver that care.‘ 
 
Delivering the benefits of medicines management requires more than the application of clinical 
pharmacy skills at the patient‘s bedside. Strategic delivery of medicines management requires 
organisational adoption and support. Accepted definitions of medicines management therefore 
include an organisational component. Stephens discusses this important aspect of medicines 
management in his book Strategic Medicines Management.(36) 
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Knowing what is a medicinal product is fundamental to identifying the benefits that medicines 
management may bring. The Medicines Act 1968 was enacted on 25
th
 October 1968 and 
remains the primary legislation that controls all aspects of medicinal products within the UK.(37) 
It was introduced as a result of concerns raised about the control of medicines following the 
thalidomide tragedy of the 1960s. Part VIII of this statute defines a medicinal product as:  
any substance or article (not being an instrument, apparatus or appliance) which is 
manufactured, sold, supplied, imported or exported for use wholly or mainly in either or 
both of the following ways, that is to say: 
(a) use by being administered to one or more human beings or animals for a medicinal 
purpose; 
(b) use as an ingredient, by a practitioner or in a pharmacy or in a hospital or in a 
business comprising the sale of herbal remedies, in the preparation of a substance or 
article which is to be administered to one or more human beings or animals for a 
medicinal purpose.  
 
The Act also defines the meaning of ‗Medicinal purpose‘ as: 
(a) treating or preventing disease; 
(b) diagnosing disease or ascertaining the existence, degree 
or extent of a physiological condition; 
(c) contraception; 
(d) inducing anaesthesia; 
(e) otherwise preventing or interfering with the normal operation of a physiological 
function, whether permanently or temporarily, and whether by way of terminating, 
reducing or postponing, or increasing or accelerating, the operation of that function or in 
any other way. 
 
For all their many uses, medicines pose a number of risks. According to the Audit Commission 
in the publication A Spoonful of Sugar these risks may be summarised under two heading – 
clinical and financial.(23) Successful medicines management will minimise these two related 
risks without limiting the benefits that medicines may provide. 
 
Clinical risks from medicines are significant. Even when medicines are used appropriately 
according to the patient‘s condition adverse reactions can result posing a hazard to the patient. 
It has been reported that 6.5% of hospital admissions are related to adverse drug reactions 
(ADRs) with 80% of these admissions directly caused by the ADR.(38) Furthermore the 
Department of Health publication in 2001 ‗Medicines for Older People: Implementing medicines-
related aspects of the NSF for Older People‘ (39) states that medicines are implicated in 5-17% 
of hospital admission in this patient group, and goes on to comment that whilst in hospital 6 –
17% of older people experience adverse reactions to medicines. 
 
The potential hazards of using medicines are further enhanced when mistakes and misuse are 
considered; and further added to by other issues – for example physical or psychological 
dependence or physiological resistance to previously effective drugs. In order to support risk 
reduction from medicines, the NHS executive produced a standards document for medicines 
management within hospitals. The revised version was published in 2000 seeking to measure 
organisational compliance to relevant legislation.(40) The standards focused on the safe and 
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secure handling of medicines within secondary care. The application of medicines management 
as described within the standards was designed to support the twin aims of reducing clinical risk 
and improving financial control. 
 
The effective implementation of medicines management is now considered as a primary 
mechanism for reducing drug related clinical risk (22, 41-43) and can also be applied with the 
aim of controlling drug budgets.(41, 44, 45) The NHS spends a huge amount of money on 
medicines – over £8.8 billion in primary care alone in 2009 (46) and both costs and numbers of 
prescriptions continues to rise, the later faster than the former.(47) The application of medicines 
management seeks to maximise health benefits whilst minimising costs and reducing risks. 
 
Medicines management therefore has four aspects. At its heart is patient focused clinical 
pharmacy, but medicines management also has an important financial component. Strategic 
delivery of these aspects requires organisational engagement, often directed by national 
guidance. The four components of medicines management is illustrated in Figure 1 below. 
 
Figure 1 The four key components of medicines management 
 
 
 
There are a number of national organisations that seek to ensure successful strategies for 
improved medicines management. For example in 1996 the Department of Health opened the 
National Prescribing Centre (48), with aims to facilitate high-quality, cost effective prescribing 
and medicines management. Another organisation, the Healthcare Commission conducted the 
first NHS Annual Health Check in 2005-2006 (49) and this has been continued by the Care 
Quality Commission since 2009.(50) This process provides guidance and support to NHS 
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organisations through a programme of audits which aims to ensure better care for everyone in 
hospital, in a care home or at home. 
 
 
1.2. National guidance on medicines management at the 
healthcare interface 
 
 
The NHS Plan (32) was published in July 2000 followed a few months later by the document 
Pharmacy in the Future - Implementing the NHS Plan.(5) The NHS Plan set out a programme of 
reform for the NHS based on patient focused services and Pharmacy in the Future described 
the role that pharmacy would play in this process. These documents encourage the expansion 
of hospital pharmacy services whilst retaining well established functions such as efficient drug 
procurement, safe and secure handling of medicines and clinical pharmacy services. A number 
of new services were encouraged including pharmacists working on admission wards to ensure 
that patients‘ medication issues were resolved early during their in-patient episode. A number of 
studies confirm the suitability of pharmacists taking medication histories.(51, 52) Other initiatives 
included the use in hospital of patients‘ own drugs (PODs), one-stop dispensing to speed up the 
discharge process and the implementation of in-patient self-administration of drugs schemes. 
The introduction of emerging technologies such as robotic dispensing was also highlighted.  
 
The Audit Commission‘s report titled A Spoonful of Sugar (23) was published in spring 2001. 
This report addressed a number of medicines management related issues within NHS hospital 
services, commenting that: 
 
This report has been written to help hospital trusts identify how well they manage 
medicines. It addresses the main strategic challenges and issues facing hospitals in 
improving the effectiveness of their medicines' management, and suggests ways in 
which potential barriers can be met and overcome. 
 
This report includes guidance on improving working across the primary-secondary healthcare 
interface and emphasised the importance of developing drug formularies, linked to NICE 
guidance, through locally established Drugs and Therapeutics Committee (DTC). Furthermore it 
comments that the DTC, a hitherto predominantly secondary care committee, should have 
primary care involvement. A change designed to improve medicines management across the 
local health economy. 
 
During July 2003 A Vision for Pharmacy in the new NHS (53) was published. Building on 
previous publications this document again emphasised the need to design services around 
patients and commented on a number of specific medicines management initiatives including:- 
the Community Pharmacy medicines management project; the Hospital Pharmacy Medicines 
Management Framework and the Medicines Management Collaborative. 
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The UK Government published a white paper concerning pharmacy services in 2008 called 
Pharmacy in England Building on Strengths – Delivering the future.(54) This document is 
intended to build on both A Vision for Pharmacy in the New NHS and another document titled 
Our health, our care, our say: a new direction for community services, published in January 
2006.(55) Encouragement for collaboration across the healthcare sectors is at best low profile in 
this otherwise influential document. Whilst the document supports collaboration, it does so 
primarily within healthcare sectors, rather than across them. For example it states in reference 
to primary care pharmacy services:  
―… there are benefits where pharmacists are active partners in collaboration with GPs.‖ 
It does however encourage cooperation between the healthcare professions. This document 
also comments on the role PCTs must play in ensuring prompt access to medicines, which as 
will be described later, is a major line of enquiry within this research programme. 
 
1.3. Medicines Management at the Primary – Secondary 
Care Interface. 
1.3.1. Prescribing and medicines access. 
 
 The vast majority of patients entitled to healthcare under the NHS will obtain 
prescription medicines through primary care agencies; prescribed by their GP and dispensed by 
a community pharmacist. According to the latest report published by the NHS Information 
Centre (46) the annual drug spend in primary care in England in the year 2009-10 exceeds £8.8 
billion with over 840 million items dispensed each year. Numbers and costs of prescriptions 
continue to grow currently at approximately 5% per annum. 
 
When a patient is admitted to hospital the responsibility for prescribing and providing the 
required medication transfers from primary care to the hospital. Following admission, patients 
are usually seen by medical staff (often as part of the clerking process) and required medication 
is prescribed on hospital approved stationery, usually dispensed by the hospital pharmacy and 
most often  administered by registered nurses (or under some circumstances self-administered 
according to local protocols). Prescribed medication will be reviewed and amended as 
necessary according to the patient‘s clinical condition and further supplies made if required. 
 
Clinical pharmacy services will often be involved in the medication process in hospitals, with 
clinical pharmacists adding their own expertise to optimise the choice of medication used. 
Patients are routinely encouraged to bring their own medication into hospital, including any 
items prescribed by their GP. Patients‘ own drugs (often termed PODs) may be used for that 
specific patient during their in-patient episode. The drugs will be assessed for suitability for use 
by pharmacy staff, and if deemed appropriate, made available to the nursing staff for 
administration to the patient. Using PODs may reduce drug costs by minimizing waste and 
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ensures that the patient continues to receive a familiar product, as opposed to a generic 
substitute. PODs may also be used as a medication reconciliation (MR) source to identify 
current medication regimens on admission (see Chapter 7). 
 
Where the hospital pharmacy is required to provide medication supplies the items may be 
dispensed in anticipation of discharge. Dispensing for discharge arrangements require the item 
to be labelled for the individual patient in such a way that the patient can be given that same 
item to take home with them on discharge. Dispensing for discharge may speed up discharge 
and reduce pressure on dispensary services. Where long-term medication is required, the 
quantity of the item provided to the patient on discharge may have been agreed, in general 
terms, between the commissioning PCT and the Hospital Trust. Arrangements vary between 
PCTs and hospitals although a minimum of 10 days supply may be a typical arrangement, with 
on average a 3 week supply of continuing medication provided as the patient leaves hospital. 
Such arrangements may support patients during the early discharge period and give patients, 
GPs and community pharmacists sufficient time to arrange for further prescriptions and 
supplies. There may also be a financial benefit from such arrangements since hospitals 
commonly pay less for their medicines than the cost listed in the Drug Tariff which provides the 
financial framework for medication supplies via community pharmacies. Whilst hospitals pay 
VAT (where appropriate) on medication purchases and community pharmacy drug purchases 
are VAT exempt, nonetheless purchase costs in hospital are less than in community often as a 
result of drug purchasing contracts. Such contracts are usually negotiated on a regional basis 
with volume related price reductions. 
 
1.3.2. Shared care arrangements 
 
 Shared care arrangements are an agreement between NHS organisations in different 
healthcare sectors that clarifies prescribing arrangements for non-hospitalised patients when 
both sectors (hospital consultant and GP) need to retain involvement in the patient‘s care.(56) 
That is, due to the nature of their medicinal needs some patients will require the continued 
involvement of their hospital consultant even though they are outside hospital and under the 
care of their GP. PCTs may provide guidance on the suitability of a drug for prescription in 
primary care, either via the GP as usual, or via a shared care agreement, and classify each drug 
accordingly.(57) These documents are typically presented as colour coded lists often using a 
traffic light arrangement to declare the category of the item; where a red drug is ‗unsuitable for 
GP prescription‘ and green is ‗suitable for GP prescription‘, with amber usually indicating that 
some further patient specific consideration will be required.(58) It is usually amber drugs that 
require shared care arrangements to ensure collaboration between the patient‘s GP and their 
hospital consultant. The list of drugs, the style of presentation, and the individual categorizations 
varies between PCTs with no national standard available.  
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To support PCTs some regional bodies provide guidance on shared care arrangements 
between primary and secondary care based on an individual drug's usage and prescribing 
characteristics e.g. Midlands Therapeutics Review and Advisory Committee (MTRAC) (59) - 
indicating when a specific drug may be appropriate (or otherwise) for GP / primary care 
prescribing. National guidance at this level of detail is limited. Even where regional advice is 
provided, local guidance, often provided by Medicines Management Committees of Primary 
Care Trusts (PCTs), concerning which medications a GP would usually prescribe may vary from 
PCT to PCT. 
 
There are occasions when a drug classified as unsuitable for GP prescription in one PCT (a 
‗red‘ drug) may be considered appropriate for shared-care management and GP prescription in 
a co-terminus PCT (an ‗amber‘ drug). For example, the drug Pulmozyme contains the active 
ingredient dornase alfa. This drug is used by inhalation for cystic fibrosis patients. The traffic 
light category of this drug varies between PCTs. In Morecambe Bay PCT it is red,(60) in East 
Lancashire PCT (co-terminous with Morecambe Bay) it is amber.(61) Paediatric hospitals may 
take tertiary referrals and may therefore accept patients from a wide geographical area. The 
variability in PCT classification of drugs adds to the complications of agreeing long-term supply 
arrangements. Furthermore the GP or primary care prescriber may accept or decline this local 
advice, adding to the variation in the process. This is further complicated when the patient 
needs an unlicensed drug. An unlicensed drug is a medicinal product that does not have a 
marketing authorization provided by the MHRA, and therefore has not been approved by the 
regulatory authorities. Unlicensed drugs, which are frequently used in paediatrics, are usually 
classified as either amber (suitable under defined circumstances for GP prescription, or for 
shared care arrangements) or red (not suitable for GP prescription).  
 
The active ingredient of a medicinal product does not in itself determine whether the product is 
licensed or unlicensed. Omeprazole is one of the most commonly prescribed medicines in the 
UK and the manufacturers of omeprazole provides a number of formulations that are licensed in 
the UK, including oral dosage forms and injectable preparations. However an oral liquid 
preparation is not available from manufacturers that hold marketing authorizations. But an oral 
liquid preparation can be obtained if requested from a ‗Specials‘ provider. These companies will 
reformulate existing preparations on request. The resulting products will not be licensed in the 
UK and are often very much more expensive than the licensed formulations. A GP may 
therefore prescribe a medicine that is, in some formulations, licensed in the UK only for the 
dispensing pharmacist to supply an unlicensed product, if the patient cannot take or tolerate the 
licensed formulations. This scenario has particular relevance for children. A GP may continue to 
provide prescriptions for long-term medication whilst the patient requires a licensed product but 
may decline to prescribe should the patient need an unlicensed formulation; in which case the 
prescribing responsibility returns to the hospital consultant.(3) 
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Therefore who will prescribe the required drug may change not simply because of which drug is 
needed. Prescribers will also be influenced by which formulation the patient requires and in 
which PCT area the GP practice is situated. Predicting whether a patient‘s GP will prescribe a 
medication for a specific patient is at best a challenge. Hospitals providing services to patients 
from a number of PCTs, which is typical of paediatric hospitals, may therefore find it particularly 
difficult to predict when a GP will be willing to maintain the supply for a child. Approximately 1 in 
3 medicines provided by the Pharmacy at Birmingham Children's Hospital (BCH) are either 
unlicensed medicines or used outside of the license agreement (so called 'off-label' medicines). 
In general practice, at least one in ten medicines prescribed for children are off-label or 
unlicensed (62). Healthcare professionals should be aware that their own responsibility when 
prescribing unlicensed drugs is greater than when prescribing a licensed medicine within the 
terms of its license. According to the MHRA: (63)  
 
Prescribers should pay particular attention to the risks associated with using unlicensed 
medicines or using a licensed medicine off-label. 
 
According to Tomlin et.al. legal liability may also be an issue for prescribers since prescribing an 
off-label or unlicensed medicine carries a greater risk of legal liability to the prescriber if any 
harm occurs to the patient (this article cites Davis v Jacobs [1999] Lloyds Rep Med 72).(64) 
 
The interaction and co-operation between primary care clinicians and those in secondary care is 
complex and variable although drug choices in general practice are often guided by hospital 
specialists.(65) In 1994 the Audit Commission (66) estimated that 16-20 per cent of primary 
care prescribing was initiated in hospital and a further 40 per cent could also be strongly 
influenced by hospital consultants. 
 
Variations in the formulation of unlicensed medicines may add to complications by adversely 
affecting medication continuity; careful and timely communication is required if errors are to be 
avoid. Unlicensed medicines may be prepared to a wide range of formulations and provided to 
the patient in unfamiliar strengths - with potential for confusion over dose and therefore volume 
required for administration.(64) The usual requirement to alter dosage as a child grows 
complicates this issue. The lack of standardisation of 'Specials' medicines may lead to the 
children being provided with an unexpected presentation of the medicine - which may hinder 
access to the medicine and complicate administration, and may result in the patient receiving 
the wrong dose. Local experience is that many patients call upon the hospital to provide 
medication urgently because of supply / access difficulties elsewhere e.g. medication from their 
usual route of supply is unable to be provided before they run out. Either because they cannot 
get a prescription in time or they have a prescription but cannot locate a timely source of supply 
from a community pharmacy. 
 
These difficulties are illustrated in a recent survey (67) , which reported that 9 different liquid 
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formulations of captopril (unlicensed) were being used in 13 tertiary paediatric cardiac centres 
and their referring hospitals. Only 3 centres and their referring hospitals were using the same 
"special" liquid captopril formulations, and 10 centres and their referring hospitals were using 
completely different formulations. Three of the liquid formulations came from specials 
manufacturers, one from an NHS manufacturing unit, four were prepared "in-house" and one 
was imported from Australia; with further probable variations in community dispensing. This 
study concluded that:  
This degree of inconsistency raises issues about optimal captopril dosing and potential 
toxicity to a level where its use may influence paediatric cardiac –surgical and 
interventional outcomes.  
 
Once a prescription is obtained getting the medicine dispensed may also be problematic. 
Unlicensed medicines are unlikely to be held in stock by a community pharmacy unless held in 
anticipation of regular prescriptions for an existing patient. Obtaining an unlicensed drug either 
as a Special (made in the UK, according to the individual patient‘s needs) or as an import (a 
drug possibly licensed and commercially available in another country, but not in the UK) may 
take some time. A number of days may be required to obtain some unlicensed medicines in 
some circumstances. Such a time delay may be unacceptable clinically and the hospital 
providing the patient‘s secondary care may have no choice but to prescribe and dispense the 
medicines concerned, at least initially. One published study has quantified medication access 
problems within paediatrics.(68) During a three month period 338 patients discharged from a 
specialist paediatric hospital were prescribed 709 unlicensed or off−label medicines. Obtaining 
these medicines in primary care was a problem for a third of patients who could be contacted 
(72 of 216) and 25% of these patients report that some treatment disruption followed. This study 
concluded that there were two major problems: (1) community pharmacies being unable to 
supply; and (2) GPs' refusal to prescribe. 
 
A patient or their carer with a prescription that cannot be dispensed quickly in the community 
pharmacy may consider requesting that the hospital pharmacy dispenses the item(s). However, 
many hospital pharmacy departments may not be in a position to legally dispense GP 
prescriptions per se. Many hospital pharmacy departments are not registered with the regulatory 
body as a Pharmacy and the few of those that are will not usually possess a Pharmaceutical 
Contract in order to legally dispense GP issued prescriptions and claim payment for doing so. In 
order for the hospital to provide the GP prescribed medicine it may therefore be necessary for a 
hospital prescription to be written before the hospital pharmacy may dispense the item. It should 
be noted that in extreme circumstances a small number of hospital pharmacy departments have 
indicated that they would be willing to provide medicines prescribed by a GP on an NHS 
prescription (commonly called an FP10) on humanitarian grounds. In the West Midlands region 
the cancer network has indicated that there are two hospital pharmacies offering this 
service.(69) 
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Whilst GP prescriptions would normally go to the community pharmacy for dispensing, hospital 
prescriptions for out-patients may follow other paths. Hospital prescribed continuing-care 
medication may be prescribed on ‗internal‘ hospital prescriptions or on so called FP10 
prescription forms, and patients may commonly obtain medicines from three sources:  
a. Hospital Pharmacy  
b. Community Pharmacy  
c. Homecare provider  
 
Since children and their caregivers may travel some distance for hospital specialist care options 
b. or c. may often be the favoured route after the initial consultation. Yet the community 
pharmacy may not always be in a position to provide the medicine within the appropriate time 
frame. Figure 2 describes the out-patient prescription pathway at BCH. 
 
Accurate and timely communication between all health care professionals involved in the 
medication process (prescribing - dispensing - administration of medicines) is required to avoid 
error and ensure continuity of medication, including that between hospital consultants and GPs. 
 
Figure 2 The out-patient prescription pathway at Birmingham Children‘s Hospital 
 
 
1.3.3. Admission and discharge 
 
Patients may be admitted to hospital as either a planned (elective) admission or as an 
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unplanned (emergency) admission. Whilst a planned admission may include some 
communication from the GP as to the current medicines being taken by the patient, until 
recently there were no national standards to guide this process and the quality of information is 
at best variable.(70) There are a number of publications which consider essential medication 
information transfer on admission.(3, 4, 6, 32, 71-73) 
 
Many patients leaving hospital after an in-patient episode will be the subject of a form 
highlighting their current medication. These forms are often called TTOs (to take out – 
medicines) or TTAs (to take away - medicines) and are typical of an ‗early discharge letter‘. 
Their purpose is two fold. First to authorize the dispensing or release of medications for the 
patient when they leave hospital and secondly to act as an early method of communication to 
the patient‘s GP to show which medicines the patient should continue taking. These forms are 
also used in some NHS hospitals as the major prompt to claim income from the patient‘s PCT 
for the episode of care provided. The quality of information provided by these forms has been 
criticised and discharge arrangements are discussed in a number of publications. (3-5, 13, 14, 
16, 56, 62, 63, 68, 72, 74-79) 
 
The 1991 guidance provided by the Department of Health (3) concerning prescribing 
arrangements between hospital and primary care, confirms that prescribing responsibilities rest 
with the doctor who holds clinical responsibility for the patient. After discharge hospital 
prescribers may retain the responsibility for some medicines and therefore may be obliged to 
maintain medication supplies by providing prescriptions for patients who have been discharged 
from hospital. Studies within the Service Delivery and Organisational Research programme 
have confirmed that patient transfer between primary and secondary care (in either direction), 
when there is a change of usual professional providing care, is a key risk factor for the 
breakdown of continuity of care.(71)  Good inter-professional communication is an important 
consideration if the risk to paediatric patient safety is to be minimised.(72) 
 
Both primary and secondary care organisations are cash limited. That is, they have a finite 
budget with which to provide their services. It is possible therefore that there are financial 
incentives for both sectors to pass the prescribing responsibility, and therefore expenditure, on 
to the other. PCTs are the major source of income for NHS hospitals. The money that hospitals 
receive is dependent on the amount and type of work they do. The payment rates are largely 
fixed by a national tariff and the current process is termed ‗Payment by Results‘ (PbR).(80)  It 
should be noted that some services are excluded from PbR arrangements and costs can be 
negotiated locally, and is a source of additional income for the provider. Continuing care (81) is 
one such exception. In effect the hospital may cross-charge the PCT for the costs of providing 
‗continuing care‘ including long-term medication. The hospital may charge for the process as 
well as the direct drug costs, so long-term medication provided by the hospital may cost the 
NHS more than if it were being provided in primary care. 
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1.3.4. Seamless care in England 
 
Seamless care is the term often applied to integrated medicines management processes as 
experienced by a patient when they are admitted and discharged from hospital. During this 
process the responsibility for the patient‘s medicinal and pharmaceutical needs transfers from 
primary healthcare services to secondary healthcare services and back again. Ensuring that this 
process works well is important for the clinical care of the patient. A definition of seamless care 
was provided by Canadian pharmacy organisations (82) in 1998 as: 
The desirable continuity of care delivered to a patient in the health care system across the 
spectrum of caregivers and their environments. Pharmacy care is carried out without interruption 
such that when one pharmacist ceases to be responsible for the patient‟s care, another 
pharmacist or health care professional accepts responsibility for the patient‟s care. 
 
There are fundamental differences in the processes to ensure seamless care between the 
countries of the UK. For example patients discharged from hospitals in Northern Ireland will not 
be provided with take-home medicines (TTOs) and must rely on sourcing supplies of medicines 
immediately from primary care services.(83) This is in contrast to discharge from English or 
Welsh hospitals where a supply of take-home medicines is integral to the processes designed to 
ensure seamless care. 
 
A number of important national documents have been produced in recent years to support 
seamless care in England. These documents include: 
 
 Moving patients, Moving Medicines, Moving Safely. Guidance on Discharge and 
Transfer Planning.(16) Published in 2005-6 by a number of national Pharmaceutical 
bodies the document, and the accompanying workbook, aims to: “… provide practical 
guidance in developing systems to tackle discharge and transfer problems between 
different settings and is based on experiences and evidence available, including 
examples and paperwork from existing schemes.” It is noteworthy that these documents 
focus on discharge planning and provides little guidance on admission arrangements. 
 
 PSG001 Technical patient safety solutions for medicines reconciliation on admission of 
adults to hospital.(17) This publication was the first patient safety guidance produced 
jointly by NICE and NPSA. It was published in December 2007. This guidance supports 
the introduction of medication reconciliation for adults on admission to hospital. The 
exclusion of children from this guidance has prompted a major line of enquiry within this 
research programme. 
 
 Medicines Reconciliation: A guide to implementation (70) was published by the NPC in 
March 2008 and aims to support the delivery of medication reconciliation as a patient is 
admitted and discharged from hospital. This document defines for the first time a 
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nationally recognised minimum dataset for transfer of essential medication information 
between primary and secondary care. 
 
 Medicines Adherence: involving patients in decisions about prescribed medicines and 
supporting adherence was published by NICE in January 2009.(84) This work 
acknowledges that patients may be under the care of healthcare professionals from 
different disciplines and specialties at the same time. Responsibility for patients‘ care 
may also be transferred between healthcare professionals. The document comments 
that: “Good communication between healthcare professionals is needed to ensure that 
fragmentation of care does not occur.” and encourages the development of robust 
processes for communicating between healthcare professionals involved in the patient‘s 
care. 
 
 Managing patients' medicines after discharge from hospital (14) was published by the 
Care Quality Commission in October 2009. This document provides advice on 
managing both admission and discharge and focuses on audits conducted in 12 
different PCTs. This work also introduces the summary care record designed to 
encourage the transfer of essential patient medication information between the sectors. 
The document highlights the responsibility of GPs in providing information to acute 
Trusts on admission of their patients to hospital and comments: “GPs and PCTs need to 
agree expectations for the information provided to acute trusts ... as it is so critical to 
safety” and "PCTs need to ... take action when GPs do not meet expectations ..." This 
document was published at the end of the data collection period of the studies 
described in this thesis but confirms important current and future national expectations 
concerning key aspects of medicines management between the healthcare sectors. 
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2. Scheme of Study 
 
This programme of research focuses on key aspects of the practical arrangements for 
medicines management in place across the primary – secondary healthcare interface for 
paediatric patients. Primary care in this context is limited to PCTs and their contractor 
professionals dealing with medicines and in particular GPs and community pharmacists. 
Secondary care includes the NHS hospital sector, incorporating tertiary care where that is also 
provided by a secondary care provider. Medicines management arrangements within social 
care, schools, the voluntary sector, or that provided by non-medical prescribers per se are 
outside the scope of this research programme. 
 
A diagnostic of the care pathway for children on admission and discharge to hospital has not 
been undertaken within this programme of research. Such diagnostics, often using lean 
methodology, are used by NHS organisations with multi-disciplinary healthcare professional 
involvement to redesign service delivery. Rather than use the lean-diagnostic methodology to 
identify service aspects for redesign, this research programme uses a comparison of medicines 
management documents in the two sectors to identify key interface issues where there appears 
to be a difference or a disparity in emphasis. Chapter 6 describes this process in detail and key 
findings. Based on this approach two key aspects of medicines management for children at the 
healthcare interface have been investigated. These are: 
 
1. Access to medicines for patients outside hospital requiring long-term medication. 
2. Continuity of care as a patient moves from primary care to secondary care and (usually) back 
to primary care. 
 
Access to medicines in this context has two major components – i. obtaining prescriptions and 
ii. getting these prescriptions dispensed so that the intended therapy is not compromised by 
delays in obtaining the medication and therefore treatment interruption. Continuity of care will 
centre on communication of medication arrangements between healthcare professionals in the 
two sectors and their patients (or their carers) and particularly during admission to hospital. 
Whilst the medicines management communication arrangements for adults are relevant to this 
work the main focus will be on paediatric patients. Service improvements in these two areas 
may reduce clinical risk. Errors in prescribing and administration of medicines to children are at 
least as common as in adults. However, the consequences of these errors can be more serious 
for children.(62) 
 
The overarching hypothesis of this research is that medicines management across the primary 
– secondary healthcare interface for paediatric patients is sub-optimal in the two focus areas, 
and current systems and processes can be improved. 
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Aims of this programme of study include: 
 
1. To identify circumstances where medicines management systems across the interface 
are variable between the healthcare sectors and may compromise patient care (Chapter 
6). 
 
2. To investigate key aspects of medicines management systems across the interface, 
where there are identifiable concerns (Chapter 7 and 8 – continuity of care and in 
particular transfer of essential information on admission, Chapters 9 to 12 – access to 
long-term medication for paediatric home patients). 
 
3. Based on this programme of study to make recommendations for changes to medicines 
management systems across the interface. 
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3. METHODS 
 
3.1. Analysis of medicines management documents from 
NHS organisations in the West Midlands 
 
This method was used to compare medicines management documents used by NHS 
organisations in the West Midlands Regional Health Authority, and specifically to identify 
differences relating to interface medicines management issues between the two main sectors: 
primary care and hospital care. A preliminary study (2007) was used to inform latter stages of 
the research programme and served as a baseline to identify changes in the documents over 
time. 
 
Two sets of documents were obtained: initially in early 2007 and then later in the summer of 
2009. 
 
3.1.1. Preliminary study 2007 – document collection 
During December 2006 and January 2007 a purposive sample of seventeen NHS bodies 
including Primary Care Trusts (7) and NHS (Hospital) Trusts (10) in the West Midlands health 
region were contacted and a copy of their then current Medicines Management Strategy or 
Policy requested. Personal contact was made with each Head of Medicines Management 
(PCTs) or Head of Pharmacy (Hospital Trusts) to make the request. The 17 organisations were 
all regularly represented in cross-sector pharmacy meetings organized at the time of the study 
by the West Midlands Strategic Health Authority. 
 
3.1.2. Main study 2009 – document collection 
An email request for relevant documents was sent to the most senior pharmacist (usually Chief 
Pharmacist or Head of Medicines Management or equivalent) of each of the NHS organisations 
in the West Midlands. See Appendix 1.  
 
The wording of this request was piloted on 8
th
 June 2009 with 3 PCT Chief Pharmacists and 1 
Acute Trust Chief Pharmacist, 3 of whom confirmed that this was suitable wording to obtain the 
appropriate documents for the study. No response was received from one pilot (PCT Chief 
Pharmacist). 
 
Recipient email addresses were obtained from existing NHS distribution lists and sent 
commencing 6
th
 July 2009 from the office of the regional lead pharmacist for medicines 
management at the request of the lead researcher. A first reminder was similarly sent by email 
to non-responders on 21
st
 July 2009. Further reminders if necessary were made by personal 
telephone call to the recipient with data collection closed on the 14
th
 September 2009.  
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3.1.3. Document analysis 
The documents to be analysed were imported into NVivo software (v8, ESR international). The 
following process was followed for the analysis: 
 
1. A preliminary coding frame was determined by: i. examination of medicines 
management documents obtained during the preliminary study and ii. interface issues 
of interest identified by the lead researcher and supervisors e.g. medication on 
admission to hospital. The coding frame was entered as free-nodes into NVivo. 
2. Each document was imported into NVivo as an internal source and each in turn was 
examined and any text relating to codes identified and recorded. Further codes were 
added as new issues were identified within the documents. 
3. After the above was completed each document was searched electronically for key 
terms relating to each of the now expanded coding frame, to ensure all relevant text 
was selected. For example, the code ‗one-stop dispensing‘ prompted searches for the 
terms: ‗stop‘; ‗one-stop‘; and ‗discharge‘ (as in the phrase ‗dispensing for discharge‘). 
4. The text for each individual code was selected for all documents and was then 
examined in turn. This was done to ensure consistency of selection and to aid 
refinement of code definitions. For example: the code ‗Access to Medicines‘ was refined 
so that physical access to medicines in each organisation was excluded. That is, text 
relating to drug cupboards was not considered relevant to this code within the context of 
the study. 
5. MS Excel 2003 was used to create a spreadsheet of results from NVivo, including the 
frequency of occurrence of each code within each document. 
6. Results were transferred to SPSS-PASW 18 for the production of descriptive statistics 
and significance testing. 
 
 
3.2. Focus Groups 
 
Two focus groups were undertaken within this programme of study. These were: 
 
1. A group to consider CP dispensing of hospital prescriptions (CP focus group) 
2. A group to consider management of home-patients requesting urgent medication from 
hospitals (Medical staff focus group) 
 
3.2.1. Community pharmacy focus group 
This focus group was designed to support the development of the community pharmacy 
questionnaire (see Chapter 12) investigating aspects of hospital generated prescriptions being 
dispensed by CPs. Group members were convened to ensure input from community 
pharmacists, hospital pharmacists, pharmacy management (both in community and in hospital) 
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and academic pharmacy practice. 
The focus group took place on 27
th
 February 2009 when the following met: 
 
AS (hospital & community experience, and senior management) 
KW (Academic pharmacy & pharmacy policy maker) 
JM (Academic pharmacy) 
FL (Community pharmacy, middle management) 
AH (Community & hospital experience at practitioner level) 
CN (Hospital experience & as a community pharmacist locum) 
DT (Hospital & community pharmacy experience, senior management in hospital and PCT) 
 
A semi-structured meeting guide was developed including questions to be placed by the 
facilitator to ensure coverage of pre-determined themes identified by the project support team 
(DT with JM, AS, KW), otherwise free conversation was encouraged to stimulate a wide-ranging 
discussion. Questions were designed to identify views and perceptions, types of problems and 
quantification, problem resolution and suitable service changes. 
 
Questions included: 
1. What is your own experience of dispensing hospital prescriptions in CP? 
2. What types of issues occur? 
3. How common are problems? 
4. How do you resolve problems and what barriers are there to these methods? 
5. What can be done to improve service arrangements and minimize problems? 
6. What support exists for CPs dispensing hospital prescriptions? 
 
This focus group provided 12,785 words of text from which 42 codes were defined against 
which a total of 164 references were recorded. The figure below shows a screen shot of NVivo 
being used for this purpose. 
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Figure 3 Screen shot of NVivo software in use to analyse the CP focus group 
 
 
 
The codes were then grouped into themes to inform the development of the survey. These 
were: 
1. Obtaining further information. 
 
a. Patient may be accessible to consult with the CP - but are they a reliable source to 
solve script problems? CP may rely on patient opinion / information? 
 
b. Problems identifying hospital prescriber? Leads to audit trail / PMR problems. 
 
c. Hospital prescription problem referred back to GP? 
 
d. Are there occasions when problems discussed with the prescriber (GP) are referred 
to the hospital consultant? Are some GP prescriptions changed by CPs after 
discussion with hospital? 
 
e. Do community pharmacy standard operating procedures require confirmation of 
unlicensed / off-label prescriptions with prescriber? 
 
f. Who wrote the hospital prescription ... often difficult to identify. What happens when 
you cannot contact the prescriber? Governance issue not being able to identify 
prescriber - driven by inadequate allocation of identifiers? 
 
g. In what order would a CP go to for advice on a hospital prescription ... patient ... GP 
... hospital prescriber ... medicines information? 
 
h. Dose / regimen confirmation issues. How to confirm? 
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2. Support for CPs. 
 
a. Support for CPs? Training event; guidance for problem solving hospital 
prescriptions; resource sign-posting; fax back for help. Would CPPE be 
interested? 
 
b. Hospital provided support ... e.g. website but would it be used? They can ring 
medicines information anyway ... how often does this happen? Hospital 
prescription problem ... ring this number?  
 
c. Centralised IT / communications e.g. read pharmacy PMRs from other sectors? 
 
d. Returning prescriptions to hospital for endorsement may present problems? 
 
e. Create section in community pharmacy standard operating procedures for 
dealing with hospital prescriptions? What exists already? 
 
f. Teaching (hospital) prescribers how to prescribe? 
 
g. Should hospital prescribers say which number to ring in the event of problems 
e.g. a hot line? 
 
h. Should there be a fax back option? 
 
 
3. Hospital prescription problems 
 
a. Is the frequency of problems on hospital prescriptions higher than those written 
in primary care? Estimation? 
 
b. Most hospital prescriptions are hand-written - which may introduce problems? 
What problems and frequency? 
 
c. Are hospital prescriptions more complex than GP prescriptions? What do we 
mean by complex? More work? 
 
d. Hospital prescriptions problems - in what ways are they different ... types & 
frequencies compared with GP prescriptions? 
 
e. Off-label use. Means outside standard texts therefore problem in confirming use 
/ dose. 
 
f. How often is there missing information on hospital prescriptions... could look at 
a large number and summarise? 
 
g. Do CP‘s record interventions? 
 
 
4. Practical issues. 
 
a. How confident are CP in dispensing hospital prescriptions? 
 
b. Do hospital prescriptions take longer to do? How much longer? 
 
c. Should hospitals be allowed to issue prescriptions for community dispensing? Is 
there national guidance on when they should be used? 
 
d. Should GP prescriptions indicate its prescribed on advice from ... hospital? 
What if it is? 
 
 Page 39 
e. Locums - additional problems ... lack of continuity? 
 
f. Should all hospital out-patient prescriptions be on FP10's to maximise patient 
choice? Conversely should all out-patient prescriptions be hospital only, 
possibly due to reduced risk / access delays? 
 
g. Is patient confidentiality adversely affected by dispensing by CP in comparison 
to hospital dispensing (e.g. hospital staff will know it has a HIV clinic in 
session)? Is the CP more familiar with patient? 
 
h. Is there a reluctance to challenge hospital prescriptions? More so than for GP 
prescriptions? 
 
i. Specials - delays in obtaining specials, increased costs, confirmation with 
prescriber, etc. 
 
3.2.2. Medical staff focus group 
This focus group was designed to support the development of the hospital medical staff 
questionnaire (see Chapter 9) investigating aspects of supporting home-patients requiring 
urgent medication. Group members were convened to ensure input from consultants and junior 
medical staff from a range of specialties and with various levels of experience. 
 
The focus group took place on 5
th
 October 2009 when the following met: 
HM – Registrar Paediatric Respiratory Department 
SA – Senior Registrar Paediatric Neurology (later Consultant) 
PD - Consultant Paediatric Rheumatology 
CM – Clinical lead Paediatric Dermatology 
 
The group was facilitated by the lead researcher. 
 
As for the CP focus group a semi-structured meeting guide was developed including questions 
to be placed by the facilitator to ensure coverage of pre-determined themes identified by the 
project support team (DT with JM, AS, KW), otherwise free conversation was encouraged to 
stimulate a wide-ranging discussion. Similarly questions were designed to identify views and 
perceptions, types of problems and quantification, problem resolution and suitable service 
changes. 
 
Questions included: 
1. What is your experience of problems your patients have getting medicines when they 
have left the hospital?  
2. What types of problems occur? 
3. How common are these problems? 
4. Are these problems specific to paediatrics or are they more widespread? 
5. How can the problems be resolved? 
6. What issues are there for GPs prescribing long-term medicines for children? 
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7. Are there training issues for prescribers? 
8. What practical changes to the system can be identified that will reduce problems? 
 
This focus group provided 9,225 words of text from which 40 codes were defined against which 
a total of 129 references were recorded. Finally the codes were grouped into themes to inform 
the development of the survey. These were: 
 
1. Issues with GP 
 
a. Communication poor 
b. ―If you agree please supply …‖ letter 
c. Electronic communication 
d. Follow-up appointments 
e. GP receptionist – patients may have problems getting to the GP 
f. GP refuses to prescribe 
g. Repeat prescriptions 
h. GP quantity too small – so patient runs out. 
i. Interface rules unclear 
j. System failure  
 
2. Issues with CP 
 
a. CP supply issues 
b. Change prescriptions 
c. Support for CPs e.g. where to get drugs 
 
[Also – from CP questionnaire the adoption of suggestions for greater clarity on 
prescriptions.] 
 
3. Duration of supply on FP10HPs  
 
a. Length of supply – inadequate on hospital prescriptions, which may run out 
before GP can take over prescribing? 
 
4. Prescriptions 
 
a. Electronic prescriptions 
b. Formulation issues 
c. Out-of-hours access to information 
d. Posting out prescriptions 
e. Prescribing responsibility 
f. Unlicensed medicines 
g. Teaching students how to prescribe 
h. Formularies 
 
5. Financial issues 
 
a. Financial aspects of continuing supply 
 
 
6. Communication with other hospitals 
 
a. Hospital doctor refuses to supply 
 
7. Parent-caregiver issues 
 
a. Instructions to parents e.g. don‘t run out 
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b. Patient hot-line 
c. Use hospital as if we were primary care 
d. Urgent requests e.g. rescue-medication 
 
8. Nurses 
 
a. Nurse involvement in access to medicines 
b. Nurse prescribing 
 
3.2.3. Analysis of focus groups 
The meetings were individually audio-recorded and professionally transcribed by a trained and 
experienced medical secretary into MS Word and checked by the facilitator (DT) for errors or 
omissions. On each occasion the facilitator revised the spelling of some technical descriptions. 
Participants were anonymously identified within the text (e.g. speaker 1, speaker 2 etc) to 
ensure the extent to which views were shared could be identified. Each participant was 
identified within the analysis as individual ‗cases‘ to facilitate cross reference. 
 
The transcripts were analysed using NVivo software (v8). Concerns and issues identified by 
participants were coded as free-nodes. All text within each code was re-examined and codes 
refined if necessary. A coding summary and themes structure was generated and used to 
inform the development of the survey instruments.  
 
 
3.3. Questionnaire design and management 
 
This programme of study led to the development of a series of surveys, where the survey 
instrument was a purpose designed questionnaire. These were: 
 
 PCT survey 2007 (Advice to GPs concerning admission medication) 
 PCT survey 2009 (Advice to GPs concerning admission medication) 
 Medical staff survey 
 Nursing staff survey (6 sites) 
 Caregivers‘ survey (rescue-medication) 
 Community Pharmacy survey 
 
A description of the methods used to develop each survey instrument is provided below. 
 
3.3.1. Methods for PCT surveys 
 
Two survey instruments were used to meet the aims of the study. The first survey was 
conducted in 2007 and the follow-up study in 2009. 
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The PCT Survey 2007 
Email was chosen as the medium for the 2007 survey. Conducting this survey by post would 
have taken longer and would have required more resources to prepare, deliver and record the 
responses, and would have added to the costs. Similarly a telephone survey was also rejected 
since approximately 150 subjects would need to be contacted and this would have been both 
time consuming and added to the costs of the study. However a list of email addresses of all 
subjects (Heads of Medicines Management, or similar, at all English PCTs) was not readily 
available and an email distribution list was assembled for the purpose of the study. An email 
address list from a local PCT was used as the basis of the subject address list and this was 
revised by telephone discussion with all PCTs not included in the original address list. The main 
switchboard of the PCTs was contacted using the telephone number listed for their organisation 
on their website. No PCT declined to provide the email address although a number were 
unclear as to who was currently the Head of Medicines Management or Lead Prescribing 
Advisor, often although not exclusively, as a result of PCT mergers.  
 
The 2007 survey was designed as an email with questions incorporated within the text of the 
email itself. The survey included 5 questions or opportunities to comment or respond. Using an 
electronic survey would have offered some potential advantages in terms of both data collection 
and response limits however it was uncertain at the time how acceptable this type of instrument 
would be to the participants and the opportunity for direct email dialogue with the lead 
researcher may also offer advantages. 
 
The 2007 questionnaire was piloted with the assistance of two senior PCT pharmacists (lead 
pharmacists for medicines management in their PCTs – JHo, JHa) and the then regional 
primary care advisor (NB).  
Suggestions for improvement included: 
1. setting out the background and potential benefits to all concerned in more detail 
2. rather than use post-discharge and published guidance as the first sentence, focus on 
the reasons why you are looking at what you are looking at and the advantages to you 
AND primary care of sorting out the system. 
 
Modifications to the introduction to the questionnaire were made as a consequence.  
Other aspects of the development and delivery of the questionnaire are shown below. 
 
 National Research Ethics Service (NRES) was consulted and confirmation that this 
study was ‗service evaluation‘ and did not therefore require formal ethics approval was 
received by email on 14th May 2007. 
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 The final 2007 questionnaire was sent to all Heads of Medicines Management or Lead 
Prescribing Advisors of Primary Care Trusts in England via personal email to named 
recipients. At the time of this study there were 149 PCTs in England. However five 
PCTs were led by a single prescribing advisor and hence the questionnaire was sent to 
145 recipients. 
 
 The 2007 questionnaire was first sent out on 22nd May 2007.  
 
 A total of 51 (35%) did not reach the intended recipient at the first attempt for the 
following reasons (and frequency): Mail box full ( n=1); Failed delivery (n=1); Does not 
exist (n=13); Not reached (n=1); Not recognised (n=7); Unknown (n=1); Unroutable 
(n=27). A series of further telephone calls to PCTs were conducted in order to clarify 
email addresses. Repeat (first) emails failed on the second attempt on nine occasions 
(including 1 x mail box full). All were successful at the third attempt. 
 
 A reminder was sent to non-responders +14 days and then + 21 days after the first 
successful email. 
 
 The questionnaire was sent from David Terry as Operations Manager - Pharmacy at 
Birmingham Children‘s Hospital. 
 
The introduction to the questionnaire is shown in Appendix 2. 
 
Respondents were advised that the questions only required a yes or no answer, although longer 
answers were welcome. Where longer answers were provided these were coded to either yes, 
no or unclassified by the lead researcher in consultation with academic supervisors. 
A schematic of the questionnaire is shown in Appendix 2. 
 
The PCT Survey 2009 
The 2009 survey was sent as an electronic questionnaire using LimeSurvey software version 
1.71+ (5498). Whilst the 2007 email-free-text survey tool elicited a useful response, some 
advantages of using an electronic survey were identified. For example, the electronic tool 
requires the respondent to self code responses according to the options provided. The 
electronic capture of data also enabled data analysis to be less labour intensive since 
responses were directly uplifted into SPSS.  
 
However, the expected benefits of email handling with the electronic survey were not realised 
due to NHS email filtering arrangements usually called ‗grey filtering‘. Unauthorised emails with 
non-NHS approved email characteristics are denied delivery to NHS recipients. The exact 
arrangements and filter settings are defined by each NHS organisation. During testing it was 
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identified that grey filtering may be applied to the emails carrying the link to the survey, since 
they originate from Aston University where the server is situated for the LimeSurvey software. 
Permission could have been sought from each recipient‘s organisation to authorise the delivery 
of the emails, but this was considered impractical with 146 different organisations involved. In 
many instances grey filtering can be overcome by repeat sending the email. That is, send the 
email once and then send it a second time 10 to15 minutes after the first. However, it was 
uncertain how often this would work and how often a recipient would receive the request to 
participate twice. Because of the grey filtering issue it was decided to send the links to the 
survey directly from the researcher‘s own NHS email account. This required extracting the 
individualised hyperlinks from LimeSurvey and sending the correct link to each individual 
recipient via personal email. Since the automated email system within LimeSurvey is now by-
passed the email invitations also had to be modified to include appropriate text giving the 
recipients background information and instructions to use the hyperlink. This process was 
managed using an MS-Excel spreadsheet constructed for the purpose. Similarly since 
LimeSurvey software had not ‗issued‘ the invitation it also did not record the delivery details of 
the response, although it did record the answers provided to the survey questions. A different 
strategy was adopted for some later sites of the Clinical Nurse Specialists‘ survey using 
LimeSurvey – see Chapter 10. 
 
The 2009 survey was sent to all PCT lead pharmacists for medicines management with repeat 
emails at + 1 week and + 2 weeks for non-responders. The invitation text is shown in Appendix 
3. 
 
The 2009 survey was developed using the 2007 survey as a template in discussion with 
academic collaborators and sent in early September 2009 as a pilot to 3 PCT Heads of 
Medicines Management for their consideration (LT, JH, MH). Following their comments minor 
changes were made to the welcome page of the electronic survey. 
 
Changes to questions in the 2009 survey in comparison to the 2007 survey are highlighted in 
the survey schematic shown in Appendix 3. The 2007 survey also included the question: Q3. If 
you send guidance are you willing for your PCT to be identified within any report? But this was 
omitted from the 2009 survey. Based on the few responses received in 2007, and ambiguous 
replies, it was agreed that permission to identify if necessary would be requested directly from 
the PCTs concerned. 
 
On 14th September 2009 the head of Research & Development at BCH confirmed that this 
study was in the category of clinical audit/service evaluation and therefore no further application 
for formal ethics consideration was required or made. 
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The results obtained from this survey can be found in Chapter 8. 
 
3.3.2. Methods for Medical staff survey 
 
An electronic survey tool was chosen as the instrument for this study. The study cohort 
comprised of all medical staff employed at the time of the study by BCH. All subjects had Trust 
email addresses and internet access administered by a single NHS organisation. Management 
of this survey by the use of purpose designed electronic survey software was therefore 
considered to be both deliverable and efficient. The problem of grey filtering was discussed with 
the organisation‘s Information technology department who offered assistance if this prevented 
delivery of the survey. 
 
The questionnaire development was supported by the medical staff focus group and the 
community pharmacy focus group. The community pharmacy focus group identified some 
actions that prescribers may take to support community pharmacists when dispensing hospital 
generated prescriptions and these were included in the survey. For example, a question was 
included to ask the doctors if they would be willing to use pre-inked stamps to show their contact 
details on FP10 prescriptions they sign. This question was included in the medical staff survey.  
 
The themes and issues identified in the two focus groups were considered for inclusion in the 
survey, including for example the need for further training. The development was also informed 
by the nursing staff questionnaire that had been finalised before the medical staff survey. 
 
A draft medical staff questionnaire was created on 7
th
 December 2009 using LimeSurvey 
Version 1.71. This professional survey software posed a number of practical problems. For 
example the text SCRIPT is a protected word in LimeSurvey to facilitate data handling. In 
practice it is not possible to have the word PRESCRIPTION appear in capitals in the survey text, 
since the text string ‗script‘ always appears in lower case, such that the output becomes 
PREscriptION. The program also centres all text, so that the opening introductory text is always 
centred. It would have been usual to left align this block of text (whole paragraphs) but a 
solution to the centre all problem could not be identified after taking expert advice. 
 
The draft questionnaire was piloted with the four doctors who attended the medical staff focus 
group (CM, HM, PD, SA) and with academic supervisors (KW and JM) and the head of R&D at 
BCH. A number of comments were received leading to changes in the survey instrument. These 
included: 
 Question 7 – add ‗Not applicable‘ option 
 Question 9 – add ‗Not applicable‘ option 
 Section B text – change word ‗frequency‘ to uppercase (to add emphasis) 
 Section C text – change some wording to uppercase (to add emphasis) 
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 Question 12 – reverse order of options 
 Question 18 to 20  – add ‗Don‘t know‘ options 
 
The resulting second draft was sent to a further group of medical staff for comments (BW, ME, 
FR, VD, IW). Further changes included: 
 Question 6 – question re-worded 
 Question 21 – comments box added 
 
The final 30 point survey tool included: respondent demographics; frequency of prescribing, 
including for home-patients; reasons for medication access problems; interaction with 
community pharmacists and improving current arrangements.  
 
The final survey was confirmed as service evaluation by the head of Research and 
Development of Birmingham Children‘s Hospital (BCH) and was registered as an audit at this 
institution. Formal ethics committee approval was not required or requested. 
 
The survey was tokenised to ensure that one invitation elicited one response only. 
 
Email addresses were obtained with permission from the organisation‘s personnel officers 
responsible for medical staff. The electronic list (Excel) was converted to a CSV file to enable 
uplift into LimeSurvey. 
 
The invitation to participate was sent from LimeSurvey to the NHS Trust email addresses of the 
study cohort with a link to the survey. First emails were sent out on 25
th
 January 2010, with 
reminders at +2 weeks and +3 weeks if necessary. Final responses were received on 24
th
 
February 2010. A total of 84 email addresses failed at the first attempt. 66 were corrected but a 
further 2 failed again at the second attempt. A total of 20 from the original list were therefore 
removed from the study. 
 
Responses were exported from LimeSurvey into MS Excel 2003 and SPSS v16 for analysis and 
production of descriptive statistics. 
 
 
3.3.3. Methods for Nursing staff surveys 
 
An electronic survey tool was chosen as the instrument for this study. The study cohort 
comprised of all the Clinical Nurse Specialists (CNS) and Advanced Nurse Practitioners (ANP) 
employed at the time of the study by BCH and then later the same staff groups at the other 5 
study sites. As in the medical staff survey all subjects within a single Trust had organisation 
specific email addresses and internet access administered by a single NHS organisation. 
Management of this survey by the use of purpose designed electronic survey software was 
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therefore considered to be both deliverable and efficient. 
 
An electronic survey tool was constructed with the support of an ANP (AD). The 12 point draft 
questionnaire was piloted with 6 members (KH, NF, AP, BC, AK, AD) of the study cohort who 
provided the following comment: 
 The start of section B.  The instructions are quite difficult to follow - complex sentences.  
Even though I know what it‘s about, I found it difficult to decipher what was wanted.  It 
also ends with the phrase answer the questions below - better following questions.  On 
one of the questions there is the phrase GP prescribe. It‘s not really clear what this 
means. 
 
Changes to the text of section B of the survey and Question 11 were made accordingly. For 
example Question 11 wording was changed from ―Require GPs to prescribe‖ to ―Require GPs to 
prescribe all medicines‖.  The text of the invitation email was also amended. See Appendix 8. 
As described for the medical staff survey there were practical problems with LimeSurvey with 
the word ‗script‘ and with text layout limitations. 
 
The survey was tokenized to ensure that one invite elicited one response only. 
 
Recipient BCH email addresses were obtained from staff records with permission of the Chief 
Nurse. The electronic list (Excel file) was converted to a csv file and imported into LimeSurvey. 
For the BCH site 9 email addresses failed at first attempt. Of these 1 was amended and was 
successfully delivered at the next attempt, 5 nurses had left the Trust and emails were deleted, 
2 email boxes were full, 1 was not resolved. 
 
The final questionnaire was sent to NRes for ethics considerations on 24/09/08 who expressed 
the opinion that the survey constituted service evaluation and that formal ethics committee 
approval was not required. 
 
The invitation to participate was sent to the BCH email address of the study cohort with a link to 
the survey. First emails were sent out on 29th September 2008. All recipients received two 
reminders if necessary at approximately weekly intervals. 
 
After the successful completion of the BCH nurse survey the study was extended to other sites 
in the UK. Further sites were chosen because of their leading role in paediatrics within their 
region (country) including: Belfast, Glasgow and Cardiff. Two further sites were included from 
England to ensure that results were obtained from another geographical area with a specialist 
paediatric hospital (Sheffield) and to ensure participation of a large paediatrics unit within a 
large Trust (Leeds). 
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The Chief Pharmacist (or equivalent) of each of the additional 5 sites was initially contacted who 
each gave their support for the study. A project proposal was then sent to the Chief Nurse or 
equivalent for their consideration and permission to survey their staff. The proposal included a 
sign off sheet giving authority to proceed and confirmed that NRes considered the study to be 
service evaluation. Permission to conduct the study was received in writing from each site 
before proceeding. 
 
Email addresses were provided by the study sites which were uplifted into LimeSurvey. The 
survey tool was individualized for each study site e.g. replace the text Birmingham Children‘s 
Hospital or BCH with Sheffield Children‘s Hospital or SCH, as appropriate. Within LimeSurvey 
each site survey was held as a separate file. Undeliverable email addresses were managed as 
for BCH. Grey filtering problems were encountered for the first time when sending the survey to 
Leeds in June 2009 and then for the later study sites Cardiff, Glasgow and Belfast. To 
overcome this problem, initial email invitations were sent twice within about 15 minutes of one 
another. The text of the invitation was modified to include the sentence: 
 
Please accept my apologies if you receive this survey invitation twice. NHS email 
filtering arrangements (grey filtering) sometimes makes this inevitable. 
 
3.3.4. The caregivers’ survey (rescue-medication) 
 
A survey tool was constructed to identify the experiences of caregivers who requested rescue-
medication directly from the Pharmacy Department of BCH. The cross-sectional self-completion 
survey instrument was designed with input from key stakeholders including hospital and 
academic pharmacists and pharmacy technicians and piloted with 3 caregivers. The tool was 
created using MS Word 2003 and registered as a service evaluation audit of BCH on 28
th
 
November 2008 (PHA10). The 18 point instrument included: patient and healthcare professional 
demographics, circumstances leading to the request for rescue-medication, and questions to 
identify the opinions of respondents. The final questionnaire is shown in Appendix 9. Since the 
survey was offered to caregivers at the point of requesting urgent help from the Pharmacy at 
BCH the front page of the instrument offered the respondent the option to decline completing 
any more of the survey; and the reasons why. 
 
Patient identity was not requested nor obtained and this study was confirmed as service 
evaluation by the head of Research & Development at BCH: formal ethics approval was not 
required. 
 
Caregivers requesting urgent support to obtain medicines were invited to complete the survey if 
attending the Pharmacy BCH during normal weekday opening and where it was clear that the 
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primary care route of supply was judged to have failed or was likely to fail. 
 
PCTs were identified from the GP‘s postcode, or if that was not available the patient‘s postcode 
was used as a proxy for the GP code (n=4). A patient‘s PCT is determined by the location of the 
medical practice they are registered with. The postcode was entered into the following website 
to determine the PCT: 
https://www.ndtms.org.uk/emids/cgi-bin/ons_locale.cgi.  
Accessed 15/3/10  
 
Classification (coding) of free text answers (questions15 and 16) was determined by an expert 
panel of pharmacy staff – three pharmacists with both hospital and community experience; and 
two pharmacy technicians, one with relevant caregiver experience. The panel was given 
suggested codes by the lead researcher and code assignments to answers given and asked to 
modify according to their judgment. The modifications were passed to all panel members and 
further modifications requested until consensus was reached or no further agreement could be 
obtained. Since free text answers could cover more than one issue a maximum of two codes 
per answer were assigned. Where answers covered more than two issues the first two issues 
mentioned in the answer were coded. 
Responses were entered into MS Excel 2003 and SPSS v16 for analysis. 
 
3.3.5. The community pharmacists’ survey 
 
3.3.5.1. Cohort selection 
 
BCH issued 34,799 hospital generated FP10s (items) that were dispensed by community 
pharmacists during the period June 2008 to May 2009 (data selected 23
rd
 July 2009). Each 
community pharmacy can be identified from ePACT records provided by the Business Services 
Agency of the NHS. All these subjects will therefore have recent experience of dispensing at 
least 1 hospital generated prescription. Whilst response rates to surveys are known to vary for 
this subject group (85-87) it seemed possible that a return rate of c. 50% would be achieved. 
Allowing for variation in prescription workload from both general practice and hospital and for 
possible differences in practice, opinions and experience between the main community 
pharmacy types (large chain, small chain, independents etc.) it seems methodologically sound 
to survey the largest group that can be practically processed. The following cohort was therefore 
selected:  
All community pharmacies with a deliverable postal address identified through 
ePACT data that are known to have dispensed a BCH FP10 during the period 
June 2008 to May 2009 
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Figure 4 Community pharmacy survey. Schematic of response 
  
3.3.5.2. Survey type 
 
A postal self completion questionnaire was used for this survey for the following reasons: 
 
1. In April 2008 there were approx.13,000 community pharmacies registered with the 
RPSGB however only 800 (6.2%) of these had recorded email addresses (Personal 
communication Registration Department RPSGB to D Terry 10
th
 April 2008: Used with 
permission). Obtaining email addresses for an electronic survey may therefore be 
impractical. 
2. 1,282 pharmacies with deliverable postal addresses were identified as dispensing BCH 
FP10 prescriptions during the period June 2008 to May 2009 inclusive. Identifying the 
pharmacist managing each pharmacy may not always be possible and where it is 
possible will have resource implications to identify over 1,200 or more pharmacists. 
Questionnaires were therefore addressed to the ‗Pharmacist in Charge‘. 
1293 
– unique IDs in ePact 
data 
5 
‗Unknown‘ 
details 
4 
Undeliverable 
2 
Not pharmacies 
(Dispensing 
doctors) 
1,282 
Entered into 
study 
1 
Declined 
607 
Completed & 
returned 
(47.3%) 
674 
Not returned 
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3. ePACT data provides the postal address of pharmacies identified as dispensing BCH 
‗FP10‘ prescriptions. 
4. Telephone surveys of a large study cohort were deemed impractical. 
5. Pharmaceutical needs assessments carried out by PCTs have successfully used postal 
surveys of community pharmacists.(88-90) 
6. Sufficient responses after 2 reminders are likely to be harvested for this cohort.(85) 
7. The survey pilot group considered that a postal survey with two reminders was an 
appropriate instrument for this type of cohort. 
 
The following survey type was therefore selected: 
Postal survey addressed to ‘Pharmacist in Charge’ with two reminders if 
necessary 
 
The instrument was constructed in MS Word, with block questions designed in MS 
Excel. The survey was printed back to back on A5 green paper in an A5 sized booklet 
style. Each booklet was uniquely numbered to identify return and facilitate reminders. 
 
3.3.5.3. Survey instrument development 
 
The following process was followed: 
1. Expert focus group to identify themes & issues 
2. Question drafts within identified themes 
3. First questionnaire drafted with support of study group 
4. Pilot of draft with 6 community pharmacists 
5. Refinement of survey instrument 
 
3.3.5.4. Instrument pilot 
 
The draft instrument with a covering letter was hand delivered on or near 25
th
 July 2009 to 6 
community pharmacists at their place of work who were previously identified as being willing to 
provide this service. All comments from participants were considered and where necessary the 
survey was modified. Changes included: 
Minor typographical errors corrected 
Emphasis enhanced (e.g. Question 5 … calendar month)  
Question wording changed (e.g. Question 8, was … to dispense a prescription, changed to … to 
dispense a single item on a script?). 
 
The final 48 point survey instrument is shown in Appendix 10 
 
Survey instrument – issue, returns and reminders 
 
The instrument was first sent by second class mail in A5 brown envelopes commencing 22
nd
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September 2009. The envelope included the following supplementary text to aid selection by 
the recipient  
 
‗Your opportunity to collaborate with Birmingham Children‘s Hospital & Aston University 
in important research‘.  
 
The date of posting and the date of return were recorded for each subject according to the 
unique identifier printed on the questionnaire. Reminders were managed using records held in 
MS Excel and sent at approx. + 3 weeks and + 6 weeks. 
 
3.3.6. Survey analysis 
 
3.3.6.1. Quality control 
 
The following measures were taken to ensure the accuracy of the results entered into SPSS. 
1. Each recipient was allocated a unique identification (ID) number and surveys were 
stamped with this number. Questionnaire management included recording ID numbers 
of surveys issued and returned. 
2. Reminders were only sent to subjects where a return was not registered.  
3. A small number of duplicate returned surveys were identified (ID occurring more than 
once, n=22). Where the demographic details were the same or substantially the same 
the survey with the earliest recorded return date was retained and any others discarded. 
Duplicates showing substantially different demographics were retained and recorded 
using a modified ID number since these indicted that a different pharmacist was 
completing the survey (n=9). 
4. Each survey question or data point was defined in SPSS v16. Closed questions were 
defined so that codes were assigned to all answer options including codes for missing 
answers (unanswered questions) and, where applicable, codes for answers = not 
applicable. Missing answers were excluded from valid results during analysis. 
5. Each survey question or data point was assigned as one of either nominal (n=11), 
ordinal (n=32) or scale (n=7) as appropriate according to the data type. 
6. Frequency statistics were generated in SPSS for each question and results examined. 
Any identified un-coded answers for closed questions were examined and corrected as 
necessary. 
 
3.3.6.2. Data entry 
 
All data was entered by hand into the pre-defined SPSS dataset file using defined codes for 
answers to closed questions. Open question free text answers were entered into SPSS 
verbatim. NVivo and MS Excel were used to record codes assigned to free text answers and the 
production of descriptive statistics. Codes were assigned by the lead researcher in accordance 
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with the perceived meaning of the text. A maximum of two codes were assigned to each free 
text answer. Codes were defined and refined as the answers were systematically considered to 
ensure consistent and appropriate codes were assigned. See results in Chapter 12. 
 
3.3.6.3. Data analysis 
 
Data was analysed using SPSS statistical tools as appropriate, with the tools ‗descriptive 
statistics - frequencies‘ and ‗descriptive statistics - descriptives‘ used most often. Histograms of 
relevant data records were used to determine the general distribution of the results e.g. whether 
normalised data was obtained. Paired samples of non-nominal data (ordinal or scale) were 
analysed with non-parametric 2 pair-sample (Wilcoxon) tests. 
 
 
3.4. Medication reconciliation 
 
The aim of this study was to: 
Determine the clinical significance of medication reconciliation on admission to hospital for 
paediatric patients taking long-term medication. 
 
A secondary aim was to: 
Determine the influence of caregiver described drug regimens on admission medication orders. 
 
3.4.1. Statistical considerations for study power 
 
The finding that at least 10% of children were at clinically significant risk in the absence of 
medication reconciliation was considered to be sufficient to support the introduction of 
medication reconciliation in this setting. With a sample size of 100, a two-sided 95% confidence 
interval for a single proportion using Wilson‘s method (91)  would range from 13.3% to 28.9% 
for an expected proportion of 20%. That is, the power of the study would be sufficient to identify 
a change from 20% to below 13.3% or above 28.9%. 
 
A study cohort of 100 was therefore targeted. Since the medication reconciliation could only be 
undertaken during pharmacy opening hours a proportionately larger population would be 
required to enroll 100 subjects. Hours of admission to the ward were approximately 3 times that 
of the Pharmacy opening hours. It was therefore estimated that a total population of some 300 
admissions would be required to recruit 100 subjects. 
 
One hundred consecutive patients (57 boys and 43 girls) who were admitted to the 
neurosurgery ward at Birmingham Children‘s Hospital between September 2006 and March 
2007 were included in this study. This cohort was derived from a total population of 293 
admissions. The study was confined to routine pharmacy operational hours – usually 9am to 
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5pm on weekdays only. Patients were excluded from the study if: 
(i) their caregiver was not available for interview 
(ii) the admission medication order (AMOs) information (e.g. medication chart) 
was not accessible 
(iii) the medication reconciliation could not be completed for practical reasons 
(e.g. at weekends) 
 
Patients admitted to this neurosurgical ward did not have a pharmacist-derived medication 
history taken nor routine medication reconciliation prior to the study period. On this ward, initial 
AMOs were expected to match prescribed pre-admission medication (PAMs) prior to clinical 
review. All medication orders were written on hospital-approved stationery by medical staff. 
 
For the purposes of this study, four assessment stages in the medication pathway were 
considered as a patient moves from primary care to hospital-care. 
 Stage 1: The patient‘s current pre-admission medication (PAM) – usually prescribed by the 
GP.  
 Stage 2: The patient‘s own drugs as dispensed (PODs) – usually dispensed by a community 
pharmacy. 
 Stage 3: Caregiver-administered or supervised drug regimens.  
 Stage 4: Initial admission medication orders (AMO) – prescribed medication orders 
immediately after admission to hospital.  
 
Medication reconciliation was conducted by the lead researcher which enabled the identification 
of medication at each of the four assessment stages. Each is described below. Information 
obtained was recorded in MS-Excel. 
 
3.4.2. Determination of PAM – Stage 1 
 
The prescribed PAM was determined by telephone contact with the patient‘s GP practice or, if 
prescribed by a hospital physician, from their referring information or hospital records. PAM 
details were provided by 38 GP practices. Two practices asked for confirmation of the request 
(confirmed by written [faxed] request on both occasions). Information was provided by the GP 
personally on one occasion; on all other occasions requested information was provided by 
reception/administrative staff. Two GP practices could not be contacted after two or more phone 
calls during office hours within the in-patient period of the patient concerned. 
 
3.4.3. Examination of the Patient’s Own Drugs (PODs) brought in on 
admission – Stage 2 
 
Details of PODs brought in on admission were recorded on the ward by qualified pharmacy 
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technicians. PODs were used within the medication reconciliation process to support the 
identification of long-term medication and were compared with PAMs. 
 
3.4.4. Identification of most recent medication regimens described 
as administered or supervised by caregiver(s) prior to 
admission – Stage 3 
 
These data were determined using a brief semi-structured interview with the patient‘s 
supervising caregiver(s). This included: 
1. Current prescribed medication being taken by the patient 
2. Any OTC or purchased medicines being taken by the patient 
3. Patient allergy status 
4. Specific enquiry about the use of inhalers or topical products 
5. Whether any PODs had been brought into hospital 
 
This information was obtained from the caregiver(s) before discussing with them the intention of 
obtaining similar details from the relevant GP practice. The caregivers‘ agreement to approach 
the GP was requested after the interview and before contacting the GP; the caregivers agreed 
on each occasion. Caregiver identified drug regimens were used within the medication 
reconciliation process to support the identification of long-term medication and were compared 
with PAMs. 
 
Stages 1–3 were used collectively to support identification of all long-term medication for each 
study patient. 
 
3.4.5. Initial AMOs prescribed on admission to the Neurosurgical 
ward – Stage 4     
 
Data for initial AMOs were sourced from the patient‘s medication treatment sheet, from their 
clinical notes, or both. AMOs were compared with PAMs and any disparities were identified. 
 
3.4.6. Source sensitivity 
 
The three medication information sources (PAM, PODs, and caregiver regimens) were 
considered by the lead researcher to determine in their opinion the most likely pre-admission 
long-term medication required by each patient at the time of admission. These are termed 
validated continuing medication (vCM). The sensitivity of each information source to identify the 
vCM was determined using the formula: 
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Sensitivity = nTrue Positives / Sum of nTrue Positives + nFalse Negatives 
 
Where: 
 True positive - source equals vCM 
 False negative - source does not equal vCM, often dose mismatch or drug not 
mentioned (that is, the source is indicating a different regime and that is incorrect) 
 False positive - source indicates a drug that is not a vCM 
 
Source specificity could not be determined within these circumstances since the source 
information could not be considered to provide an accurate (true) negative result. That is, within 
the methodology a source could not provide a true negative result. 
 
All data were ultimately recorded and manipulated using Microsoft Office Excel® 2003. Ethical 
approval for this study was deemed to be unnecessary since the Central Office for Research 
Ethics Committees advised that the investigation was considered to be a service evaluation. 
Patient anonymity was maintained throughout the study by removing patient identifiers from 
study records (MS-Excel) after all results were collected. 
 
3.4.7. Expert clinical panel 
 
An expert clinical panel was convened on the 7th July 2008 to consider the clinical significance 
of identified prescribing disparities within the medication reconciliation study. The 
multidisciplinary panel consisted of: 
Consultant paediatric neurosurgeon 
Two junior paediatric surgeons 
Clinical nurse specialist 
Two hospital clinical pharmacists 
 
A prescribing disparity was defined as a difference between the PAM and the initial AMOs. The 
panel were presented with the following information: 
1. Patient‘s age 
2. Pre-admission medication (usually most recent GP regimen) 
3. Corresponding AMO (or ‗not prescribed‘ if omitted) 
4. The defined categories of disparities. 
 
Using the method established by Cornish et al., (73) the panel determined the clinical 
significance of each disparity identified in the study. The panel considered the likely outcome as 
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if the change in medication were to be maintained for an indefinite length of time during the in-
patient episode and for a minimum of 7 days. 
 
Each disparity was ranked to one of the following three classifications  
Class 1: Unlikely to cause patient discomfort or clinical deterioration. 
Class 2: Potential to cause moderate discomfort or clinical deterioration. 
Class 3: Potential to result in severe discomfort or clinical deterioration.  
 
Each disparity was assessed individually, and the clinical significance of the findings was 
considered by the panel in open discussion until a consensus was reached. Thereby, each 
disparity was allocated an integer score of 1, 2, or 3. A consensus was reached in all cases. 
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4. Statistics 
 
Statistical analysis was conducted using SPSS v16 (Statistical Package for Social Services) or 
PASW Statistics v18 software – both copyright IBM Corporation. 
 
The following data tables were created during the course of this programme of study: 
 
1. Medicines management strategies in West Midlands (prevalence of codes) 
2. Advice provided by PCTs to GPs concerning medication on admission to hospital 
3. Medical staff survey 
4. Nursing staff survey 
5. Rescue-medication survey (caregivers) 
6. Community pharmacists survey 
 
Variables were defined according to their measures and assigned as one of the following: 
nominal, ordinal or scale. Where appropriate missing responses were defined for variables to 
enable appropriate statistical handling of the data. 
 
Descriptive statistics were created for all variables to facilitate the production of summary results 
and as a quality control measure for data. All variables within a table were examined and any 
identified data anomalies corrected before the production of statistical values. 
 
Data distribution (e.g. Normal distribution) was considered before selection of the appropriate 
statistical test for significance. The following tests for significance were used during this 
programme of study: 
 
1. Wilcoxon – 2-paired samples of ordinal or scale data 
2. Pearson Chi squared – for cross-tabulation data 
3. Fisher‘s exact test – for cross-tabulation data where cell values are small (e.g. < 5) 
4. Jonckheere -Terpstra test – for trends in medians across categorical data. 
 
Significance testing between variables was undertaken after a hypothesis of a relationship was 
determined.  
 
4.1. Calculated mid-points 
The total frequency of responses to closed numerical values was estimated based on the mid-
point of the range. For example, the table below shows the frequency of response by hospital 
nurses to organize repeat prescriptions for home-patients.  See Table 21 
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Rxs in 
3/12 
Frequency 
Valid 
Percent 
Never 57 26.6 
1 to 5 80 37.4 
6 to 10 29 13.6 
11 to 30 29 13.6 
> 30 19 8.9 
Total 214 100.0 
No 
answer 
5 
  
Grand 
total 
219 
  
 
The estimated frequency of response to requests to organise repeat prescriptions for home-
patients, total frequency of response, was calculated by using the mid-points of each range and 
multiplying by the frequency of occurrence. Where the range was open-ended (e.g. > 30) the 
band width was considered to be in the same ratio as the percentage of cases in the previous 
highest band, then rounded to nearest integer. 
 
Worked example: 
To determine the band-width of > 30 category. 
Using 11 to 30 band, the band-width = 19 (30 -11) and the percentage of cases = 
13.6% (29/214). The ratio of band-width to percentage of cases = 140 (19 / 0.136).  
For the > 30 band, the ratio of the band-width to the percentage of cases is assumed to 
be the same, 140. Therefore the assumed band-width of the > 30 category is 12 since 
the percentage of cases in this category is 8.9% (12.46 / 0.089 = 140 and the nearest 
integer is 12). 
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5. LITERATURE SEARCHES 
 
A total of 9 major literature searches were conducted within this study programme. These were 
conducted often utilizing the following terms: 
 
 PHARMACISTS 
 PHARMACIES 
 OUTPATIENTS 
 MEDICINES-MANAGEMENT 
 CLINICAL PHARMACY 
 PHARMACEUTICAL CARE 
 INTERFACE 
 MEDICINES RECONCILIATION 
 PRIMARY CARE 
 SECONDARY CARE 
 HEALTH SERVICES ACCESSIBILITY 
 INTERPROFESSIONAL RELATIONS 
 PRESCRIPTIONS DRUG 
 PHARMACY 
 HOSPITAL PHARMACY 
 PHARMACY RETAIL 
 PHARMACY SERVICE 
 PATIENT CARE TEAM 
 COMMUNITY PHARMACY SERVICES 
 PHARMACY SERVICE HOSPITAL 
 PRESCRIPTIONS DRUG 
 DRUG THERAPY COMPUTER ASSISTED 
 CLINICAL PHARMACY INFORMATION SYSTEMS 
 HOME CARE SERVICES HOSPITAL BASED 
 CONTINUITY OF PATIENT CARE 
 DELIVERY OF HEALTH CARE INTEGRATED 
 AFTERCARE 
 PATIENT ADMISSION 
 PATIENT DISCHARGE 
 PRIMARY HEALTH CARE 
 CO-OPERATIVE BEHAVIOUR 
 MEDICATION ERRORS 
 REPEAT PRESCRIBING 
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 SEAMLESS CARE 
 INTEGRATED HEALTH CARE 
 
In addition to these terms search strategies were tailored to the individual studies described 
within this thesis. 
 
The following databases were used: 
 Cinahl 
 Embase (1974 to date) 
 King‘s Fund 
 Medline (1950 to date) 
 DH Data 
 
Access was via Dialog Data-star using Athens accounts.  
 
Usually abstracts of references were reviewed to identify suitable publications for full review. 
 
Copies of articles and reports were either downloaded via internet library facilities or hard copies 
have been obtained from The Royal Pharmaceutical Society of GB library, Birmingham 
Children‘s Hospital Library or Aston University Library upon completion of copyright declaration 
forms. References were managed using EndNote software (version 10). 
 
Zetoc alerts were requested for key terms including medicines management. 
 Page 62 
6. Medicines management strategies in the West 
Midlands Health Economy: the inclusion of interface 
issues 
 
6.1. Introduction 
 
In July 2004 the Department of Health published a revised set of overarching standards for all 
NHS healthcare organisations. The standards reflected the direction set by the NHS 
Improvement Plan (92) and provide a framework for continuous improvement in the quality of 
care patients receive. The then Healthcare Commission (HCC) held responsibility for assessing 
performance of all NHS Trusts against these standards.  
 
These standards are organised within seven domains. Each domain contains compulsory ‗core 
standards‘ and ‗developmental standards‘ against which progress is measured. Within the 
Safety domain there is a Core Standard requiring NHS organisations to have systems in place 
to ensure that medicines are handled safely & securely (C4).(93) To be compliant with this core 
standard NHS bodies must show that they  
“… keep patients, staff and visitors safe by having systems to ensure that medicines are 
handled safely and securely.” 
The national results of the audit for 2006-2007 (standard C4d) are shown below. Nationwide 
84% of Trusts were declared to be compliant with 87% compliance within the West Midlands 
region. 
 
Table 1 National results of HCC Annual Health Check 2006-2007 for standard C4d 
 
 
Standard C4d * classification Frequency 
C = The trust is compliant against this standard            332 
IA = The trust has insufficient assurance to fully 
determine whether it is compliant against this standard                    14 
NM = The trust has not met this standard 41 
DA = The trust has had its declaration of compliance 
adjusted. This means that we found that other evidence 
(gathered, for example, during an inspection visit) did not 
adequately support this trust's declaration of compliance 
against this standard 
7 
N/A = This standard is not applicable to this type of trust 0 
 
* Standard C4d states: „Healthcare organisations keep patients, staff and visitors safe by having 
systems to ensure that medicines are handled safely and securely.‟ 
 
Possibly the most common method to satisfy this standard is to have in place a medicines 
management policy or strategy. These documents, ratified by the Boards of the organisations, 
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set out the key medicines management issues for each organisation and how they will deliver 
their obligations for safe, effective and efficient use of medicines. 
 
This study aimed to identify healthcare interface themes within the medicines management 
strategies of NHS organisations within the West Midlands and to compare and contrast these 
across the healthcare sectors (primary care and acute/hospital services). By definition interface 
issues require the collaboration of organisations in both sectors. Where both sectors place 
emphasis on an interface issue then collaboration and service delivery may be supported. 
Where sectors place different importance on any interface themes then collaboration and 
service delivery may be impaired. 
 
A preliminary study was conducted during 2007. Objectives of this study were: 
 
1. To obtain suitable documents from NHS organisations in the West Midlands 
2. To compare and contrast interface issues across the sectors 
3. To support the identification of changes to interface issues over time (The 2007 study 
may provide sufficient background to identify changes in strategies obtained in 2009). 
 
An in depth knowledge of the medicines management interface issues, as described by NHS 
organisations in the West Midlands, also directs identification of issues for further investigation 
and provides a basis for this programme of studies. 
 
PCTs commission services from acute Trusts and so key medicines management issues for 
PCTs are likely to be included in SLAs agreed with PCTs. Therefore medicines management 
issues important in the view of PCTs, but needing delivery by their commissioned acute Trusts 
are expected to be included in PCT medicines management documents. 
 
6.2. Results 
 
By following the described methods a total of 16 medicines management interface themes were 
identified and coded. These are: 
 
1. Patient‘s own drugs (PODs) – where the documentation indicates the use of PODs in 
the organisation (or commissioned organisations). 
2. Discharge summaries - where the documentation indicates transfer of information to 
primary care (hospital to GP). 
3. FP10HP(s) – or equivalent prescription forms, written in the organisation concerned but 
dispensed by CPs. 
4. Pre-packs. Pre-packed medication, that allows supply by non-pharmacy staff, in use in 
the organisation (or commissioned organisations). 
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5. Improve cost effectiveness. Where the documentation indicates interface working to 
improve the cost effective use of medicines. 
6. Unlicensed medicines. Where the documentation indicates the use of medication 
unlicensed in the UK within the organisation (or commissioned organisations). 
7. Out-patient prescriptions.  Where the documentation indicates the arrangements for 
issuing out-patient prescriptions within the organisation (or commissioned 
organisations). 
8. Joint formularies. Where the documentation indicates cross-sector collaboration to 
agree and use defined drug formularies. 
9. Admission medication. Where the documentation describes the arrangements for 
confirming admission medication, usually by using medication reconciliation. 
10. High cost drugs / PbR (Payment by results). Where documentation describes the 
arrangements for managing high cost drugs, usually in relation to Payment by Results, 
within the organisation (or commissioned organisations) and across the health 
economy. 
11. NICE – National Institute for Health and Clinical Excellence. Where documentation 
describes the arrangements for managing NICE guidance within the organisation (or 
commissioned organisations). 
12. ESCA – Essential Shared Care Agreement. Where documentation describes the 
development and / or use of shared care agreements across the primary – hospital 
healthcare interface. 
13. Seamless care. Where documentation describes the processes for promoting 
medicines related seamless care as a patient transfers from one healthcare sector to 
another. 
14. Access to medicines. Where documentation demonstrates the organisation‘s processes 
to support access to medicines by patients e.g. such that where prescriptions are 
received by patients they have acceptable access to the required medicines; or working 
with out-of-hours providers and LPCs & community services to ensure medicines 
availability.  
15. Safer use of medicines (across the primary – hospital healthcare interface). Where 
documentation supports this aspect of medicines management e.g. arrangements for 
methadone administration transfer between organisations; safe use of medicines within 
commissioning; committees with a remit to promote this aspect of care (e.g. Area 
prescribing committees). 
16. One-stop dispensing. Where documentation describes the use of one-stop dispensing 
within the organisation (or commissioned organisations). 
 
A total of seven strategies/policies were obtained (41%) during the preliminary study. Reasons 
for declining to provide a strategy/policy were: existing documents were out of date or being 
revised (8 cases) or due to a recent merger policies needed to be coalesced (1 case). 
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Documents were received from one further organisation but these were deemed to not be 
equivalent to a medicines management strategy/policy and were excluded from the results. The 
7 documents (4 from PCTs, 3 from hospital trusts) were examined for aspects relating to 
interface (medicines management) issues.(59, 74-79) 
 
The following documents were collected and analysed during the preliminary study.  
 
Table 2 Medicines management documents analysed during the preliminary study 
 
ID Organisation Category 
Sub-
category Document 
Implement-
ation Date  
1.BUR 
Burton Hospitals 
NHS Trust Hospital 
General 
Hospital 
Medicines 
Management Policy 24.08.2006 
1.HER 
Hereford Hospitals 
NHS Trust Hospital 
General 
Hospital 
Medicines 
Management 
Strategy 25.07.2005 
1.GHH 
Good Hope 
Hospital NHS Trust Hospital 
General 
Hospital 
Medicines 
Management 
Strategy 26.05.2004 
1.HOB 
Heart of 
Birmingham PCT PCT PCT 
Medicines 
Management 
Strategy 01.04.2005 
1.SW-
PCT Sandwell PCTs PCT PCT 
A strategy for 
medicines 
management and 
pharmacy 
development in 
Sandwell Primary 
Care Trusts 2005-
2008  24.11.2005 
1.SB-
PCT 
South Birmingham 
PCT PCT PCT 
Prescribing and 
Medicines 
Management 
Strategy 2005 - 
2008 09.11.2005 
1.W-PCT Walsall PCT PCT PCT 
Medicines 
Management 
Strategy 01.03.2005 
 
Each of these documents was analysed to identify the Interface themes described above. The 
frequency of occurrence of each theme within the preliminary documents is shown below. 
Where statistical significance between the organisation categories is determined the p value is 
also shown. 
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Table 3 Coding frequency of medicines management documents (preliminary study, 
hospital & PCT significance testing) 
 
  Category   
Code 
Hospital 
(n=3) 
PCT 
(n=4) 
Fisher’s Exact Test 
(p value) 
PODs 3 2   
Discharge summaries 0 2   
FP10(HP)s 1 0   
Pre-packs 1 0   
Improve cost 
effectiveness 2 3   
Unlicensed medicines 3 0 0.03 
Out-Patient Rxs 0 0   
Joint formularies 2 4   
Admission medication 0 0   
High cost drugs / PbR 2 3   
NICE 3 4   
ESCA 1 3   
Seamless care 1 1   
Access to medicines 0 2   
Safer use of meds 
across the interface 0 3 0.14 
One-stop dispensing 1 1   
 
 
6.2.1. Main study 2009 
 
Of the 44 NHS organisations in the West Midlands a total of 21 organisations provided 
documents (48%). Of these 3 were not analysed: 1 organisation had their pharmacy services 
provided by another WM NHS Trust and used their policies and procedures; one was from the 
WM Ambulance Service and was not considered appropriate for this study; and another was 
from a Mental Health partnership Trust where the documentation did not relate to medicines 
management policy or strategy. Therefore 18 documents (42%) were analysed. The WM 
Ambulance Service was excluded from the study cohort (n = 43). 
Of the 23 non-responders: 
 3 did not have a document of this description 
 3 stated their documentation was not suitable for consideration 
 1 promised to provide the document but none was received 
 16 no replies 
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Figure 5. 2009 WM medicines management strategies study. Response schematic 
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The documents shown in Table 4 were obtained and analyzed. 
 
At the time of the analysis (01.11.2010) 4 of the documents were past their declared review date 
and another 6 did not show a review date. Eight documents were therefore confirmed as 
current. 
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Table 4 Medicines management documents analyzed (main study) 
 
ID Organisation Category 
Sub-
category Document Date 
BSM 
Birmingham & Solihull 
Mental Health NHS 
Trust Hospital 
Mental 
Health Medicines Code Nov-07 
BCH 
Birmingham Children's 
Hospital NHS Trust Hospital Paediatrics Medicines Policy Oct-08 
BUR 
Burton Hospitals NHS 
Trust Hospital 
General 
Hospital 
Medicines 
Management Policy Sep-07 
GEH 
George Elliott Hospital 
NHS Trust Hospital 
General 
Hospital 
Medicines 
Management Strategy 2008 
HEF 
Heart of England NHS 
Foundation Trust Hospital 
General 
Hospital 
Pharmacy and 
Medicines 
Management Strategy  2007 
HER 
Hereford Hospitals NHS 
Trust Hospital 
General 
Hospital 
Medicines 
Management Annual 
Report 2008/9 10/07/2009 
H-
PCT Herefordshire PCT PCT PCT 
Prescribing & 
Pharmacy LDP 
2004/05 - Medicines 
Management Strategy 
Spring 
2004 
W-
PCT NHS Walsall PCT PCT 
Medicines 
Management Strategy Oct-08 
NSCT 
North Staffordshire 
Combined Healthcare 
NHS Trust Hospital 
Mental 
Health 
North staff combined 
Medicines 
Management Policy 15/01/2009 
SWB 
Sandwell & West 
Birmingham Hospitals 
NHS Trust Hospital 
General 
Hospital 
Medicines 
Management Policy Dec-07 
SMH 
Sandwell Mental Health 
& Social Care Trust Hospital 
Mental 
Health 
Medicines 
Management Policy 12/11/2008 
SW-
PCT Sandwell PCT PCT PCT 
Medicines 
Management Strategy Oct-09 
SCT Solihull NHS Care Trust PCT Care Trust 
Policy For The 
Handling Of Medicines 
Within Healthcare 
Services Dec-08 
SB-
PCT South Birmingham PCT PCT PCT 
Prescribing and 
Medicines 
Management Strategy 2008 
SSS 
South Staffordshire and 
Shropshire Healthcare 
NHS Foundation Trust Hospital 
Mental 
Health 
Medicines 
Management and 
Pharmacy Strategy 2007 
T-
PCT Telford & Wrekin PCT PCT PCT 
Medicines 
Management Strategy 2009 
UHB 
University Hospitals 
Birmingham NHS 
Foundation Trust Hospital 
General 
Hospital Medicines Policy 27/11/2008 
UHC 
University Hospitals 
Coventry & 
Warwickshire NHS 
Trust Hospital 
General 
Hospital Medicines Policy Mar-05 
 
The frequency of coding is shown in Table 5 together with Fisher‘s Exact Test estimates where 
significance is indicated or approached. 
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Table 5 Coding frequency of medicines management documents (main study, hospital & 
PCT significance testing) 
 
  Category   
Aspect 
Hospital 
(n=12) 
PCT 
(n=6) 
Fisher’s Exact Test 
(p value) 
PODs 10 2 0.11 
Discharge summaries 3 4   
FP10(HP)s 5 1   
Pre-packs 5 0   
Improve cost 
effectiveness 3 4   
Unlicensed medicines 11 2 0.02 
Out-Patient Rxs 4 2   
Joint formularies 6 6 0.05 
Admission medication 7 5   
High cost drugs / PbR 2 5 0.01 
NICE 5 6 0.04 
ESCA 6 3   
Seamless care 3 3   
Access to medicines 2 1   
Safer use of meds 
across the interface 5 5   
One-stop dispensing 5 2   
 
 
Statistical analysis of results at the sub-category level of NHS organisations is inappropriate 
since there are too few results within each grouping to provide meaningful results when using 
Fisher‘s Exact Test. 
 
Preliminary (2007) verses main study (2009) 
When taken as a whole (all categories of organisations), there is one statistically significant 
difference between the preliminary study results and those from the main study concerning 
‗medication on admission‘ which was not found in any of the preliminary documents (n = 0) but 
was found in the main study (n = 12) (p = 0.003, Pearson‘s Chi-squared). 
 
PCT changes between preliminary (2007) and main study (2009) 
One statistically significant difference was found between PCT documents in the preliminary 
study and in the main study: ‗medication on admission‘ (preliminary n = 0, main n = 5, p = 0.048 
Fisher‘s exact test). 
 
Hospital changes between preliminary (2007) and main study (2009) 
No statistically significant changes were found for hospital documents in the preliminary study 
and those in the main study using Fisher‘s exact test. However, 5 themes were not found in the 
2007 documents (n = 0) but were in the 2009 documents. These are; discharge summaries (n = 
3), medication on admission (n = 7), access to medicines (n = 2), safer use of medicines across 
the interface (n = 5) and out-patient prescriptions (n = 4). 
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6.3. Discussion 
 
6.3.1. Main findings 
 
Table 3 shows the frequencies of interface issues found within the documents in 2007 and 
separated into the two sectors. At this point in time there was statistical significance between 
the sectors for unlicensed medicines (hospital n=3, PCT n=0, p=0.03) and the issue safer use of 
medicine across the interface approaches significance (hospital n=0, PCT n=3, p=0.14). 
However, both may be considered important findings. 
 
Arrangements for the prescribing of unlicensed medicines are an important issue across the 
healthcare sectors for paediatrics. Many children needing long-term medicines will require 
unlicensed medicines, (63, 68, 94) since there are difficulties in the development and provision 
of age-related formulations. There may be uncertainty over which sector will prescribe on-going 
unlicensed medicines for children: hospital or GP. Clarity of arrangements for prescribing such 
items post discharge from hospital is a prerequisite for seamless care. In 2007 unlicensed 
medicines appear to be an important issue for hospitals (n=3) but less so for PCTs (n=0). The 
2007 study pre-dates the recent rise in interest in unlicensed medicines by PCTs as evidenced 
by letters on the subject to their GPs, (95) and the media (96) and through guidance provided 
by the NPC in 2009.(57) In contrast hospital pharmacy departments are likely to have to 
manage unlicensed drugs used in their institutions and the additional risks they pose, and this 
may account for the inclusion of this issue in hospital documents in 2007. This difference 
between the two sectors is also seen in 2009 (hospital n=11, PCT n=2, p=0.02). In fact only one 
PCT includes comments about monitoring the prescribing of unlicensed medicines in the 2009 
study. Maintaining access to both licensed and unlicensed medicines for children outside 
hospital is essential for their clinical management and is a requirement within the NSF for 
children.(62) The lack of cross-sector arrangements to ensure access to long-term medicines 
for children has prompted a major line of enquiry within this study programme and conclusions 
and recommendations are described elsewhere. 
 
This study indicates a change in the inclusion of ‗safer use of medicines across the interface‘ 
issues within the documents analysed. In 2007 this issue was only identified within the PCT 
documents (hospital n=0, PCT n=3, p=0.14). By 2009 some hospital Trusts had included this 
issue in their documents (hospital n=5, PCT n=5, p=0.15). In some measure hospitals appear to 
be catching up with PCTs over this issue. The NPC describes Area Prescribing Committees 
(APCs) as having an important role in this aspect of cross-sector collaboration.(97) Traditionally 
APCs were managed and run by PCTs and as commissioners they are predictably concerned 
with medicines safety across the interface. The greater inclusion of this issue within hospital 
Trust‘s documents by 2009 is welcome and may reflect an increasing level of collaboration 
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between the sectors, with hospital Trusts adopting a more integrated approach to medicines 
management.  One of the four programme aims of the Commissioning for integrated Medicines 
Management initiative by the NPC was: To enable the safer use of medicines (98) which was 
reported in 2009. 
 
This study also demonstrates some important changes over time in respect to admission 
medication, and the exchange of medication related information from primary care to hospital on 
admission. In 2007 no documents were found to address this issue (hospital n=0, PCT n=0) and 
this observation prompted a survey of PCT provided guidance to GPs (Chapter 8) within this 
study programme. By 2009 this issue was appearing in documents (hospital n=7, PCT n=5) and 
is the only statistically significant change between 2007 and 2009 when both sectors are 
included in the analysis (p=0.003). Two national guidelines were produced in the interim period 
2007 to 2009. In December 2007 NICE-NPSA published guidance regarding medication 
reconciliation for adults on admission to hospital, (17) and in March 2008 the NPC published a 
guide to the implementation of medication reconciliation.(70) Before either of these guidelines 
was published PCTs were surveyed in May 2007 as part of this programme of study (see 
Chapter 8). Perhaps as a consequence of this work the lead researcher (DT) was appointed to 
the NPC focus group that provided support to the NPC publication. This publication provided for 
the first time a minimum dataset for medication information on admission to hospital. The 
change for PCTs (2007 n=0, 2009 n=5 from 6) is statistically significant using Fisher‘s exact 
test, but not so for hospital Trusts although there is a large increase (2007 n=0, 2009 n=7 from 
12). The lack of cross-sector arrangements for transfer of medication information on admission 
to hospital for paediatrics has prompted a major line of enquiry within this study programme and 
conclusions and recommendations are described elsewhere. 
 
The preliminary study in 2007 has provided an invaluable insight into cross-sector medicines 
management issues for paediatrics. In particular it confirmed concerns relating to: 
1. Information transfer on admission to hospital 
2. Access to long-term medication for children outside hospital, since there were important 
issues relating to both ‗access to medicines‘ (of minor importance for hospitals, n=0) 
and ‗unlicensed medicines‘ (of minor importance for PCTs, n=0). 
 
The preliminary study generated too few results to provide in itself conclusive evidence for 
interface problems relating to paediatrics. However it consolidated identified problems during 
field work at the beginning of this research programme and confirmed the importance and 
potential usefulness of the studies reported in this thesis.  
 
The 2009 study demonstrates some changes in the medicines management documents of the 
organisations concerned over a two year period and current differences between the sectors. 
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In addition to the issue of unlicensed medicines discussed above, the sectors show a 
statistically important difference in 2009 for 4 other identified themes. These are: 
 
1. Patients‘ own drugs PODs (hospital n=10, PCT n=2, p = 0.11, approaching but not 
reaching usual interpretations of significance at the 5% level). The importance to 
hospitals of managing PODs appears to be more important than for PCTs. This is as 
expected since using PODs for in-patient episodes, pending their individual 
examination and approval, is now widespread in hospital practice. Interestingly the 
NMC has recently confirmed that under certain circumstances trained registered 
nurses may approve PODs for use (by their owners) when in-patients.(99) This use of 
primary care supplied medicines within a secondary care setting breaches usual 
understandings of funding pathways for drugs. Since the hospital is funded by the 
commissioner (PCT) to provide care for the in-patient, including for all medication 
within the terms of PbR (81) arrangements, the use of PODs may be a sensitive issue. 
PCTs may be reluctant to openly support such schemes even though this is expected 
practice and linked closely with one-stop dispensing endorsed by government 
policy.(23, 59) 
 
2. Joint formularies (hospital n=6, PCT n=6, p=0.05). All PCT documents focus on joint 
cross-sector formularies, whereas only half of hospital documents describe joint 
formularies. Perhaps as much as 40% of primary care prescribing is known to be 
influenced by secondary care recommendations.(59) PCTs may therefore see joint 
formularies as a measure to control primary care as well as secondary care 
prescribing.(97) In practice PCT organised Area Prescribing Committees may take the 
lead in developing joint formularies whereas hospital Trusts‘ formularies may be 
managed by their Drugs & Therapeutics Committees (DTC). These committees may 
have representation from primary care but are arguably less focused on cross-sector 
issues than APCs. 
 
3. High cost drugs / payment by results (hospitals n=2, PCT n=5, p=0.01). The text of 
PCT documents focuses on the management and control of high cost drugs and 
especially those outside of tariff within PbR; with the expected outcome of managing 
drug related financial risks. Only two hospital documents comment on this issue. Both 
of these state that agreement to use high cost drugs not included in PbR funding 
arrangements need the approval of the relevant PCT. Hospitals that use these non-
tariff drugs may incur the financial burden of their use without reimbursement from 
PCTs unless and until the PCT has agreed that they may be used. Such requests, 
often submitted as an ‗Individual Funding Requests‘ (IFRs) usually require prior 
agreement from the patient‘s PCT if the funding is to be recovered. Hospitals that do 
not follow this process are likely to be at financial risk, which can amount to quite large 
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sums of money. BCH claimed over £400,000 for one month December 2010 via this 
mechanism. [Information on file, provided 28
th
 January 2011, used with permission.] It 
is therefore surprising that such important financial processes are not usually found in 
greater numbers of hospital policies. 
 
4. NICE (hospital n=5, PCT n=6, p=0.04). Appropriate consideration and adoption of 
NICE guidance is found in all PCT documents but in less than half of those for 
hospitals. All NHS organisations in England are obliged to consider NICE guidance 
within 3 months of publication. Adherence is not strictly required but a reasoned 
management plan for the organisation is required. Funding of NICE guidance must be 
made available for a technology appraisal within three months of final guidance being 
issued by NICE. Other types of NICE guidance, such as clinical guidelines, are not 
covered by the funding directive, which is confirmed within the NHS Constitution. (100) 
PCTs may expect ‗… robust implementation … ‗  (79) , ‗ … prescribing … in line with 
NICE … guidance …‘, (59) and may require provider units to ‗… demonstrate 
implementation …‘ of NICE guidance.(101) PCTs may see implementation of NICE 
guidance as evidence of good clinical practice and of patient management that is 
independently and nationally considered to be appropriate for funding. Adopting NICE 
guidance may therefore be seen as a safe option for PCTs. Hospitals are seemingly 
less concerned to describe NICE management within their medicines management 
documents. Is local consideration of NICE guidance of less importance to hospital 
Trusts than for PCTs? This seems unlikely since they have a clear responsibility to 
respond to NICE guidance. Other explanations for this difference between sectors 
include:  
 specialist hospital Trusts may expect that a proportion of NICE guidance does 
not apply to them and there are 3 specialist Trusts amongst the 12 hospital 
Trusts in this study cohort; 
 the local adoption of NICE guidance across the health economy may be 
considered to be driven by PCTs in collaboration with hospital Trusts; 
 the study sample is not representative of the population it is purported to 
represent. 
 
6.3.2. Strengths of this study 
 
As far as can be determined this study identifies for the first time the similarities and differences 
concerning medication interface issues expressed in medicines management documents of 
NHS organisations. 
 
This unique study has successfully identified important differences in the strategies of NHS 
organisations in the different sectors relating to medicines management interface issues. 
Conclusions can be attributed to board endorsed policies and can be readily verified. The 
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documents were relatively accessible and it is possible to track changes over time as the 
documents are revised and updated by the organisations. The effect of NHS re-organisations on 
these issues can also be tracked by this method. 
 
The methodology uses standard qualitative techniques to identify themes within the documents 
obtained. 
 
6.3.3. Limitations of this study 
 
It is acknowledged that the responding organisations may also have other written policies on 
medicines management interface themes even if not included within their Medicines 
Management Strategy or Policy. However it may be argued that these documents demonstrate 
the major medicines management considerations of the organisations since all of these 
documents are endorsed by their Trust Boards, as their strategy / policy, and were provided for 
this study in the full knowledge of its purpose. 
 
Only 7 documents were obtained during the 2007 preliminary study and results may not be 
representative of WM NHS organisations at the time. Comparisons of this data across the 
sectors and between this data and that obtained in 2009 are therefore limited. However, it 
should be noted that the study cohort were all regularly represented at regional medicines 
management meetings convened around the time of the study to consider cross-sector issues 
and that these 7 organisations represent 41% of this group. 
 
6.3.4. Comparisons with other studies 
 
In 2003 the BMJ published an article titled; ―Continuity of care: a multidisciplinary review‖.(102) 
This paper describes the findings of a literature review relating to continuity of care, and the 
emphases placed by different healthcare domains. This work focused on the meaning of 
continuity of care in the different settings as found in the existing literature at the time. The 
authors conclude that continuity of care has two attributes. These are care over time and a 
focus on individual patients. By this definition the present study does not consider continuity of 
care but rather describes elements of service processes that contribute to cross-sector co-
ordination of care. 
 
No other studies could be identified that compares medicines management policies or 
documents between NHS organisations. 
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6.4. Conclusions 
 
A number of medicines management interface themes were successfully identified within the 
documents obtained and comparisons drawn between the sectors (hospital and primary care).  
 
This study has: 
1. provided background on interface issues within medicines management policy across 
NHS Trusts in the West Midlands 
2. prompted two major lines of enquiry within this study programme. These are: 
a. information transfer following paediatric admission to hospital 
b. the involvement of hospital services to support access to medicines for children 
in the community 
3. demonstrated important differences between the sectors for key interface issues 
4. indicates change in managing interface issues over a two year period 
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7. Medication reconciliation for paediatric patients on 
admission to hospital 
 
7.1. Introduction 
 
Current guidance from the Department of Health in the UK describing the responsibility for 
prescribing between hospital prescribers and general practitioners (GPs) is more than 19 years 
old,(3) but it continues to provide the basis for professional guidance.(56) In general, published 
guidance by UK national healthcare organisations, relating to this issue, focuses on the transfer 
of care and associated essential medication information during discharge (9, 13-16) with little 
emphasis on the admission process. The National Service Framework for Children, Young 
People and Maternity Services emphasizes the need for good communication between 
prescribers in secondary and primary care.(62) However, this guidance is also primarily directed 
at the transfer of patients from secondary care to primary care (discharge). As a consequence, 
the quality of medication information during admission to hospital has been studied less 
extensively than that for discharge, especially in the paediatric setting. The National Institute for 
Health and Clinical Excellence (NICE) in collaboration with the National Patient Safety Agency 
(NPSA) issued guidance in December 2007 concerning medication reconciliation (MR) at 
hospital admission.(17) Medication reconciliation uses the principles of taking a drug history and 
expands on them. Rather than relying on patient or caregiver descriptions of the medication 
they take, MR involves collecting essential medication information from a number of different 
sources and using these to conclude what a patient should be currently taking.(70) This process 
has been shown to give clinical benefits by reducing risk from unintentional changes to drugs in 
the general hospital population, (103-107) and in recent studies in paediatrics.(108-110) The full 
MR process involves performing this assessment at admission and then notifying the next 
healthcare sector of changes made to the admitting medication during the course of the 
patient‘s therapy in the current sector. NICE-NPSA guidance specifically requires MR to be 
conducted on admission to hospital and they have also provided a costing and reporting tool 
indicating that a resource requirement of £12.9 million for England per year would be needed to 
fulfill this requirement each year.(111) However, both the NICE guidance and the costing tool 
specifically exclude patients aged younger than 16 years. Prior to this present study the 
literature demonstrated the clinical importance of MR in adults on admission to hospital but did 
not provide sufficient evidence for paediatrics as reflected in the NICE-NPSA guidance of 2007.  
 
Medication-related problems on admission frequently result from inadequate essential 
information transfer between healthcare professionals and also between healthcare providers 
and patients. (2, 43, 73, 112) The National Prescribing Centre commented that ―… systems and 
communication often break down at the interface between healthcare settings (e.g. between 
primary and secondary care), leading to poor patient care‖.(34) The National Patient Safety 
 Page 77 
Agency confirms that the transfer of medication information across the healthcare interface is a 
research priority for NICE.(2) 
Evidence indicates that pharmacist-derived medication histories augment those taken by 
medical colleagues, (51, 52, 113)  and pharmacists may be ideally suited to performing 
MR.(114) NICE-NPSA guidance also suggests that MR on admission should be undertaken by 
a pharmacist. (17) 
 
In 2003, the Royal Pharmaceutical Society of Great Britain (RPSGB) published guidelines for 
medication history-taking by pharmacists on admission to hospital (114) and guidance for 
conducting patient discharge in relation to medication.(7) More recently, the RPSGB, along with 
other organisations, has published a workbook for discharge and transfer planning.(9) 
According to the Hospital Pharmacists‘ Group of the RPSGB,(114) a full patient medication 
history should include determination of the current medication regimens as prescribed by the 
patient‘s GP. However, obtaining details of GP-prescribed medication at source may not always 
be practical, and hospital prescribers may rely on other sources of information. Prescribing 
decisions may therefore be based on information provided by a patient or caregiver, and this 
may become even more commonplace with the move towards greater patient/caregiver 
autonomy. The accuracy of information provided by this method is largely unknown although 
one recent study suggests this is a reliable source.(110) However this paper reports on a cohort 
of medically complex children and it may be expected that in this population caregivers will be 
familiar with the medication their children are receiving regularly, usually under their own 
supervision.  
 
The primary objective of the present study was to determine the clinical significance of MR in 
children on admission to hospital. Supplementary objectives include: determining the influence 
of caregiver provided information on Admission Medication Orders (AMOs, the initial hospital 
prescriptions following admission) and identifying the sensitivity of available information sources 
to prescribed validated continuing medication. The principle reference point (gold standard) was 
taken as the current primary care prescriptions for long-term medication immediately prior to 
admission. This study considered activity in a paediatric neurosurgical unit, but is likely to reflect 
practice in other paediatric specialties where medication reconciliation is not conducted for 
children taking long-term medication. 
 
The present study, conducted under the audit programme of Birmingham Children‘s Hospital, 
considered the prescribing pathway for paediatric patients as they transferred across the 
primary–secondary healthcare interface. The study identifies any ‗continuing prescribed 
medication‘ (CPM) for the study cohort. The definition of CPM within this study is shown below. 
 
Definition of Continuing Prescribed Medication (CPMs) 
Medication identified by at least one source during the medication reconciliation process 
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as being taken or seemingly being taken by the subject on transfer across the primary-
hospital healthcare interface and likely to continue to be required. 
 
For the purposes of this study, four assessment stages in the medication pathway for CPMs 
as a patient moves from primary care to hospital care were considered. These were: 
 Stage 1: The patient‘s current pre-admission medication (PAM) – usually prescribed by the 
GP.  
 Stage 2: The patient‘s own dispensed drugs (PODs) – usually dispensed by a community 
pharmacy. 
 Stage 3: Caregiver administered/described drug regimens.  
 Stage 4: Initial admission medication orders (AMO) – prescribed medication orders 
immediately after admission to hospital 
 
 
Analysis of medication policy documents described in Chapter 6 identified two major lines of 
enquiry within this programme of study. These were: 
a. information transfer following paediatric admission to hospital 
b. the involvement of hospital services to support access to medicines for children 
in the community 
This is the first of two studies described within this thesis investigating medication information 
transfer following paediatric admission to hospital.  
 
 
7.2. Results 
 
Subjects were recruited to the medication reconciliation study during the period September 
2006 to March 2007. Figure 6 below shows recruitment of patients into this study. Exclusion 
criteria are described in section 3.4.1. 
 
Figure 6 Recruitment of patients to medication reconciliation study 
 
 
 
 
 
 
 
 
293 
Admissions to ward 
site 
100 
Eligible for inclusion 
193 
Excluded 
1 
Results incomplete 
99 
Included in results 
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The ages of the patients included in the study ranged from 4 months to 16 years, with a median 
age of 7 years and 4 months. Forty percent of study patients (n = 40) had identifiable CPMs at 
the time of admission.  
 
Information concerning one patient was incomplete and was excluded from the remainder of the 
study. The number of CPMs identified at the time of admission ranged from zero to eight per 
patient. The median number of CPMs prescribed for those children taking CPMs was 2. In 
addition to CPMs some patients were also taking short term medication for acute clinical 
problems, most notably antibiotics. 
 
 
Table 6. Frequency of prescribed CPMs following admission to the medication 
reconciliation study site during the study period 
 
No. of CPMs at time of 
admission 
No. of patients Total no. of CPMs 
0 60 0 
1 11 11 
2 10 20 
3 7 21 
4 4 16 
5 3 15 
6 2 12 
7 1 7 
8 1 8 
Total 99 110 
 
A total of 110 individual CPMs were recorded on admission, of which 75% (n = 83) were for oral 
administration. Seventy-nine percent (n = 87) of CPMs were confirmed as prescribed by the 
patient‘s GP and a further 9% (n = 10) by the patient‘s hospital physician. Therefore, the total 
number of identified prescribed PAM orders was 97. The remaining 12% (n = 13) are accounted 
for as follows: an inability to identify or contact the GP practice (n = 5); the patient was taking a 
prescription-only medication that was not prescribed for them (n = 2); the prescription could not 
be confidently attributed to either the GP or hospital physician (n = 4); a lack of clarity as to 
whether the prescription was current (n = 1); and an inability to confirm details within the 
timeframe of the study (n = 1).  
Of the 39 patients receiving a CPM, four had medication prescribed exclusively by their hospital 
physician (hospital-issued prescriptions), although for one patient (subject 3) the origin of 
prescriptions for 4 items was unconfirmed. Five subjects had CPMs prescribed by both the GP 
and the hospital physician. Five subjects had CPMs prescribed from an unconfirmed source 
although there is some evidence that these were prescribed by the patient‘s GP. The remainder 
of patients (n = 25) had CPMs prescribed exclusively by their GP. Details of CPMs identified 
can be found in Appendix 4. 
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7.2.1. Comparison of Patient’s own drugs (PODs) with prescribed 
Pre-admission Medication (PAM)  
Of the 97 prescribed PAM orders identified, 62 were presented as PODs and were physically 
examined on admission, however 3 were excluded from consideration since these related to 
PAMs where prescribed doses could not be confirmed. Of these, 75% (n = 44) matched the 
intended PAM orders (stage 1 = stage 2). However, 25% (n = 15) did not match the PAM orders, 
including 19% (n = 11) which did not have a dispensing label and 5% (n = 3) which were 
labelled with a different dose from that currently prescribed (stage 1 ≠ stage 2). One medicine 
presented as a POD was medication prescribed for the patient‘s mother.  
 
Details of PODs compared with PAMs can be found in Appendix 4. 
 
7.2.2. Comparison of Caregiver-Described Regimens with PAM  
Of the PAM orders, there was an unequivocal match with the caregiver-described regimen in 56% 
(n = 54) of cases (stage 1 = stage 3). Of the remaining 44% (n = 43), there were differences 
between the caregiver-described regimen and the PAM orders, including 2% (n = 2) which were 
considered minor differences (e.g. Viscotears
®
 eye drops to be administered to both eyes when 
required [PAM] versus four times daily [caregiver description]). Nine percent (n = 9) of PAM 
orders were not mentioned by the caregiver at the interview. Other mismatches between 
caregiver-described regimens and PAM orders consisted of a difference in dose (11% [n = 11]), 
dose frequency (5% [n = 5]), or both (5% [n = 5]); lack of administration of the prescribed 
medicine by the caregiver on ten (10%) occasions; and a description by the caregiver of a drug 
regimen prescribed by the GP which subsequently proved not to be the case (and therefore is 
not included as a prescribed PAM ). See table in Appendix 4. 
 
7.2.3. Comparison of Initial AMOs with PAM  
The initial AMOs matched the PAM orders in 54% (n = 52) of cases (stage 4 = stage 1). Of the 
remaining 46% (n = 45) of cases, there was a difference between the initial AMOs and the PAM 
orders, of which 7% (n = 7) were not considered disparities and were not appropriate for clinical 
assessment. The 7% consisted of ‗when required‘ doses of inhalers (e.g. two puffs when 
required) to defined doses (e.g. two puffs four times daily) [n = 2]; urgent dose adjustments on 
admission, e.g. for asthma (n = 2); PAM-described doses as ‗advised by hospital‘ (n = 2); and 
the caregiver-described regimen not actually prescribed by the GP (n = 1). The remaining 39% 
(n = 38) of CPMs were identified as disparities and were considered by the expert clinical panel 
for clinical significance. See Table 7 below.  
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Table 7 Medication reconciliation study. Disparites between PAM and AMOs and clinical assessment 
 
PATIENT 
NO. Rx'er route CPM PAM AMO (BCH) 
PAM = 
AMO 
DIS-
PARITY ASSESSED LEVEL 
31 GP ORAL PIZOTIFEN 0.5MG BD 0.5MG TDS NO YES YES 1 
10 GP ORAL CARBAMAZEPINE 
80MG OM, 120MG 
ON 100MG BD NO YES YES 1 
29 GP ORAL HYDROCORTISONE 10MG AM, 5MG PM 10MG AM, 7.5MG PM NO YES YES 1 
38 GP NASAL NASONEX 2P OD 1P BD NO YES YES 1 
18 GP INH SALBUTAMOL INH 2P QDS PRN 1p QDS NO YES YES 1 
25 CONS ORAL CLOBAZAM  2.1ML BD 2.1ML TDS NO YES YES 1 
13 GP ORAL TRIMETHOPRIM 10MG ON 20MG ON NO YES YES 1 
27 GP ORAL TRIMETHOPRIM 20MG ON 22MG ON NO YES YES 1 
23 GP ORAL CLOBAZAM  2MG TDS 2MG, 3MG, 4MG NO YES YES 1 
3 UNK ORAL OMEPRAZOLE 4MG OM 3MG OD NO YES YES 1 
15 GP ORAL DOMPERIDONE SUSP 3MG TDS 4MG TDS NO YES YES 1 
6 GP ORAL ATENOLOL 100MG OD 50MG BD NO YES YES 1 
11 GP ORAL RANITIDINE 150MG BD 50MG BD NO YES YES 1 
30 GP ORAL CLOBAZAM  5MG BD 5MG TDS NO YES YES 1 
35 GP ORAL GABAPENTIN 300-600MG TDS 600MG BD NO YES YES 1 
4 GP ORAL SOD VALPROATE 7ML TDS 8ML, 7ML, 8ML NO YES YES 1 
15 GP ORAL FEREDETATE 2.5MLS TDS NO RX NO YES YES 1 
3 UNK ORAL CALOGEN 3ML QDS NO RX NO YES YES 1 
21 GP ORAL MOVICOL PAED 1 ON NO RX NO YES YES 1 
4 GP INH BECLOMETASONE INH 200MCG BD 100MCG BD NO YES YES 2 
4 GP ORAL SENNA SENNOKOT 10ML ON 18ML ON NO YES YES 2 
16 GP ORAL DESMOPRESSIN 50MCG QDS 300MCG DAILY NO YES YES 2 
1 GP ORAL HYDROCORTISONE 7.5MG AM 5MG PM 7.5MG OM NO YES YES 2 
16 GP ORAL MOVICOL PAED 2 OD NO RX NO YES YES 2 
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PATIENT 
NO. Rx'er route CPM PAM AMO (BCH) 
PAM = 
AMO 
DIS-
PARITY ASSESSED LEVEL 
20 GP INH BECLOMETASONE INH 50 2P BD NO RX NO YES YES 2 
2 GP INH SALBUTAMOL INH 2P MDU NO RX NO YES YES 2 
31 GP ORAL OMEPRAZOLE 40mg od 4/7 NO RX NO YES YES 2 
38 GP INH BECLOMETASONE INH 50MCG BD NO RX NO YES YES 2 
21 GP INH SALBUTAMOL INH 1P MDU NO RX NO YES YES 2 
21 GP ORAL SENNA 15MG ON NO RX NO YES YES 2 
26 CONS ORAL CICLOSPORIN 31MG BD 150MG BD NO YES YES 3 
6 GP ORAL DESMOTABS 100MCG TDS 200MCG TDS NO YES YES 3 
23 GP ORAL VIGABATRIN 750MG BD 500MG BD NO YES YES 3 
16 GP ORAL PREDNISOLONE SOL 5MG ALT DIE NO RX NO YES YES 3 
19 GP INH 
TERBUTALINE TURBO 
INH 1p q2h-q4h prn NO RX NO YES YES 3 
2 GP INH 
BUDESONIDE INH 
50MCG 8P OD NO RX NO YES YES 3 
21 GP ORAL DESMOPRESSIN 400MCG ON NO RX NO YES YES 3 
23 GP ORAL NITRAZEPAM 2.5MG BD NOT GIVING NO YES YES 3 
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7.2.4. Clinical Significance 
 
The method used to determine the clinical significance of disparities is described in section 3.4.7 on 
page 56. The classifications determined by the expert panel were as follows:  
 50% (n = 19) of disparities were classified as class 1 (e.g. oral atenolol 100 mg once daily 
compared with 50 mg twice daily);  
 29% (n = 11) as class 2 (e.g. beclometasone inhaler 200 µg twice daily compared with 
100 µg twice daily);  
 21% (n = 8) as class 3 (e.g. budesonide inhaler 50 µg eight puffs daily compared with not 
prescribed).   
 
Of the 39 subjects admitted taking CPMs: 
 ten (26%) had class 1 disparities 
 five (13%) had class 2 disparities 
 seven (18%) had class 3 disparities 
 17 (43%) did not have a disparity. 
 
On 5% (n=2) of occasions, the panel concluded that the unintentional change to the PAM on 
admission, prompted by the caregiver-described regimen, was likely to lead to a clinical benefit. 
These were oral ranitidine 150 mg twice daily (PAM) changed to 50 mg twice daily (AMO) for a 
patient aged 15 months, and oral trimethoprim 10 mg at night (PAM) changed to 20 mg at night 
(AMO) for a patient aged 23 months. On both occasions, the change led to AMOs in keeping with 
accepted regimens for the size of the patient.  
 
 
7.2.5. Sensitivity of source data 
 
The sensitivity of the three sources of data (PAMs, PODs and Carer information) has been 
estimated against the validated continuing medication (vCM), as described within the methods (see 
page 55). The following results were determined: 
 
PAM sensitivity = 0.83 
POD sensitivity = 0.45 
Carer sensitivity = 0.66 
See Table 9 below where: 
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TP is True positive e.g. source equals vCM 
FN is False negative e.g. source does not equal vCM, often dose mismatch or drug not 
mentioned  
FP is False positive e.g. source indicates a drug that is not a vCM 
 
Table 8. Medication reconciliation study. Sensitivity of data sources against validated 
continuing medication (vCM) 
 
  PAM POD CARER 
TOTAL TP 77 42 62 
TOTAL FN 16 51 32 
TOTAL FP 2 1 0 
UNCLASSIFIED 15 16 16 
        
TOTAL VALID  95 94 94 
% TP 81% 45% 66% 
% FN 17% 54% 34% 
% FP 2% 1% 0% 
        
Sensitivity 0.83 0.45 0.66 
 
 
7.3. Discussion 
 
7.3.1. Main findings 
 
This study found that in the absence of medication reconciliation, there was a disparity between the 
initial AMOs and the PAM orders in 39% of cases (CPMs), and that 50% of these changes had the 
potential to lead to moderate (class 2) or severe (class 3) discomfort or clinical deterioration. Of the 
39 children included in this study taking CPMs, 12 (31%) were found to be at risk of class 2 or class 
3 changes. 
 
Knowledge of the patient‘s current medication regimen as presented by the patient or their 
caregiver is a prerequisite for determining the AMOs. However, the hospital prescriber also needs 
to know the most recent medication regimen as prescribed by the patient‘s usual healthcare 
professional. Clearly, identification of differences between these sources of information is of clinical 
importance. This present study demonstrates the clinical significance of lay modifications to 
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prescribed medication and that the changes can be endorsed unintentionally as a patient moves 
from one healthcare setting to another. Further studies will be needed to determine if such 
unintentional changes are perpetuated on discharge from hospital but this seems likely if the 
disparity is not corrected during the in-patient episode. 
 
In this study approximately 12.5% of children were receiving medication from both their GP and 
hospital consultant. Accommodating both these sources of CPMs will be necessary when 
constructing medication reconciliation processes for children admitted to hospital. 
 
Interestingly, this study concluded that approximately 1 in 20 unintentional prescribing changes 
prompted by the parents/caregivers are likely to result in some clinical benefit to the patient. Of 
course the caregivers may be acting on advice from a healthcare professional, but this was not 
identified during the study. 
 
From personal experience, hospital pharmacy staff often place reliance on the information taken 
from PODs brought in by patients and their families. However, with nearly 20% of drugs brought into 
hospital being unlabelled and a further 5% labelled differently from the CPM, as reported in the 
present study, this assumed reliance has to be questioned. 
 
Based on these findings, the current NICE-NPSA guidance concerning medication reconciliation in 
hospitals (17, 111) does not appear to be justified in omitting children. The NICE-NPSA guidance 
uses adult studies, showing the clinical significance of MR, to provide the supporting evidence for 
their conclusions and recommendations. This study finds comparable results for children. See 
section 7.3.4 below. Denying children the benefit of MR on admission to hospital not only exposes 
them to additional risk during the inpatient episode but also following discharge from hospital. 
Uncorrected unintentional medication disparities on admission may be perpetuated as a patient is 
discharged, with possible increased risk.(115) 
 
While the present study considered activity in a paediatric neurosurgical unit, it is likely to reflect 
practice in other paediatric specialties where medication reconciliation is not conducted for children 
taking long-term medication. Whilst the extent of disparities in the absence of medication 
reconciliation is in keeping with other adult studies generalisability remains unconfirmed. A research 
grant has been received (DT as project co-lead) to undertake similar studies at other sites in 
England with the aim of determining an optimal medication reconciliation process for paediatrics. 
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7.3.2. Strengths of this study 
 
One hundred patients were admitted to this study from a total available cohort of 293 during the 
study period. This level of recruitment has been reported by others (73) and was accommodated 
within the length of the study period to recruit target numbers. Pharmaceutical services required to 
conduct the study were limited to pharmacy operational hours, usually 8 hours per week-day, 
approximately one-third of the operational period of the ward. 
 
Standard medication reconciliation processes were used to obtain results within this study and 
therefore the study methods does not add significantly to workload / resource requirements for 
organisations undertaking medication reconciliation. 
 
This study used NICE-NPSA approved methods to determine clinical significance of identified 
disparities.(17, 116) 
 
7.3.3. Limitations of this study 
 
Generalisability of this study is limited since the study cohort was taken from one institution and 
from one specialty. Numbers of patients taking long-term medicines recruited into the study is also 
limited. Further studies are required to provide a reliable basis for conclusions and practice 
recommendations. 
 
In determining the clinical significance of the disparities detected, the expert panel considered the 
likely outcome as if the change in medication were to be maintained for an indefinite length of time. 
However, it is acknowledged that in the hospital setting, any errors in a patient‘s medication 
regimen that have the potential to cause clinical deterioration are likely to be identified and 
remedied. Conversely, there is a large body of evidence that demonstrates that medication errors in 
hospital can harm patients, including paediatric patients. (11, 33, 43, 48, 62, 72, 107, 116-127) 
 
Children will often require dosage adjustments as they develop. It is therefore likely that any source 
of information concerning CPM for children could be out of date with the patient‘s clinical needs. 
However, the present study was designed to minimize these effects by identifying the most up-to-
date information from both the GP practice and caregiver(s) as soon after admission as possible. 
 
Using the most recent GP medication records (PAMs) as the baseline (gold standard) for disparities 
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may seem incongruent with expected clinical practice and the validated continuing medication (vCM) 
as determined by the ward clinical pharmacist may seem preferable. Both of these baselines have 
been examined within this study. From a study perspective the GP PAMs are identifiable and 
demonstrable where as the vCMs are subjective measures and may be variable. The PAMs are the 
most up-to-date records from the preceding healthcare professional and therefore the study focuses 
on PAMs as the standard for identifying disparities with the AMOs. Not all researchers agree with 
this conclusion.(110) Interestingly the PAM is more sensitive for identifying vCMs than any other 
source. 
 
This study identifies disparities in medication soon after admission to hospital and therefore prompts 
their resolution during the in-patient episode. What is less clear is what would happen if the 
intervention were not made. Would other healthcare professionals act to resolve the disparity? Non-
interventional studies should be considered to identify the expected outcomes in the absence of 
medication reconciliation. 
 
7.3.4. Comparisons with other studies 
 
 
Table 54 (Appendix 7) describes the validated continuing medication (vCM) as determined by a 
single experienced clinical pharmacist (DT) and enables comparison to sources of information 
recorded during this study. The vCM is in effect a subjective view of what the patient should be 
taking and may be described as the ward pharmacist‘s recommended therapy at the point of 
admission and prior to clinical review. The subjective nature of this parameter makes this measure 
less suitable than the PAMs as the primary reference point for this study, although Stone et. al. 
used it as their main reference point.(110) Estimations of test sensitivity for vCM are also shown in 
Table 12 using methodology similar to Stone. This present study shows highest sensitivity for PAMs 
(0.83) and least for PODs (0.45), with caregiver information (0.66) in between. Stone obtained very 
different results with caregiver most sensitive (0.75), then PODs (0.64) and PAMs (0.25), and made 
the observation that: ―… Parents provide accurate and only minimally incomplete information when 
available;”. Methodology between the two studies varies (e.g. Stone used 5 information sources) 
and cohort types were also different (Stone = medically complex children, this present study = 
neuro-paediatrics). However these cohort differences seem unlikely to fully explain the differences 
in results. This present study shows that prescribers of AMOs place considerable reliance on 
caregiver information but that this is not a reliable indicator of PAMs nor of vCMs. Indeed this 
present work concludes that clinically useful medication reconciliation requires obtaining PAMs from 
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the GP. Further work is required to examine these issues in more detail and across other cohorts 
for paediatrics. 
 
NICE-NPSA guidance confirms the need for medication reconciliation in adult patients and quotes 
studies that demonstrate the benefits in this population.(17) One of these studies, by Gleason et al., 
(116) considered medication reconciliation in 204 direct admissions to an adult medical-surgical unit. 
This study classified the clinical significance of discrepancies between pre-admission medications 
and AMOs into multiple categories, and reported these in three groupings. Similar results to the 
present study were reported for the potential for harm during the hospitalisation period; 23% of 
discrepancies could have necessitated patient monitoring or intervention to preclude harm (middle-
risk grouping) and 22% could have resulted in patient harm (high-risk grouping). While the 
classification groupings differ in definition between the study by Gleason and this present study, the 
percentages of patients in the middle and high-risk categories in the Gleason et al. study of adult 
patients are similar to those in this study in paediatric patients. NICE-NPSA quote Gleason in their 
guidance and so should consider the findings in this present study as evidence for medication 
reconciliation in patients less than 16 years of age. 
 
7.4. Conclusions 
 
In the absence of medication reconciliation, initial AMOs may be based on inadequate information 
and may lead to unintentional changes to a patient‘s existing prescribed medication. The practice, 
by hospital pharmacy staff and possibly others, of using PODs as a reliable information source of 
pre-admission prescribed medication is not supported by this present study. This finding has 
implications for routine ward pharmacy practice and SoPs for MR should reflect the limitation of 
PODs as an information source. 
 
This study provides evidence of the clinical importance of medication reconciliation for children 
taking long-term medication on admission to hospital and promotes the adoption of this process, 
although not currently recommended by NICE-NPSA. The absence of medication reconciliation on 
admission to hospital for children increases their exposure to risks from inappropriate prescribing 
changes. National guidance should reflect such risks and include children within the categories of 
patients for whom medication reconciliation on admission to hospital is required. Performing 
medication reconciliation has the potential to reduce patient harm for children admitted to hospital. 
 
Publications relating to this study are listed within the references.(128-132) 
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8. Medicines management on admission to hospital: 
advice provided by PCTs to GPs. 
 
8.1. Introduction 
 
Chapter 7 of this thesis demonstrates evidence of the clinical importance of medication 
reconciliation for children on admission to hospital. Central to conducting this service is obtaining 
essential medication information from the referring healthcare organisation, usually the GP. 
Analysis of medicines management strategies or policies described in Chapter 6 show a significant 
difference over time between primary care and hospital Trusts in respect to admission medication. 
Hospitals place greater importance on this issue than PCTs within the documents analysed. To 
ensure that medication reconciliation for children is facilitated it is important that the two sectors 
collaborate together to ensure transfer of essential information. 
 
The NICE-NPSA published guidance in 2007 concerning medicines reconciliation on admission for 
adults has been described in the previous chapter.(17) However it is noteworthy that this guidance 
requires admitting organisations to identify all medication being taken on admission rather than 
requiring the referring organisation to provide the details. More recently in March 2008 a minimum 
dataset for the transfer of essential medication information between healthcare sectors was defined 
by the National Prescribing Centre.(70) This guidance recommends that the dataset is made 
available to admitting organisations. Furthermore, in 2009 the NPSA published guidance (2) 
requiring Primary Care Organisations to review the processes used to transfer medication 
information across the healthcare interface, stating 
“Actions in relation to specific areas of medication-related risk should include: a review of 
processes for the accurate and timely transfer of medication-related information across all 
interfaces, but in particular in conjunction with the acute sector.” 
 
Prior to publication of these documents the role of GPs in providing prospective advice about 
medication on admission of a patient to hospital lacked national guidance. Furthermore it was 
unknown if PCTs provided local guidance on this matter to their contractor GPs.  
 
This study seeks to identify the provision of local guidance by PCTs to GPs to support medication 
information transfer for patients on admission to hospital: and does so at two points in time. Firstly 
in 2007 prior to the publication of national guidance and again in 2009 after the guidance from 
NICE-NPSA and the NPC was published. 
 
 Page 90 
Aim:  To identify guidance provided by English Primary Care Trusts to General  
Medical Practitioners concerning essential medication information  
transfer (e.g. minimum data sets) on admission of patients to hospital. 
 
Objectives:  To develop a suitable survey instrument to identify guidance  
provided by PCTs within this study area. 
To complete a two point longitudinal survey of all English PCTs in 2007 and 2009. 
To identify the frequency of guidance provided by PCTs for GPs  
within this study area and how has this changed during the period  
2007-2009. 
 
Research Questions:  What is the frequency of guidance provided by PCTs  
for GPs within this study area and how has this changed during the period 2007-2009? 
 
 
The 2007 survey instrument was designed to determine if PCTs provide advice to GPs concerning 
the provision of prescribed medication when a patient is admitted to hospital. Where PCTs provide 
advice the questionnaire requested details of the provision of that guidance and permission to share 
that advice with others. The 2009 survey instrument was a follow up study designed to harvest 
similar information as in 2007 and thereby identify changes during the intervening period. 
 
Analysis of medicines management policy documents described in Chapter 6 identified two major 
lines of enquiry within this programme of study. These were: 
c. information transfer following paediatric admission to hospital 
d. the involvement of hospital services to support access to medicines for children in 
the community 
This is the second of two studies described within this thesis investigating medication information 
transfer following paediatric admission to hospital.  
 
 
 
8.2. Results 
 
8.2.1. 2007 survey 
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A total of 72 questionnaires (49.7%) were completed and returned. See figure below. One recipient 
declined to respond. 
 
Figure 7 PCT study. Response to 2007 survey 
 
145 surveys sent 
by email
No response 
n = 72 (49.7%)
by email (100%)
Response 
received
n = 72 (49.7%)
Declined
n = 1 (0.7%)
 
Responses were received from day 0 to day 24 after the first email was (successfully) delivered. 
See figure below. 
 
Figure 8 PCT survey. Time response to 2007 survey 
 
This survey asked 4 questions. The questions and summary responses are described below. 
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Question 1 
Does your PCT provide operating guidelines to GPs in respect to prescribing 
information to be provided to the hospital when a patient is referred or admitted to 
hospital? 
 
Summary of results: 
No   n = 54 (75.0%) 
Yes  n = 7 (9.7%) 
Unclassified  n = 11 (15.3%) 
Total  n = 72 (100%) 
 
Unclassified responses were received from 11 respondents and 12 comments were coded as: 
 GP computer system changes (n=1) 
 Take all meds into hospital (e.g. green bag scheme) (n=5) 
 Determining secondary care requirements (n=1) 
 Provide general advice regarding good practice (n=1) 
 Guidance is being drafted (n=2) 
 Guidance is provided but not by PCT (n=1) 
 Uncoded (n=1) 
 
 
Question 2 (if Q1 = No) 
If answer to Q.1 is no are you aware of any plans for your PCT to provide such 
guidance? 
 
Summary of results (responses where Q1 = No): 
No   n = 37 (68.5%) 
Yes  n = 10 (18.5%) 
Unclassified  n = 4 (7.4%) 
No answer n = 3 (5.6%) 
Total  n = 54 (100%) 
In addition to the above responses a further 2 respondents confirmed that they have plans to 
provide guidance. These are not included in the summary above since they provided an 
unclassified answer to question 1. Therefore a total of 12 PCTs indicated that they had plans to 
provide such guidance in the future. 
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Unclassified responses to this question were received from 4 respondents and were coded as: 
 Currently under review (n=1) 
 Possible preparation in the future (n=3) 
 
Question 2 (if Q1 = Yes) 
If answer to Q.1 is yes would you be willing to provide a copy of that guidance? 
 
Summary of results: 
No   n = 0 (0%) 
Yes  n = 3 (42.9%) 
Unclassified  n = 4 (57.1%) 
Total   n = 7 (100%) 
 
A total of 3 documents were provided by PCTs in response to the survey and were shared with 
those who requested them. These documents were: 
 
1. A draft document with the caveat: ―Can say we have a form but don‘t share form yet as 
it is still in development stage‖ (n=1) 
2. Transfer of Care document (n=1) 
3. Full guidance (n=1) 
 
The survey elicited a number of free text comments. These were coded and are summarised below: 
 If the referral is through Choose & Book (all relevant information is automatically sent 
through to the hospital electronically) (n=3) 
 providing PCT guidance is a good idea (n=4) 
 expect to provide guidance in the future (n=6) 
 patients take PODs into hospital (which provides sufficient information) (n=1) 
 need standard discharge information (n=1) 
 issue not raised by local hospital (n=1) 
 transfer of care report has been developed (GP computer system) and provided to local 
hospital (n=2) 
 guidance can be found incorporated within a number of documents (=1) 
 guidance is provided by the acute trust (n=2) 
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Question 3 asked ―If you send guidance are you willing for your PCT to be identified within 
any report?” A total of 11 respondents answered this question, with 8 (72.7%) answering the 
question with Yes. 
 
Question 4 was an invitation to request aggregated data obtained during the study, which was 
requested by 44 respondents (61%). 
 
8.2.2. 2009 survey 
A total of 65 electronic questionnaires (51.6% of those successfully delivered) were completed on-
line. Dates of completion of the survey were not recorded. Figure 9 shows the response statistics. 
 
Figure 9 PCT survey. Response to 2009 survey 
 
146 surveys sent 
by email
Email not 
delivered n = 20 
Email delivered 
successfully 
n = 126 (100%)
Questionnaire 
response recorded
n = 72 (57.1%)
Actively declined 
to participate 
n = 3 (2.4%)
No response 
n = 51 (40.5%)
Questionnaire 
completed n = 65
(51.6% - 65/126)
Questionnaire not 
completed 
n = 7 
(5.6% - 7/126)
 
 
The questionnaire was considered to be not completed if there was no response to both questions 
1 and 2. Responses to the 2009 survey (5 questions) are shown below, together with equivalent 
responses in 2007 for questions 1, 2 and 5, for ease of comparison. Modifications to the wording of 
the 2007 survey are underlined in the question text. Appendices 2 and 3 show details of the 
surveys. 
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This study found that in 2007, 9.7% (n = 7) of PCTs provided operating guidelines to GPs in respect 
to medication information on admission to hospital. The study in 2009 found that this figure had 
risen to 23.1% (n = 15). See question 1 below. In 2007 a total of 12 (22%) PCTs confirmed they had 
plans to develop guidance (see section 8.2.1 above), rising to 22 (44%) in 2009. Of those PCTs 
who confirmed they had written guidance in 2009 (n =15) more than half (n = 8, 53%) stated that 
national guidance was a major or full influence to do so. This same sub-group of 15 PCTs was 
asked to rate the expected impact on patient care of their guidance. Nine PCTs (60% of this sub- 
group) stated that the guidance was expected to provide a major or full impact on patient care. 
Detailed responses are shown for questions 1 to 5 below. 
 
Question 1 
Does your PCT provide written operating guidelines to GPs in respect to prescribing 
information to be provided to the hospital when a patient is referred or admitted to 
hospital? 
 
 
Q1 response 2009 2007 
No n = 50 (76.9%) n = 54 (75.0%) 
Yes n = 15 (23.1%) n = 7 (9.7%) 
Unclassified Not applicable n = 11 (15.3%) 
Total n = 65 (100%) n = 72 (100%) 
 
Question 2 (offered where Q1 = No)  
Are you aware of any plans for your PCT to provide such guidance? 
 
Q2 response 2009 2007 
No n = 28 (56.0%) n = 37 (68.5%) 
Yes n = 22 (44.0%) n = 10 (18.5%) 
Unclassified Not applicable n = 4 (7.4%) 
No answer Not applicable n = 3 (5.6%) 
Total n = 50 (100%) n = 54 (100%) 
 
 
Question 3 (offered where Q1 = Yes)  
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How influential was national guidance in the preparation or revision of your 
guidance? 
Summary of results: 
No influence   n = 1 (6.7%) 
Little influence  n = 0 (0%) 
Moderate influence n = 6 (40.0%) 
Major influence  n = 6 (40.0%) 
Full influence  n = 2 (13.3%) 
Total   n = 15 (100%) 
 
Question 4 (offered where Q1 = Yes)  
How would you describe the expected impact of your guidance on patient care? 
Summary of results: 
No impact   n = 0 (0%) 
Little impact  n = 2 (13.3%) 
Moderate impact n = 3 (20.0%) 
Major impact  n = 7 (46.7%) 
Full impact  n = 2 (13.3%) 
No answer  n = 1 (6.7%) 
Total   n = 15 (100%) 
 
 
Question 5 (offered where Q1 = Yes)  
Are you willing to provide a copy of your current guidance? 
 
Q5 response 2009 2007 
No n = 2 (13.3%) n = 0 (0%) 
Yes n = 8 (53.3%) n = 3 (42.9%) 
Uncertain / 
Unclassified 
n = 3 (20.0%) n = 4 (57.1%) 
No answer n = 2 (13.3%) n = 0 (0%) 
Total n = 15 (100%) n = 7 (100%) 
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Five respondents made free text comments within question 5. In summary, these were: current 
guidance is being developed or updated (n=3); GPs are expected to write their own guidance (n=1); 
an appropriate audit is under development (n=1). 
 
The survey offered to provide aggregate results if a recipient‘s email address was provided. 27 
respondents provided an email address [in 2007 44 respondents requested aggregate results]. 
 
An opportunity to add further free text comments was also made available at the end of the survey 
and 13 respondents did so. These comments are summarised in themes below: 
 
 Audit of information provided on transfer (n=4) 
 MUR pre-admission (n=1) 
 MUR post-discharge (n=1) 
 Cross-sector collaboration on guidance (n=5) 
 Acute Trust defined minimum dataset for admission (n=1) 
 Elective admission information template in use (n=1) 
 Information on admission is not part of GP contract (n=1) 
 Monitoring of information on admission added to acute trust contract (n=1) 
 Existing policy needs major revision (n=1) 
 Need electronic exchange of information (n=1) 
 Admission letter to patients includes take in repeat medication details (n=1) 
 PCT requests GP to fax information to hospital on admission – with little success (n=1) 
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8.3. Discussion 
 
8.3.1. Main findings 
 
The two surveys have identified the provision of PCT guidance to GPs concerning medication 
information transfer at two points in time, 2007 and 2009. Prior to these studies the frequency of the 
provision of advice by PCTs to GPs in this subject area was unreported. This study demonstrates 
that there has been an increase in the provision of guidance during the two years between the 
surveys, rising from approximately 1 in 10 PCTs in 2007 to almost 1 in 4 by 2009. Even so, by 
2009, a large majority of PCTs failed to provide clear direction in this matter to their GP contractors. 
  
During the two year period between the surveys three major national documents were published. 
These publications were designed to encourage the development of medicines management 
seamless care processes between the healthcare sectors. Two of these, NICE-NPSA and NPC 
guidance, both concern the introduction of  medication reconciliation and primarily focus on 
admission processes.(17, 70) The third document, a report by the Care Quality Commission, has a 
wider brief and considers both admission and discharge processes. The influence of national 
guidance on respondents was explored in this study. Over 50% of respondents who provided their 
own guidance to GPs stated that national guidance was a major or full influence. However, these 
national documents failed to prompt over 75% of PCTs to provide any substantial guidance to their 
GPs. Why would over three quarters of PCTs fail to provide such guidance in the light of national 
recommendations? It may be suggested that at the time of this present study PCTs believed no 
action was required of them or their medical contractors. Anecdotal evidence suggests that primary 
care organisations expected secondary care Trusts to obtain admission medication information from 
GPs, rather than the GPs to actively provide it themselves. Further studies will be required to test 
this hypothesis.  
 
The Care Quality Commission report was published in October 2009 and is probably too late to 
have influenced respondents in this present study. However, the responsibility of PCTs to promote 
appropriate transfer of essential medication information on admission to hospital is implicit within 
this document. A key recommendation of this report is that: 
“ … PCTs need to ensure that better information is sent to hospitals on admission, 
particularly in emergency cases.” (14) 
 
This present study may also have stimulated the development of PCT guidance to GPs. The 
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documents provided by respondents and made available for sharing with other PCTs in the 2007 
study were sent to those who requested such feedback and this may have contributed to the 
change. Further provision of documents in 2009 may also stimulate PCT action.  
 
Reporting the baseline of PCT provided guidance in 2009 as less than 1 in 4 of respondent PCTs 
(15 of 65), in the context of national recommendations from the CQC, may further promote local 
action by NHS organisations. 
 
The absence of appropriate data on admission to hospital may contribute to the unintentional 
changes to medication on admission described elsewhere in this thesis. However, at present it may 
be accepted by acute Trusts that it is necessary for them to obtain the medication information from 
the patient‘s primary care providers since this process is noted within the West Midlands Medication 
Reconciliation operating policy approved by the West Midlands (acute Trusts) Clinical Pharmacy 
Network.(133) Interestingly, primary care organisations clearly expect details of discharge 
information to be sent to them, rather than obtain it or request it themselves. (9, 11, 12, 16, 134)   
 
As described in Chapter 6, it is noteworthy that advice on the provision of medication information 
transfer was not found within the Medicines Management Strategies of the NHS organisations in 
either sector in 2007 and at that time, appears to be at best of low importance for both the primary 
care and secondary care sectors. By 2009 this had changed significantly for PCTs when 5 (83%) 
included admission medication in their medicines management documents, and was found in a 
further 7 (58%) documents from hospital Trusts. 
 
The preliminary study (2007 data only) was accepted as an abstract and poster at the British 
Pharmaceutical Conference 2009 under the heading: 
 Guidance provided by English Primary Care Trusts to General Practitioners concerning 
medication information on admission to hospital.(135) 
 
8.3.2. Strengths of this study 
 
The methods used elicited useful response rates in both surveys and at a frequency reported by 
others for this type of research within this field of practice. (136) The survey was sent to the whole 
population (all PCT medicines management leads in England) and obtaining results from 
approximately half of the total population may be considered useful. 
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8.3.3. Limitations of this study 
 
Whilst the response rates (49.7% in 2007 and 51.6% in 2009) are in keeping with other studies of 
this cohort some consideration of bias due to the absence of data from the non-responders should 
be made. Direct enquiry with the non-responders was considered inappropriate since the most 
acceptable route of communication (email) did not in itself bring about a response after 3 attempts 
and other modalities of enquiry were seen as too aggressive and possibly abrasive. Across the two 
surveys a total of 4 subjects declined to take part, commonly citing work pressures as the reason for 
their non-participation. It may be argued that if reporting bias has been introduced due to non-
response that this would most likely be in the positive direction, since respondents with guidance 
available may be more likely to share their good practice by participation within the surveys. 
Maximising response is desirable and options to modify the methods used for this study may need 
consideration. In total both surveys used 3 email invitations to participates if necessary, which may 
be considered standard practice within this type of survey for this subject group.(136) In both 
surveys the third and final request led to additional responses (n=17 in both 2007 & 2009). A fourth 
invitation may therefore have produced a greater response. However, whilst this may seem 
attractive it was decided not to do so since the third emailing was described as the final reminder 
and another after this may have led to discontent by the subjects of the study. Furthermore the 
declaration that the third emailing was the last reminder may in itself have prompted a response 
from the late participants. Stating that less than 1 in 10 PCTs in 2007 and less than 1 in 4 PCTs in 
2009 had provide guidance to their GPs may best be qualified in stand alone statements by 
including the relative response rates of the surveys. 
 
Cognitive testing of the survey questions was not undertaken. The response to pilot questionnaires 
indicated that the wording of the questions was acceptable for this class of healthcare professional. 
 
8.3.4. Comparison with other studies 
 
Literature searches failed to identify any similar published works in this subject area. 
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8.4. Conclusions 
 
This study had three objectives, all of which have been met within the limitations of the methods 
employed in that: 
1. Suitable survey instruments were developed and were used to identify guidance provided by 
PCTs within this study area. 
2. Two cross-sectional surveys of all English PCTs during both 2007 and 2009 were completed. 
3. The frequency of guidance provided by PCTs for GPs within this study area and how this 
changed during the period 2007-2009 was determined. 
 
This study confirms that advice from PCTs to GPs concerning medication information transfer on 
admission is not usually provided, although this has increased during the period 2007 from 1 in 10 
to almost 1 in 4 by 2009 and that a number of other PCTs are developing such guidance. 
 
At the close of the study in 2009 a large majority of PCTs failed to provide guidance to GPs 
concerning the provision of medication information on admission to hospital. This failure prompts 
acute Trusts to collect this information themselves within the medication reconciliation process 
following admission. Responsibility to provide this data would enhance the provision of medication 
reconciliation and embed the clinical benefits that this process brings to patient care. Defining 
responsibilities within the transfer of care process may be beneficial. For example if the transferring 
organisation were mandated to provide information to the next healthcare organisation then this 
could be audited and delivery enhanced. In the absence of electronic transfer of information it may 
be useful to ensure that the patient or their caregiver also receives information describing their 
current regular medication. Benefits may be realised if patients taking long-term medicines were 
given a card highlighting the details that they could pass on to their next healthcare professionals. 
Providing such information in lay terms for the patient, including the purpose of each prescribed 
drug may enhance patient understanding and compliance with prescribed medication regimens. 
Further studies considering the provision of long-term medication information to patients or their 
carers are recommended. 
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9. Hospital medical staff involvement in provision of 
medication for paediatric home-patients 
 
9.1. Introduction 
 
 
As described in section 1.3.2 on page 27 paediatric patients needing long-term medication may 
experience particular problems in obtaining their medicines. There are some published reports that 
clinical units in hospitals may provide support for patients in primary care who need help to obtain 
the medicines they require. Support is typically provided via telephone helplines, where patients or 
their caregivers can request help to obtain their medicines.(137, 138) This support may include 
providing hospital written prescriptions, including those that can be dispensed in the community 
usually described as FP10HPs. This study focuses on paediatric patients and their caregivers who 
request urgent help from hospital staff, to obtain the medicines they need when at home (home-
patients). 
 
This study aims to identify the involvement of paediatric hospital medical staff in supporting home-
patients to obtain the medicines they need, usually by providing prescriptions and / or arranging for 
the hospital pharmacy to provide the medication. Where prescribing responsibility has been 
transferred from the GP to the hospital (this patient cohort would then be defined as continuing-care 
patients) then the patient ceases to be classified as a home-patient and is excluded from this study. 
Patients receiving hospital prescriptions as either out-patient or Emergency Department attendees 
are also excluded from this study. Definitions of these two groups are shown below: 
 
Continuing-care Patients. Patients where some or all of their long-term medications are 
provided by hospital services. Prescribing responsibility rests with hospital staff. 
 
Home-patients. Patients located outside hospital, usually at home and for whom 
prescribing responsibility rests with their GP. 
 
The study also explores the opinions and costs of hospital medical staff in prescribing for paediatric 
home-patients: an activity known locally as providing rescue-medication. 
 
Analysis of medication policy documents described in Chapter 6 identified two major lines of enquiry 
within this programme of study. These were: 
a. information transfer following paediatric admission to hospital 
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b. the involvement of hospital services to support access to medicines for children in the 
community 
 
This is the first of four studies described within this thesis investigating the involvement of hospital 
services to support access to medicines for children in the community. 
 
 
9.2. Results 
 
The electronic survey was successfully delivered to 340 medical staff at BCH. Thirteen confirmed 
that they did not wish to take part. A total of 167 surveys (49.1%) were returned although two 
included only demographic details and therefore descriptive statistics are based where appropriate 
on a cohort of 165 (48.5%). 
 
9.2.1. Demographics 
The number of years experience in paediatrics of the respondents ranged from 0 years to 30 years 
with over 83% having more than 2 years experience (mode = 9 years). See table below. 
 
Table 9 Medical staff survey. Years experience in paediatrics of respondents 
 
Paed years Frequency 
Valid 
Percent 
0 < 2 28 16.8 
2 < 6 27 16.2 
6 < 11 39 23.4 
11 < 16 35 21.0 
16 < 21 23 13.8 
21 < 26 10 6.0 
26 < 31 5 3.0 
TOTAL 167 100.0 
 
 
Responses were received from 24 different specialties with frequency range from n=1 to 19. 
Responses were received from all the major medical specialties and sub-specialties at Birmingham 
Children‘s Hospital and included: psychiatry (n=19); general-surgery (n=15), anaesthetics (n=14); 
emergency medicine (n=12). Respondents included 89 consultants (53.6%) and 77 junior doctors 
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(46.4%). Designations are shown in Table 10 below. 
 
Table 10 Medical staff survey. Designation of respondents 
 
DESIGNATION Frequency 
Valid 
Percent 
Consultant 89 53.6 
Other 15 9.0 
Registrar 39 23.5 
SHO 20 12.0 
Staff Grade 3 1.8 
Total 166 100.0 
Missing  1   
Grand total 167   
 
9.2.2. Prescribing data and risk 
 
The majority of respondents (n=126, 76.4%) confirmed that they signed so called FP10HP NHS 
hospital prescriptions each month (all reasons) at a median frequency of 11 per month. The total, 
determined using the calculated mid-points method (see page 58), combined for all respondents 
per month = 1,742. Table 11 shows the frequency with which respondents signed prescriptions in 
one month. 
 
Table 11 Medical staff survey. Frequency of signing FP10HP prescriptions in one month 
 
FP10HPs 
in 1 month 
Frequency 
Valid 
Percent 
None 39 23.6 
1-5 56 33.9 
6-15 46 27.9 
15-30 14 8.5 
31-100 8 4.8 
> 100 2 1.2 
Total 165 100.0 
Missing 2  
Grand total 167  
 
[Estimated total frequency = Sum(56x3, 46x11, 14x23, 8x66, 2x109) = 1,742 per month] 
 
Nearly half of respondents (49.1%, n=81) provided urgent prescriptions (rescue-medication) for 
home-patients in the preceding 3 months. The total frequency of writing rescue-medication 
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prescriptions for home-patients during a three month period is calculated as 714 prescriptions for an 
estimated 600 patients. The responses are shown in Table 12 below. 
 
Table 12 Medical staff survey. Frequency of writing rescue-medication prescriptions in a 3 
month period 
 
Rescue-med 
prescriptions 
Frequency 
Valid 
Percent 
None 81 50.0 
1-5 46 28.4 
6-10 18 11.1 
11-30 14 8.6 
31-60 3 1.9 
Total 162 100.0 
Missing 5   
Grand total 167   
 
[Estimated total frequency = Sum(46x3, 18x8, 14x21, 3x46) = 714 (3 month period)] 
 
 
A majority 65.7% (n=84) of respondents stated they often or always knew who held prescribing 
responsibility for the patient (GP or hospital). These respondents are confirming that they were able 
to discern when they were prescribing for home-patients or continuing-care patients. Prescriptions 
provided for home-patients are described as rescue-medication. 
 
Nearly half (44.7% n=34) of those who wrote prescriptions for home-patients described the risk to 
patients if they did not provide this service as ―high‖ or ―very high‖.  (consultants n = 22, 50%; junior 
doctors n = 12, 37.5%). 
 
9.2.3. Causation 
 
Respondents were given 5 possible options to express their opinion of the cause of medication 
access problems, summarised as: carer issue, pharmacy issue, formulation issue, communication 
issue or GP issue. The option selected with the highest frequency 44.5% (n = 65) was ―GP Issue‖.  
See Table 13 below. 
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Table 13 Medical staff survey. Reason for problems 
 
Reason Frequency 
Valid 
Percent 
Carer Issue 19 13.0 
Pharmacy Issue 9 6.2 
Formulation Issue 2 1.4 
Communication Issue 25 17.1 
GP Issue 65 44.5 
Don't know 25 17.1 
Other 1 0.7 
Total 146 100.0 
Missing 12   
Not applicable 9   
Grand total 167   
 
Respondents were ambivalent when asked to consider their agreement with the statement: 
GP's are reluctant to prescribe continuing medication for children. With: 
 23.8% (n=37) disagree or strongly disagree 
 37.4% (n=58) neither agree nor disagree 
 38.7% (n=60) agree or strongly agree. 
 
Respondents were given a list of seven possible reasons to express their opinions why GPs might 
decline to provide repeat prescriptions for children. The response scale was: very unlikely – quite 
unlikely – sometimes – quite likely – very likely. Responses are summarised below in order of the 
frequency of respondents selecting either quite likely or very likely: 
 
 Clinical concerns about the drug or regimen required – 56% (n=84) quite likely or very 
likely 
 Communication issues – 52% (n=78) quite likely or very likely 
 PCT influence or instruction – 47.4% (n=71) quite likely or very likely 
 Money / finances – 44.7%  (n=67) quite likely or very likely 
 Inadequate supporting information – 44.7% (n=67) quite likely or very likely 
 Drug(s) not on GP computer system – 26.6% (n=40) quite likely or very likely 
 Workload – 19.4% (n=29) quite likely or very likely 
 
9.2.4. Interaction with community pharmacists 
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Respondents were asked: In the last 12 months approximately how often have you been contacted 
by a community pharmacist concerning a hospital prescription you or a BCH colleague has written? 
Responses are shown in the table below.  
 
Table 14 Medical staff survey. Contact with CPs in last 12 months 
 
CP contact in 12 months Frequency 
Valid 
Percent 
Never 72 48.0 
1-12 68 45.3 
13-24 7 4.7 
25-52 3 2.0 
Total 150 100.0 
Missing 17   
Grand total 167   
 
The two variables (1) CP contact in 12 months and (2) the frequency of signing FP10HPs were 
plotted as a cross-tabulation. See table below. The frequency of CPs contacting hospital 
prescribers can therefore be determined. As expected these two parameters show a statistically 
significant relationship (p < 0.001). 
 
Table 15 Medical staff survey. Contact with CPs in last 12 months against numbers of 
FP10HPs signed. 
 
FP10s 
per 
month 
CP contact in 12 months 
Total Never 1-12 13-24 25-52 
None 33 2 0 0 35 
1-5 28 24 0 0 52 
6-15 11 25 3 2 41 
15-30 0 11 2 0 13 
31-100 0 5 1 1 7 
> 100 0 1 1 0 2 
  72 68 7 3 150 
 
 
A group of four questions examined actions prescribers might take to support CPs dispensing their 
prescriptions. Responses are summarised below, in order of the frequency of respondents selecting 
that they would be prepared to take that action: 
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 Would you be prepared to use a pre-inked stamp to show your name clearly on FP10HPs 
you sign? – Yes = 94.8% (n=127) 
 If you prescribe dose regimens on FP10HPs which are not included in standard texts would 
you be prepared to acknowledge that you have done so knowingly on the prescription (e.g. 
endorse: NOT-BNF)? – Yes = 89.8% (n=114) 
 Would you be prepared to indicate the dose calculation as well as the final dose on 
FP10HP prescriptions you sign (where applicable)? e.g. state mg per kg as well as 
calculated dose. – Yes = 84.7% (n=111) 
 Would you be prepared to always add YOUR hospital telephone number to FP10HPs you 
sign? – Yes = 82.3% (n=107) 
 
9.2.5. Service changes 
 
Respondents were given three possible service changes and were asked to indicate in their opinion 
how beneficial the proposed change to national guidance would be in reducing the problems 
associated with prescribing for paediatric patients in primary care. These proposals were: 
A. Require GPs to prescribe all continuing medicines 
B. Require hospitals to prescribe & dispense unlicensed / uncommon medicines 
C. Enable hospital pharmacies to dispense GP prescriptions 
 
Responses are shown in the table below. 
 
In summary, the numbers of respondents indicating the benefit of each option to be either ―high‖ or 
―very high‖ (scale no benefit – small benefit – moderate benefit – high benefit – very high benefit) 
were: 
 
1. Require GPs to prescribe all continuing medicines 63.2% (n=79)  
2. Require hospitals to prescribe & dispense unlicensed / uncommon medicines 37.9% (n=50) 
3. Enable hospital pharmacies to dispense GP prescriptions 34.5% (n=44) 
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Table 16 Medical staff survey. Response to proposed service changes 
 
Response 
A. GPs to 
prescribe all 
B. Hosp to 
prescribe  ULMs 
C. Hosp Pharm disp 
GP Rxs 
No benefit n=8 (6.4%) n=21 (15.9%) n=20 (15.7%) 
Small 
benefit 
n=8 (6.4%) n=26 (19.7%) n=30 (23.6%) 
Moderate 
benefit 
n=30 (24%) n=35 (26.5%) n=33 (26%) 
High 
benefit 
n=43 (34.4%) n=35 (26.5%) n=36 (28.3%) 
Very high 
benefit 
n=36 (28.8%) n=15 (11.4%) n=8 (6.3%) 
Total n= 125 (100%) n=132 (100%) n=127 (100%) 
Missing n=19 n=20 n=20 
Don't know n=23 n=15 n=20 
Grand total n=167 n=167 n=167 
 
Respondents were invited to give their opinion of which single achievable change would bring 
about the most benefit for patients concerning problems associated with interface (primary 
care - hospital) prescribing. 114 free text responses were provided and coded. Each 
response was assigned a maximum of 2 codes. The two codes with the highest frequency 
were: 
 Improve communication n=42 
 GP to prescribe all n=10 
The 42 ‗improve communication‘ responses were further sub-coded. Of this cohort the two 
sub-codes with the highest frequency were: 
 Improve hospital to GP communication n=14 
 Improve communication in general (non-specific) n=9 
 
9.2.6. Dispensing arrangements 
Respondents were asked: Please indicate your opinion about the statement below: 
In my opinion hospitals should ensure that all out-patient prescriptions are 
dispensed by the hospital pharmacy (i.e. FP10HPs are not required). 
 
Table 17 shows responses to this question. 42.2% (n=62) of respondents disagree or strongly 
disagree with this statement. 
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Table 17 Medical staff survey. All out-patient prescriptions should be dispensed by the 
hospital pharmacy 
 
HP disp all OP 
Rxs 
Frequency 
Valid 
Percent 
Strongly disagree 19 12.9 
Disagree 43 29.3 
Neither 38 25.9 
Agree 33 22.4 
Strongly agree 14 9.5 
Total 147 100.0 
Missing 20   
Grand total 167   
 
9.2.7. Prescriber training 
 
Respondents were asked: Please indicate your opinion about the statement below.  
I would benefit from further training concerning the writing of 
prescriptions. 
Responses are shown in the table below, indicating that the respondents were ambivalent about 
this issue. 
 
Table 18 Medical staff survey. Benefit from further training 
 
Training Frequency 
Valid 
Percent 
Strongly 
disagree 
15 10.2 
Disagree 39 26.5 
Neither 48 32.7 
Agree 39 26.5 
Strongly 
agree 
6 4.1 
Total 147 100.0 
Missing 20   
Grand 
total 167   
 
 
9.3. Discussion 
 
9.3.1. Main findings 
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To the best of my knowledge this study identifies for the first time the frequency of provision of 
prescriptions by hospital prescribers for home-patients. The total number of prescriptions prescribed 
annually for home-patients by the respondents was estimated to be 2,856. Similarly the study 
allows an estimate of the total number of FP10HPs to be calculated, when prescribed for all 
purposes by the respondents annually. The annual total equals 20,904. The proportion of FP10HPs 
used by the respondents for home-patients is therefore estimated to be 13.7%. In this setting 
prescribers often use FP10HPs for routine hospital purposes including for out-patients, emergency 
department attendees and occasionally as discharge medication, in addition to providing rescue-
medication. According to the Prescription Pricing Authority, BCH issues some 36,000 FP10HPs 
(items) per year at a cost of approximately 2 million pounds (GBP). Using the same proportions the 
total number of items provided for home-patients by all BCH prescribers may therefore be estimated 
to be 4,918. 
 
In order to estimate the number of prescriptions supplied to home-patients the respondents must 
know who holds prescribing responsibility for any individual patient. Almost two-thirds of 
respondents state they often or always know who holds prescribing responsibility, and this cohort of 
respondents may be expected to make the most accurate estimation of prescriptions supplied to 
home-patients. The percentage of prescriptions provided by this specific cohort can be estimated by 
filtering results where responsibility equals often or always. The result for this cohort is found to be 
13.8%, a modest increase from the 13.7% for the whole study cohort, supporting the validity of the 
result of the study. 
 
The cost of dispensing the medicines provided to home-patients was not determined in this study, 
however based on proportions the value may be in the order of £300,000. Total annual drug 
expenditure for FP10s in this institution was £2.2M and 13.7% of this figure equals £301,400.  
Further studies will be required to obtain a more reliable estimate. Similarly the service costs of 
responding to urgent requests for support may be estimated since such activity may attract a 
possible service fee of £26 per event: a figure currently endorsed by the DH for telephone 
consultations. (Personal communication Commissioning Department Birmingham Children‘s 
Hospital to D Terry 1st February 2010: Used with permission). Annual service fees may therefore 
be in the region of £125,000 calculated by 13.7% of 36,000 each at £26. The combined total cost of 
providing these items to home-patients is therefore £425,000 per annum. Since this activity is 
supporting primary care service delivery these costs may be recovered from the PCTs concerned. 
In order to claim the costs incurred, patient details must be identified and details supplied to their 
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PCT. There are practical problems in identifying the patient for whom FP10HPs have been written.  
The PPA provides access to a database of dispensed FP10s known as ePACT. The ePACT 
database is designed to manage costs incurred by CPs so that they may be paid for the work they 
have done. This database does not include patient details and therefore hospital Trusts are 
disadvantaged when seeking to recover costs of drugs supplied via FP10HPs dispensed by CPs. 
One method to overcome this problem is to request copies of dispensed FP10HPs from the PPA 
and thereby identify the patient concerned. However this creates significant resource issues for the 
PPA and the hospital Trust will then have to manually extract the required information from the 
forms. Since November 2010 the PPA have automatically provided details of dispensed FP10HPs 
where the net ingredient cost (NIC) exceeds £1,000.(139) If the estimate of rescue-medications in 
this study is correct (4,918 items costing £301,400), then average costs per item is estimated to be 
£61 each. Therefore very few prescriptions will exceed the £1,000 threshold. 
 
44.7% (n=34) of those who write prescriptions for home-patients describe the risk to patients if they 
did not provide this service as ―high‖ or ―very high‖. Interestingly 42.9% (n=27) of consultants 
assess the risk as ―high‖ or ―very high‖ compared with 26.3% (n=16) of junior doctors: a statistically 
significant difference (p < 0.05%). There are two obvious explanations for this difference between 
the groups. These are: 1. Junior doctors may not have sufficient experience to appreciate the 
problems of getting long-term medicines, and especially unlicensed medicines, in primary care and 
2. Junior doctors may not see themselves as the last line of support for such patients where as 
senior medical staff may more readily assume this responsibility. 
 
This present study asked the respondents to assess five possible causes for home-patients seeking 
urgent hospital support to obtain their medicines (see section 9.2.3). Examples of these reasons 
may include: carer issue e.g. the caregiver not obtaining a prescription in time or not giving the 
community pharmacist adequate time to source and dispense the medicines before they run out; 
pharmacy issue e.g. the pharmacy cannot obtain and provide the item within the required time 
frame; formulation issue e.g. the prescriber or pharmacy have not prescribed or dispensed a 
formulation suitable for the patient to take; communication issue e.g. GP has not received details 
of hospital recommended treatment; GP issue e.g. GP declines to prescribe an unlicensed 
medicine. In this study respondents selected ‗GP issue‘ with the highest frequency and indicate that 
this may be because of clinical concerns. Further studies are required to identify the opinions of 
other stakeholders, including those of GPs. 
 
The options for improving services offered within the survey were chosen to reflect perceived 
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problems identified within field work, including the medical focus group, and are not necessarily 
practical solutions. Not surprisingly the option selected with highest frequency in this study is 
require GPs to prescribe all continuing medicines. The option require hospitals to prescribe & 
dispense unlicensed / uncommon medicines is the opposite solution and attracted much less 
support by the respondents. The final option enable hospital pharmacies to dispense GP 
prescriptions was included to accommodate the view that access to paediatric medicines is 
hindered by inadequate community pharmacy arrangements and therefore the patient not having 
access to suitable medicines. This option attracted the least support. These three options were also 
used in the survey of hospital nursing staff and the implications of the findings are discussed further 
in the discussion relating to that study (see page 135). When asked which single achievable change 
would bring about the most benefit for patients the most frequent response was improve 
communications. More detailed analysis of these responses, using sub-codes, reveals that hospital 
to GP communications is the most popular aspect of communications to be improved. Which facets 
of hospital to GP communications are important has not been explored within this current 
programme of studies. However, timeliness of communications may be an issue, since the medical 
focus group discussed the problems of discharge letters taking 6 weeks to be issued. 
 
The interaction between hospital prescribers and CPs is important when considering options for 
service changes. For example, it may be argued that primary care services fail to provide suitable 
access to medicines for children requiring long-term medicines. A possible service change to 
address this observation is to mandate hospitals to provide the medicines children require. Any 
evaluation of this proposal must consider the dispensing of hospital generated prescriptions by CPs 
since children and their caregivers may have problems in attending a hospital to collect their 
medication. The need to have prescriptions dispensed locally to the patient and therefore by CPs is 
endorsed, at least in part, by respondents in this present study: 42.2% of respondents disagree or 
strongly disagree that the hospital pharmacy should dispense all out-patient prescriptions. 
 
The survey enables an estimation of the average number of FP10HPs signed per BCH prescriber 
per year. This figure is calculated as 126 (20,900 prescriptions by 165 prescribers). Such 
substantial numbers of hospital prescriptions may be expected to generate a number of queries 
from CPs dispensing these prescriptions (see Chapter 12). This present study estimates the 
number of prescriptions signed per call from a CP as approximately 13, which is in keeping with the 
survey of CPs which estimates the figure to be 9.7 items per call.  The respondents confirm they are 
willing to support CPs by modifying the information they provide on the prescriptions they write. 
Over 80% of respondents confirmed they were willing to adopt each of the four suggested changes. 
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See page 108.  
 
The respondents are ambivalent about the benefits of further prescribing training. In this respect 
there is also no statistical difference between consultants and junior doctors. 
 
9.3.2. Strengths of the study 
 
A questionnaire was chosen as the study tool on the basis of the type of questions to be asked, 
their ease of completion, practicalities of data handling and availability of email addresses. The 
study cohort were all medical staff employed at the time of the study by BCH. All doctors surveyed 
had Trust email addresses and internet access. The response rate was in keeping with 
expectations and the opinions of over 165 hospital paediatricians were harvested. A large majority 
of respondents had significant experience in paediatrics. The survey successfully canvassed the 
opinion of all major clinical specialties and sub-specialties provided by the Trust. 
 
The results obtained are in keeping with known prescribing statistics for this institution provided by 
the Prescription Pricing Authority. 
 
9.3.3. Limitations of this study 
 
This single site study may not be generalisable to other paediatric hospitals and further studies are 
required to determine if this is a national problem or a local phenomenon. An explanation for this 
problem as a local issue can be put forward. For example, if BCH fails to provide a sufficient supply 
of medicines post-discharge then patients may need to return to the hospital during the early post-
discharge period. At best, patients are provided with 3 weeks supply of medicines on discharge 
from BCH. There are anecdotal reports, identified within the medical focus group relating to this 
study that discharge letters to GPs post-discharge may take 6 weeks to process.  If this is the case 
then patients may have up to a three week period when their GP does not have appropriate 
medication details when their TTO medication has run out. Patients and their caregivers will have 
TTO copies that they can present to the GP but details may be unclear and GPs may be reluctant to 
prescribe without full details from the hospital. However other studies reported in this thesis indicate 
that this phenomenon is found elsewhere and supports the view that this is a national issue (see 
Chapters 10 and 11). 
 
The survey asked respondents to express their level of agreement or disagreement with the 
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statement: GP's are reluctant to prescribe continuing medication for children. Results were 
ambivalent and this may reflect the ambiguity of the question.  
 
9.3.4. Comparisons with other studies 
 
Literature searches failed to identify any other similar published studies. 
 
 
9.4. Conclusions 
 
This study demonstrates the high activity rates undertaken by BCH medical staff to support 
paediatric patients to obtain the medicines they need but cannot easily obtain, through primary care 
services. This unfunded and previously unreported service may cost in excess of a third-million 
pounds per annum at the study institution and adds considerably to the workload of this important 
staff group. Based on this evidence the suitability of primary care services to provide long-term 
medicines for children has to be questioned. When presented with a list of possible causes 44.5% 
(n=65) selected ―GP issue‖ with 55% (n=84) stating that ―clinical concerns‖ were quite likely or very 
likely to be the reason for GPs not providing prescriptions. However respondents indicate that the 
single achievable service change which would bring about the most benefit for patients is to 
improve communication. In particular improving communication between hospitals and GPs is 
highlighted by the respondents. 
 
A preliminary report of this study has been published.(140) 
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10. Hospital nursing staff involvement in provision of 
medication for paediatric home-patients 
 
10.1. Introduction 
 
NHS patients treated outside hospital are by default the clinical responsibility of their GP.(3) When a 
patient is referred to a hospital consultant this may be considered an advisory service with the 
hospital physician advising the GP on how to manage their patient.(141) Should a GP wish the 
hospital staff to assume prescribing responsibility for any long-term medication this can often be 
arranged through local negotiation. Where responsibility is accepted by the hospital staff, the 
patient may be considered as a ‗continuing-care‘ patient, which is an exemption under Payment by 
Results funding pathways.(81) Under these arrangements the hospital may claim costs of the 
medication and service fees from the patient‘s PCT. As described in the previous chapter, two 
categories of NHS patients are identifiable: patients for whom the GP retains prescribing 
responsibility (home-patients); and those for whom the hospital takes prescribing responsibility 
(continuing-care patients). Home-patients receive their prescribed medication supplies via 
prescription from their GP dispensed by their CP. Continuing-care patients will receive their 
prescriptions from their hospital physician or prescriber. These may be dispensed by the hospital 
pharmacy. However, because of the practical difficulties for patients or their caregivers returning to 
the hospital for repeat supplies the hospital may issue FP10HP prescriptions that can be dispensed 
by CPs. Over 5.5 million hospital generated FP10s are dispensed by CPs in England each year 
[personal communication NHSBSA to D Terry used with permission. Copyright NHSBSA. 23
rd
 July 
2009]. 
 
Home-patients may encounter two types of problems when trying to obtain repeat supplies of 
medication: 1. the GP may be reluctant or unwilling to write a prescription and 2. the CP may be 
unable to dispense the prescription.(68) The later problem may also be encountered by continuing-
care patients trying to get hospital generated FP10s dispensed by a CP. Both types of problems 
may be considered a failure of primary care services to provide care for the patient. This study 
seeks to identify the involvement of hospital nurses in supporting patients encountering either of 
these types of problems. Clinical units in hospitals may provide support for patients in primary care, 
often via telephone helplines (137, 138) and it is known that nurses are involved in such 
services.(137)
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This study targeted hospital Clinical Nurse Specialists and Advanced Nurse Practitioners. 
 
According to one careers website (142): 
 
A specialist nurse (SN), also known as a clinical nurse specialist specialises in a particular 
area of nursing, caring for patients suffering from diseases such as cancer, diabetes or 
Parkinson's, viruses such as HIV/AIDS, or other conditions such as chronic heart failure. An 
SN provides direct patient care and support and can play a vital role in helping improve 
quality of life by educating the patient on the management and control of symptoms and 
offering support following diagnosis. In many cases, the involvement and intervention of an 
SN can prevent patient re-hospitalisation. The role varies from trust to trust. Some clinical 
nurse specialists also have a teaching and advisory role. They may be involved in advising 
medical and nursing staff about caring for patients with particular conditions and/or in 
teaching nurses and other professionals. 
 
The RCN (143) defines an advanced nurse practitioner as: 
 
 a registered nurse who has undertaken a specific course of study of at least first 
degree (Honours) level and who: 
 makes professionally autonomous decisions, for which he or she is accountable 
 receives patients with undifferentiated and undiagnosed problems and makes an 
assessment of their health care needs, based on highly developed nursing 
knowledge and skills, including skills not usually exercised by nurses, such as 
physical examination 
 screens patients for disease risk factors and early signs of illness 
 makes differential diagnosis using decision-making and problem-solving skills 
 develops with the patient an ongoing nursing care plan for health, with an emphasis 
on preventative measures 
 orders necessary investigations, and provides treatment and care both individually, 
as part of a team, and through referral to other agencies 
 has a supportive role in helping people to manage and live with illness 
 provides counselling and health education 
 has the authority to admit or discharge patients from their caseload, and refer 
patients to other health care providers as appropriate 
 works collaboratively with other health care professionals and disciplines 
 provides a leadership and consultancy function as required. 
 
 
Both Clinical Nurse Specialists (CNS) and Advanced Nurse Practitioners (ANP) are senior hospital 
nurses who provided clinical or psycho-social support for patients usually within a clinical specialty 
or sub-specialty and may manage direct patient requests for support. Within their role they are 
clinical decision makers.
 
 
At total of 338 paediatric CNS and ANPs were invited to participate in this study from 6 sites across 
the UK:  
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Birmingham Children‘s Hospital 
Sheffield Children‘s Hospital 
Leeds Teaching Hospitals NHS Trust 
Royal Belfast Hospital for Sick Children  
University Hospital of Wales-Cardiff 
Greater Glasgow NHS Board 
 
The objectives of this study were:  
1. to identify the involvement of paediatric hospital nursing staff in supporting home-patients to 
obtain the medicines they need when they are out of hospital, where prescribing 
responsibility rests with the GP. 
2. to quantify their involvement and estimate resource costs 
3. to establish if this is a national issue 
4. to determine why these issues occur in the view of the study cohort 
5. to identify process changes that may reduce such problems. 
 
10.2. Results 
 
An overall response rate of 64.8% (n=219) was obtained after 2 reminders, usually at weekly 
intervals. Site specific response rates ranged from 47.7% to 78.0%. See Table 19. 
 
Table 19 Nursing staff survey. Responses by site & survey start date 
 
SITE Respondents 
Valid 
Percent 
Cohort 
Response 
rate Survey start date 
BCH 78 35.6 100 78.0% 29
th
 September 2008 
SCH 39 17.8 64 60.9% 17
th
 February 2009 
LEEDS 28 12.8 49 57.1% 23rd June 2009 
BELFAST 19 8.7 27 70.4% 2
nd
 December 2009 
CARDIFF 24 11.0 33 72.7% 18
th
 November 2009 
GLASGOW 31 14.2 65 47.7% 18
th
 November 2009 
Total 219 100.0 338 64.8%  
 
10.2.1. Demographics 
 
Respondents were drawn from 32 different clinical paediatric specialties and sub-specialties 
(excluding ‗educator‘, ‗other‘ and ‗management‘). Specialties and numbers of respondents from 
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each site are shown in Table 20.  
Table 20 Nursing staff survey. Specialties of respondents 
 
Specialty 
Site 
Total BCH SCH LEEDS BELFAST CARDIFF GLASGOW 
Cardiology 7 0 2 1 6 2 18 
Dermatology 4 1 0 0 0 1 6 
Diabetology 3 1 2 2 0 1 9 
Endocrinology 2 0 2 1 0 0 5 
Gastroenterology 3 1 2 1 1 1 9 
Haematology 4 2 1 2 0 1 10 
IMD 2 2 0 0 0 0 4 
Liver 5 0 0 0 0 0 5 
Neurology 1 4 1 0 0 1 7 
Oncology 13 3 3 2 3 1 25 
Plastics 8 0 1 0 0 0 9 
Renal 3 0 2 1 0 4 10 
Respiratory 4 5 3 1 4 4 21 
Other 4 2 2 2 3 2 15 
Educator 1 0 0 0 0 2 3 
Stoma care 0 1 0 0 0 1 2 
Pain 2 2 2 1 0 2 9 
General Paeds 1 1 0 0 1 1 4 
Management 1 0 0 0 0 1 2 
Rheumatology 2 0 2 0 0 1 5 
Control Of Infection 
1 1 0 0 0 0 2 
Ophthalmology 1 0 0 0 0 0 1 
Intensive care 3 1 0 1 0 2 7 
Nutrition 1 0 0 0 0 0 1 
Burns 1 0 0 0 0 1 2 
Gen Surg & Ortho 0 4 2 0 2 0 8 
Immunology 0 2 1 0 0 0 3 
Continence 0 2 0 0 1 0 3 
ADHD 0 1 0 0 0 0 1 
Child Protection 0 1 0 2 0 0 3 
Community nursing 
0 1 0 0 0 0 1 
Audiology 0 1 0 0 0 0 1 
Emergency 0 0 0 1 0 0 1 
Neurosurgery 0 0 0 0 2 0 2 
Psychotherapy 1 0 0 0 1 0 2 
Missing 0 0 0 1 0 2 3 
Total 78 39 28 18 24 29 219 
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A majority (63%, n=138) of respondents worked more than 30.1 hours per week (0.8 whole time 
equivalent) with19.2% (n=42) stating they are independent or supplementary prescribers, or both. In 
total across all study sites: 
 43% (n=94) provided domiciliary visits 
 77.6% (n=170) worked with inpatients 
 77.6% (n=170) worked with outpatients 
 71% (n=155) provided advice concerning medication 
 67% (n=143) confirmed that their role was mainly clinical and 13% (n=28) mainly 
psychosocial 
 
10.2.2. Supporting prescriptions and risk estimation 
 
Respondents were asked:  
In the last 3 months how many times have you been called upon to organise repeat 
prescriptions for your patients? 
 
The responses are summarised in the table below. A majority of respondents (73.4%, n=157) 
had organized repeat prescriptions during the preceding 3 months. The estimated total number 
of prescriptions organized over the same period equals 1765. Mid-points, where necessary, 
were estimated using the method described on page 58. 
 
Table 21 Nursing staff survey. Frequency of organising repeat prescriptions 
 
Prescriptions in 3 
months 
Frequency Valid Percent 
Never 57 26.6 
1 to 5 80 37.4 
6 to 10 29 13.6 
11 to 30 29 13.6 
> 30 mid-point = 36 19 8.9 
Total 214 100.0 
No answer 5   
Grand total 219   
 
 
Service costs were estimated using a value of £26 per event. Estimated service costs per site were 
calculated and varied from £15,184 to £58,240 per annum. Combined annual service costs (all sites) 
were estimated to be £183,560. Site specific responses are summarised in the table below.  
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Table 22 Nursing staff survey. Frequency of prescriptions organised by site (3 months) and 
estimated annual service costs 
 
  Site 
  BCH SCH Leeds  Belfast  Cardiff  Glasgow  Total 
Never 22 11 4 7 4 9 57 
1 to 5 29 6 15 6 12 12 80 
6 to 10 13 7 3 0 4 2 29 
11 to 30 9 9 3 3 2 3 29 
> 30 (Mid-point is 
36) 5 6 3 2 1 2 19 
Total respondents 78 39 28 18 23 28 214 
Total prescriptions 560 479 240 153 146 187 1765 
Median freq 3 8 3 3 3 3 3 
% with freq >10 17.90% 38.50% 21.40% 27.80% 13.00% 17.90% 22.40% 
Annual Service 
Costs £58,240 £49,816 £24,960 £15,912 £15,184 £19,448 £183,560 
 
A hypothesis was constructed that some sites will experience different levels of problems compared 
with others i.e. there is variation across the nation of medication access problems as evidenced by 
the frequency of organizing repeat prescriptions. However, the Pearson Chi-squared test shows no 
significant difference between the sites (p = 0.234). Similarly no significant difference was found 
between the two Celtic and England regions (p = 0.465). See table below. That is, analysis of the 
data confirms that there is no statistically significant difference between the sites or regions in the 
frequency with which they organize repeat prescriptions. The hypothesis is rejected. 
 
Table 23 Nursing staff survey. Frequency of organizing repeat prescriptions verses region 
 
FREQ 
Region 
Total English Celtic 
Never 37 20 57 
1 to 5 50 30 80 
6 to 10 23 6 29 
11 to 30 21 8 29 
> 30 14 5 19 
Total 145 69 214 
 
Respondents were asked:  
In the last 3 months for how many patients have you been asked to organise repeat 
prescriptions? 
The estimated number of home-patients attended to by the respondents in a 3 month period was 
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determined using the calculated mid-points method and was found to equal 1637. The responses 
are summarised in the table below. 
 
Table 24 Nursing staff survey. Number of patients attended to by the respondents in a 3 
month period and estimated total number of patients (n(total)) 
 
  BCH SCH Leeds Belfast Cardiff Glasgow Total 
None 23 11 5 7 3 9 58 
1 to 5 31 7 15 5 13 12 83 
6 to 10 11 8 3 0 4 2 28 
11 to 30 7 9 3 3 3 3 28 
> 30 (Mid-point = 36) 6 4 2 2 0 2 16 
Total respondents 78 39 28 17 23 28 213 
Total patients 544 418 204 150 134 187 1637 
 
 
A total of 13.6% (n=29) respondents confirmed that supporting medication access to home-patients 
was included in their job description (JD), with range across the sites of 0% (Cardiff) to 23.1% 
(SCH). 
 
Table 25 shows summary responses to the question: ‗How would you describe the risk to patients if 
you did not help patients access their medicines?‘ A clear majority of respondents in 4 sites 
considered the risk to be significant or highly significant. In contrast only 31.8% of respondents in 
one site (Cardiff) described the risk as either significant or highly significant. 
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Table 25 Nursing staff survey. Response to the question: ‘How would you describe the risk 
to patients if you did not help patients access their medicines?’ 
 
  
Site 
Total BCH SCH LEEDS BELFAST CARDIFF GLASGOW 
Not Applicable 13 6 2 3 3 4 31 
Insignificant 
1 1 2 2 0 2 8 
Moderately 
significant 
13 10 5 2 12 8 50 
Significant 28 16 15 4 5 7 75 
Highly 
significant 
23 6 4 6 2 7 48 
Total 78 39 28 17 22 28 212 
         
Significant or 
highly 
significant 
51 22 19 10 7 14 123 
% significant or 
highly 
significant 
65.4% 56.4% 67.9% 58.8% 31.8% 50.0% 58.0% 
 
 
A hypothesis was constructed that respondents from some sites perceive risks differently to other 
sites (e.g. some areas may not experience such problems to the same degree as other sites and 
therefore the perceived risks may be less). The table below shows the distribution of responses by 
site for ‗risk‘.  
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Table 26 Nursing staff survey. Risk category frequency verses site (abridged results) 
 
      
RISK   
      Moderately 
significant Significant 
Highly 
significant Total 
Site BCH Count 13 28 23 64 
% within 
Site 
20.30% 43.80% 35.90% 100.00% 
SCH Count 10 16 6 32 
% within 
Site 
31.30% 50.00% 18.80% 100.00% 
LEEDS Count 5 15 4 24 
% within 
Site 
20.80% 62.50% 16.70% 100.00% 
BELFAST Count 2 4 6 12 
% within 
Site 
16.70% 33.30% 50.00% 100.00% 
CARDIFF Count 12 5 2 19 
% within 
Site 
63.20% 26.30% 10.50% 100.00% 
GLASGOW Count 8 7 7 22 
% within 
Site 
36.40% 31.80% 31.80% 100.00% 
  Total Count 50 75 48 173 
% within 
Site 
28.90% 43.40% 27.70% 100.00% 
 
Note: The categories of ‗not applicable‘ and ‗insignificant‘ have been removed from the statistical 
considerations of this relationship and others below, since ‗not applicable‘ is akin to missing values and 
‗insignificant‘ returned relatively low numbers. 
 
The Pearson Chi-squared test confirms statistically significant variation in the data set (p = 0.009). 
Similarly significance was tested for a regional split of the data (English and Celtic (non-English) 
sites). See figure and table below. Fisher‘s exact test confirms statistical significance between the 
regions (p = 0.029). That is, the respondents from the English regions perceive the risks to be 
greater than their colleagues in the non-English regions. The hypothesis is proved. 
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Figure 10 Nursing staff survey. Bar chart of frequency of risk category verses region 
(abridged results) 
 
 
 
 
Table 27 Nursing staff survey. Risk category frequency verses region (abridged results) 
 
      
RISK   
      Moderately 
significant Significant 
Highly 
significant Total 
region English Count 28 59 33 120 
% within 
region 
23.30% 49.20% 27.50% 100.00% 
Celtic Count 22 16 15 53 
% within 
region 
41.50% 30.20% 28.30% 100.00% 
  Total Count 50 75 48 173 
% within 
region 
28.90% 43.40% 27.70% 100.00% 
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A hypothesis was constructed that the more frequently the need to organize repeat prescriptions 
the greater the perceived risk to respondents. The table below shows cross-tabulated results for 
these two variables (combined results from all sites). 
 
Table 28 Nursing staff survey. Frequency of organizing repeat prescriptions verses risk 
(abridged results) 
 
RISK 
FREQUENCY 
Total Never 1 to 5 6 to 10 11 to 30 > 30 
Moderately 
significant 4 28 5 7 6 50 
Significant 9 30 17 11 8 75 
Highly 
significant 
9 16 7 11 5 48 
Total 22 74 29 29 19 173 
 
 
However, the Pearson Chi-squared test shows no significant difference (p = 0.258). That is, there is 
not a statistically significant relationship between these two variables and therefore the hypothesis 
is rejected. 
 
10.2.3. Causation 
 
The table below shows responses to the question: ‗In your opinion what is the most common 
reason why carers experience problems in obtaining suitable medications (one that the child can 
use or take)?‘ Five defined options were provided for selection by the respondents and these are 
ranked according to frequency within the table. The option selected with the highest frequency 
when all sites‘ responses were combined was ‗communication issue‘ (25%, n=53). Four sites 
ranked this option in first or joint first place. 
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Table 29 Nursing staff survey. Opinions why carers experience problems in obtaining 
suitable medication and ranking 
 
 BCH SCH LEEDS B‘FAST C‘DIFF G‘GOW TOTAL RANKING 
Communication 
issue 
16 7 7 5 8 10 53 1 
Prescriber issue 25 14 7 1 4 0 51 2 
Other 15 6 3 5 2 7 38 3 
Pharmacy issue 13 5 5 1 5 5 34 4 
Carer issue 5 5 4 3 2 1 20 5 
Formulation 
issue 
4 2 2 2 1 5 16 6 
Total 78 39 28 17 22 28 212   
 
 
A hypothesis was constructed that there may be regional differences in the perceived reasons for 
the problems. The table below shows cross-tabulated results for these two parameters. For this 
data, Pearson‘s Chi-squared test shows that there is significant difference (p = 0.003) at regional 
level, but not at site level (p = 0.119). Fisher‘s exact test was calculated for the regional level data 
(p = 0.001), confirming a significant difference between these regions. That is, the English regions 
perceive the reasons for medication access problems for children to be different to their colleagues 
in other UK home countries. The hypothesis is proved. 
 
Table 30 Nursing staff survey. Opinions why carers experience problems in obtaining 
suitable medication and ranking by region 
 
Region 
Carer 
issue 
Pharmacy 
issue 
Formulation 
issue 
Communication 
issue 
Prescriber 
issue 
Other TOTAL 
 England 14 23 8 30 46 24 145 
Non-
England 
 
6 11 8 23 5 14 67 
Total 20 34 16 53 51 38 212 
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Table 31 Nursing staff survey. Specialty verses reason for problems 
 
  
Reason 
Total 
Carer 
issue 
Pharmacy 
issue 
Formulation 
issue 
Communication 
issue 
Prescriber 
issue Other 
Cardiology 3 ** 7 ** 0 1 3 2 16 
Dermatology 0 2 0 2 2 0 6 
Diabetology 2 0 0 3 0 4 9 
Endocrinology 0 2 0 1 0 2 5 
Gastroenterology 1 1 0 2 ** 4 ** 1 9 
Haematology 2 2 1 1 2 2 10 
IMD 0 1 0 1 2 0 4 
Liver 1 1 0 0 3 0 5 
Neurology 0 0 1 3 3 0 7 
Oncology 4 4 3 2 ** 8 ** 4 25 
Plastics 0 2 0 3 2 2 9 
Renal 1 0 1 3 2 1 8 
Respiratory 0 1 1 ** 14 ** 3 2 21 
Other 1 5 1 1 4 3 15 
Educator 0 1 0 1 0 1 3 
Stoma care 0 0 0 1 1 0 2 
Pain 1 2 1 1 3 1 9 
General Paeds 0 0 1 2 1 0 4 
Management 0 0 0 1 0 1 2 
Rheumatology 0 1 2 0 2 0 5 
Control Of 
Infection 
0 0 0 0 0 2 2 
Ophthalmology 0 0 0 1 0 0 1 
Intensive care 0 0 1 1 0 ** 5 ** 7 
Nutrician 0 0 0 0 0 1 1 
Burns 0 0 1 1 0 0 2 
Gen Surg & 
Ortho 
1 0 1 3 2 1 8 
Immunology 1 0 0 0 2 0 3 
Continence 0 0 0 1 1 1 3 
ADHD 1 0 0 0 0 0 1 
Child Protection 1 0 0 1 0 0 2 
Community 
nursing 
0 1 0 0 0 0 1 
Audiology 0 0 0 0 0 1 1 
Emergency 0 0 0 1 0 0 1 
Neurosurgery 0 1 0 0 1 0 2 
Psychotherapy 0 0 0 1 0 1 2 
Total 20 34 15 53 51 38 211 
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A hypothesis can be constructed that some specialties may have specific reasons for problems (e.g. 
some specialties may have particular problems with paediatric formulations of commonly used 
drugs). This hypothesis was tested. Table 31 shows descriptive statistics concerning specialty and 
reason. 
 
Numbers are too few within any individual specialty to support statistical analysis. However cells are 
highlighted and marked with a double asterix (**) where frequencies of a defined problem stand-out 
for individual specialties. These are: cardiology with ‗pharmacy issue‘; gastroenterology and 
oncology with ‗prescriber issue‘; respiratory with ‗communication issue‘; and intensive care with 
‗other‘.  
 
 
10.2.4. Service changes 
 
The survey gave opportunity for the respondents to indicate how services could be better organised 
to minimise disruption to the patient‘s therapy. The respondents were provided with three options 
and their responses are shown in the table below. Options were not mutually exclusive: 
respondents could respond to each individual option. When results were combined from all sites the 
option selected with the highest frequency was ‗Require GPs to prescribe all continuing medicines‘ 
(66.2%, n=145). 
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Table 32 Nursing staff survey. Responses to the question: 'In what ways can services be 
better organized to minimize disruption to the child’s therapy’. 
 
  
Site 
Total Rank BCH SCH LEEDS B‘FAST C‘DIFF G‘GOW 
Require GPs to 
prescribe all 
continuing 
medicines 
No 30 10 7 9 7 11 74 
1 
Yes 48 29 21 10 17 20 145 
  Total 78 39 28 19 24 31 219 
Percentage (Yes)   61.5% 74.4% 75.0% 52.6% 70.8% 64.5% 66.2% 
Require hospitals to 
prescribe and 
dispense 
unlicensed / 
uncommon 
medicines 
No 41 26 20 12 18 23 140 
2 
Yes 37 13 8 7 6 8 79 
  Total 78 39 28 19 24 31 219 
Percentage (Yes)   47.4% 33.3% 28.6% 36.8% 25.0% 25.8% 36.1% 
Enable hospital 
pharmacy to 
dispense GP 
prescriptions 
No 54 33 21 14 15 26 163 
3 
Yes 24 6 7 5 9 5 56 
  Total 78 39 28 19 24 31 219 
Percentage (Yes)   30.8% 15.4% 25.0% 26.3% 37.5% 16.1% 25.6% 
Other Un-
selected 
69 29 23 15 16 28 180 
4 
Selected 9 10 5 4 8 3 39 
  Total 78 39 28 19 24 31 219 
Percentage (Yes)   11.5% 25.6% 17.9% 21.1% 33.3% 9.7% 17.8% 
Don't know Un-
selected 
70 36 24 17 22 27 196 
5 
Selected 8 3 4 2 2 4 23 
  Total 78 39 28 19 24 31 219 
Percentage (Yes)   10.3% 7.7% 14.3% 10.5% 8.3% 12.9% 10.5% 
 
 
Since there is a difference between the regions for perceived reasons for the problems there may 
also be differences between the regions relating to how systems can be improved. This hypothesis 
was tested. The Pearson‘s Chi-squared test was run for results from each region for each of the 
three options given in the survey to improve services. The following results were obtained: 
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 Require GPs to prescribe all continuing medicines p = 0.547 
 Require hospitals to prescribe and dispense unlicensed / uncommon medicines p = 0.09 
 Enable hospital pharmacy to dispense GP prescriptions p = 0.98 
 
 
Therefore statistical significance was not found between the regions for the proposed improvement 
options, although the second option (Require hospitals to prescribe and dispense unlicensed / 
uncommon medicines) approaches significance. 
 
 
Table 33 Nursing staff survey. Summary of codes assigned to free text comments recorded 
in 'improve services’ section and in ‘additional comments’ 
 
CODE BCH SCH LEEDS BELFAST CARDIFF GLASGOW TOTAL 
Care pathways     1       1 
Caregiver training   3 1     1 5 
Clinic letter system 1 2         3 
CP helpline 1           1 
CP training 1           1 
ESCAs     1       1 
Funding (of drugs)   1         1 
GP Rx all   1       1 2 
GP Rx disp by HP       1     1 
GP training 1     2     3 
Homecare 1         1 2 
Hosp Rx - CP dispense 1     2 1   4 
Hosp Rx all   1         1 
HP dispense all 1           1 
Improve 
communication  
(see below) 9 4 4 1  0 3 21 
More admin support   2         2 
NICE guidance   1         1 
No change?     1       1 
Nurse prescribing 1           1 
Nurse training   1         1 
Pharmacy interface 
team 3           3 
Postal Rxs   1         1 
Reduce GP Rx time   1         1 
Sector collaboration 1 2 2 1   1 7 
Unassigned 18 6 6 2 7 7 46 
TOTAL 39 26 16 9 8 14 112 
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Improve communication 
sub-code BCH SCH LEEDS BELFAST CARDIFF GLASGOW TOTAL 
Clinic letters 1 1         2 
Electronic           1 1 
General 3   2     1 6 
Hosp - GP 2 2 2 1   1 8 
Hosp hotline 1           1 
HP - CP   1         1 
HP - HP 1           1 
Rx details 1           1 
TOTAL 9 4 4 1 0 3 21 
 
Free text responses relating to service changes were recorded and coded, and a summary is 
shown above. Codes were assigned to free text comments obtained in both the ‗improve services‘ 
section (In what ways can services be better organized to minimize disruption to the child‘s therapy) 
and in the final comments section, where comments were considered to be promoting a service 
development.  
 
Free text comments coded as ‗improve communications‘ were returned with the highest frequency 
(n=21, 18.8%). These comments were further sub-coded. The improve communications sub-code 
returned with the highest frequency (n=8) was ‗hospital to GP‘ communications. See Table above. 
 
10.3. Discussion 
 
10.3.1. Main findings 
 
In terms of demographics, most of the study cohort were either working full-time or approaching full-
time (0.8 whole time equivalent or more, 64.5%), few were prescribers themselves (16%), most 
worked with in-patients and / or out-patients (78%) and most were clinical (65%). This group may 
therefore provide a useful insight into supporting home-patients with medication access problems, 
without (usually) being prescribers themselves.  
 
A majority of respondents had organized repeat prescriptions for their home-patients over a 3 
month period (n=157, 74%): at an average frequency of approx. 7.8 occasions each and an 
average number of patients per nurse of 7.3. The cost of this activity has been calculated for each 
site based on a possible service fee of £26 per event. This fee is based on the lowest fee for a 
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healthcare intervention and may not reflect the true cost of delivering this service and a higher 
figure may be sought through negotiation. One site (BCH) is considering claiming a service fee of 
£126 for each time a medication is provided in this way. (Personal communication Commissioning 
Department Birmingham Children‘s Hospital to D Terry 1st February 2010: Used with permission). 
However commissioners may have a different view. If a fee per supply is to be agreed it needs to be 
recognized that multiple agencies within the hospital will be involved in providing the medication 
including nurses, doctors, pharmacy and finance staff. The frequency of actions taken by each 
group cannot simply be summed to identify the total activity and therefore costs. 
 
Clearly for the large majority of participants this activity is not included in their job descriptions (86.4% 
across all sites), which may raise the question of whether this activity is recognised and funded. 
 
The clinical benefit of this activity is indicated by responses to the question ―How would you 
describe the risk to patients if you did not help patients access their medicines?‖ This question 
elicited a range of responses from 31.8% (Cardiff) to 67.9% (Leeds) replying that this activity is 
‗significant‘ or ‗highly significant‘. This wide range of results is unexpected and if an accurate 
reflection of the respondents‘ views requires further investigation. However, the wording of the 
response scale may be being interpreted differently by the respondents in the two sites with the 
most extreme responses. Table 25 shows the results. In Cardiff most respondents chose 
‗moderately significant‘ where as in Leeds the majority chose ‗significant‘. Whilst the question 
makes the scale clear the difference between ‗moderately significant‘ and ‗significant‘ may be open 
to misinterpretation. The result may not be fully reliable, however if these two extremes are 
excluded a clear majority of respondents still consider the risk to be either significant or highly 
significant. Interestingly the lowest response is from the same site (Cardiff) where this activity is not 
found at all in their job descriptions.  
 
Respondents were asked to choose one of 5 possible options that in their view was the most likely 
cause of these problems. The options were:  
 
1. Cannot obtain a prescription (in time) ... carer issue  
2. Cannot get medication dispensed ... pharmacy issue  
3. Child cannot use the formulation provided … formulation issue  
4. GP has not received communication (eg. clinic/discharge letter) … communication issue  
5. GP will not prescribe (eg because it is an unlicensed medication) … prescriber issue  
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6. Other 
 
Combined results for all sites indicated that, in the opinion of the respondents, the most common 
reasons for home-patients access to medicines problems is ‗GP has not received communication 
(e.g. clinic/discharge letter) … communication issue‘ at a frequency of 25% (n=53) although 2 sites 
(BCH and SCH) ranked the response ‗GP will not prescribe (e.g. because it is an unlicensed 
medication) … prescriber issue‘ higher. Both of these causes focus on GPs although the former is 
not directly within their control. The benefit of ensuring timely communication across the healthcare 
interface and especially the sending out of discharge letters promptly is implicit within these 
observations and supports similar conclusions by the Care Quality Commission.(14) Combined 
responses from the English sites (Birmingham, Leeds and Sheffield) are significantly different to 
those from the non-English (Celtic) sites (Belfast, Cardiff and Glasgow) (p = 0.001, Fisher‘s exact 
test). The English sites indicate that ‗GP will not prescribe (e.g. because it is an unlicensed 
medication) … prescriber issue‘ is the leading reason and this agrees with the medical staff survey 
undertaken in Birmingham. Non-English sites conclude that the leading reason is ‗GP has not 
received communication (e.g. clinic/discharge letter) … communication issue‘. Whilst this difference 
is drawn across geographical areas it is not clear if this observation is related to site location alone 
since there is also a time differential between the two groupings with English sites surveyed before 
non-English sites. It is known that seamless care arrangements vary between the countries of the 
UK. For example patients leaving hospital in Northern Ireland do not receive take-home (TTO) 
medication, where as in England this is a fundamental service and an important part of the 
discharge process. Further work should explore these differences and their effect on service 
outcomes related to medicines management. 
 
There is evidence that some PCTs have provided advice to GPs concerning prescribing of 
unlicensed drugs.(59) Professional advice to GPs reminds them that they are not obliged to 
prescribe such items and that hospital provision of some items may be more appropriate. There is 
also concern about the cost of unlicensed drugs provide through primary care (144) prompting the 
DH with the PSNC to develop new arrangements for the pricing of specials. GP‘s may have 
increasing reasons to decline to prescribe unlicensed drugs, commonly used in paediatrics. 
 
Additional free-text comments concerning reasons for the problems were provided by 27 
respondents. However, these free-text comments have not been coded since they offer little 
additional information and largely support the options provided in the questionnaire. 
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The respondents were given 3 possible service changes to respond to the question: ‗In what ways 
can services be better organized to minimize disruption to the child‘s therapy?‘ The response 
attracting the highest selection was: ‗Require GPs to prescribe all continuing medicines‘ ranked in 
highest (1st) position for each site. This option was selected almost twice as often as any of the 
other options, and in this respect there is concordance between nurses & medical staff (see page 
112). This result is perhaps unremarkable since there was general opinion from the respondents 
that GP related issues were the cause of the problems. Whilst this option may seem attractive it 
may not be practical nor appropriate to adopt this measure since GPs have already received 
confirmation from the Department of Health that they do not NEED to prescribe (including hospital 
recommended prescriptions).(3) The self-selection options for this question were based on 
preliminary field work but may not cover a wide enough range of service changes to improve 
perceived problems and not all the reasons for problems offered in the survey have corresponding 
options for improvement. For example the improvement option ‗Require GPs to prescribe all 
continuing medicines‘ may align with the reason ‗prescriber issue‘, but none of the improvement 
options adequately covers the ‗communication issue‘ reason. The questionnaire was designed to 
allow free-text responses for improving services and 30 were provided by respondents. The 
questionnaire concluded with another opportunity to express additional free-text comments and 77 
were provided. Both of these sets of free-text answers were coded. In total 21 responses (32% of 
comments assigned to codes) were coded as ‗Improve communications‘. Because of the high 
response rate these responses were further divided into sub-codes. The sub-code recorded with 
the highest frequency was (improve communication between) ‗hospital and GP‘. Poor 
communication between primary care and secondary care seems to be a leading cause of patients 
needing hospital intervention to obtain long-term medication, and improving communication is 
understandably a way forward. What is less clear is how communication can be improved and even 
if clear timely communication is achieved whether this will alleviate the problems in accessing 
medication. 
 
This present study has not attempted to identify total activity for any individual organisation. Neither 
has the drug costs relating to this activity been estimated in this study. An audit of neurology 
patients in BCH during 23 days in December 2006 showed that this department provided 21 
prescriptions for rescue-medications to 16 different patients.(145) An estimate of rescue-medication 
drug costs per annum for this specialty at BCH was estimated to be approximately £22,300. Such 
drug costs are recoverable using current funding streams from the patients‘ PCTs since by 
definition these are covered under continuing-care exemptions from existing acute Trust contracts. 
Drug costs for BCH were estimated within the medical staff survey and are described on page 111. 
 Page 136 
 
10.3.2. Strengths of this study 
 
A questionnaire was chosen as the study tool on the basis of the type of questions to be asked, 
their ease of completion, practicalities of data handling and availability of email addresses. The 
study cohort were all CNS and ANPs employed at the time of the study by the 6 participating NHS 
Trusts. All nurses surveyed had Trust email addresses and internet access. Whilst the mean 
response rate was 64.8% (n=219) (after a maximum of two reminders) this varied across the sites 
(range 47.7% Glasgow – 78.0% Birmingham). The reason for this variation is unclear but seems 
unlikely to be linked to perceived risk within each organisation since one site (Cardiff) returned the 
lowest risk (31% stating risk was significant or very significant) with a high return rate of 72.7%. 
 
This multisite study provides strong evidence that these problems are widely experienced across 
the UK. The sites not only cover a range of geographical areas but also include a number of 
different hospital types including: specialist children‘s hospitals in England (BCH, SCH) and 
Northern Ireland (Belfast), large general hospitals with paediatric units (Leeds, Cardiff), and a 
paediatric unit within a Scottish health board. 
 
10.3.3. Limitations of this study 
 
A limitation of this study is that options provided in the survey to enable respondents to identify 
reasons for the problems do not align directly with options for improvement. See main findings 
above. A 1 to 1 relationship between reason codes and improve codes would provide more 
comprehensive options for the respondents. This limitation has been offset in part by the coding of 
free text answers provide by respondents to these issues. 
 
10.3.4. Comparisons with other studies 
 
Extensive literature searches failed to identify similar reported studies. 
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10.4. Conclusions 
 
This present study demonstrates the extent to which CNS and ANPs act to support home-patients 
to obtain the long-term medicines they require. This activity was identified at each of the 6 sites 
from across the UK and therefore appears to be a national issue. The study has enabled an 
estimate of this activity at each site and facilitated the calculation of a resource cost based on DH 
funding arrangements ranging from £15,000 to almost £60,000 per annum at the study sites. 
According to advice received from professional NHS commissioning staff these costs are 
recoverable from local commissioners, usually PCTs. 
 
The reasons most commonly cited for these problems are communication issues or prescriber 
issues. The most frequently selected option concerning improving services was ‗require GP to 
prescribe all continuing medicines‘ although improving communication, especially from hospital to 
GP staff, is also recommended. 
 
In summary this study:  
 Has identify the involvement of paediatric hospital nursing staff in supporting home-patients 
to obtain the medicines they need when they are out of hospital, where prescribing 
responsibility rests with the GP. 
 Has quantified their involvement and estimate resource costs. 
 Has provided some evidence that indicates that this is a national issue. 
 Has determined why these issues occur (reasons) in the view of this cohort. 
 Supports the identification of process changes that may reduce such problems (see 
programme conclusions). 
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11. The provision of rescue-medication at the request of 
caregivers of paediatric home-patients 
 
11.1. Introduction 
 
Chapters 9 and 10 describe investigations into the role of hospital medical staff and hospital nurses 
in supporting paediatric home-patients to access prescribed long-term medicines. The aim of this 
study was to identify the circumstances in which parents or carers find themselves needing to 
request paediatric rescue-medication from the Pharmacy at BCH. Pharmacy staff at BCH are often 
called on by caregivers of children to provide ‗rescue-medication‘. Rescue-medication is the local 
term used when medication is provided urgently by secondary care because of a failure or expected 
failure of primary care services to provide the medication. 
 
Published studies relating to medication access problems for children requiring long-term medicines 
outside hospital tend to focus on unlicensed and off-label medicines (146, 147) but these may not 
be the only issues and there is little empirical evidence as to the type and frequency of other 
factors. Around 1 in 4 prescribed medicines in paediatric wards in UK hospitals are unlicensed or 
used off-label.(148) Forty-six per cent of hospital prescriptions for children across Europe are either 
unlicensed or used off label with 67% of this population receiving at least one unlicensed or off label 
medication.(149) Wong et. al. (68) has shown that 12% of medicines prescribed at the point of 
discharge from a London paediatric hospital (GOSH) were either unlicensed medicines or used off-
label. This same study has shown that a third of caregivers faced some difficulties in primary care 
when trying to obtain these medicines after discharge. Reported issues include the reluctance by 
GPs to prescribe off-label or unlicensed medicines and difficulties in obtaining these items from 
community pharmacies. 
 
The survey instrument is shown in Appendix 9. 
 
11.2. Results 
 
A total of 88 caregivers were invited to complete the survey during the period 21st November 2008 
to 14
th
 January 2010.  All of this cohort requested rescue-medicines from the Pharmacy at BCH.  
However 28 respondents did not fully complete the survey. The survey provided the opportunity to 
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indicate why the respondent did not wish to complete the remainder of the survey. Of this cohort, 25 
selected the option: Did not complete survey- not a good time/insufficient time to complete; and 3 
gave ‗other‘ reasons for not completing the survey. No further details were provided by these 
respondents to survey questions. Therefore 60 completed surveys were obtained and analyzed. 
The figure below shows the accumulated responses during the study data gathering period. 
 
Figure 11 Accumulated completion of Rescue-Medication survey 
 
11.2.1. Demographics 
 
The patient‘s home postcode was recorded on 59 occasions. The approximate distance by road 
from the patient‘s postcode to BCH (B4 6NH), one way, was determined using: 
http://www.postcode.org.uk/free-postcode-distance-calculator/ 
 
accessed 15/3/10. Distances ranged from 1.9 miles to 112.3 miles (mean average = 14.7 miles). 
One postcode could not be accessed directly by road (Belfast) and was excluded from the results. 
Identical patient postcodes were recorded twice on two occasions: which may represent the same 
patient or possibly siblings: patient identifiers were not requested. 
 
Respondents recorded GP practice details on 56 occasions (93.3%). 52 different GP practices were 
recorded: 49 practices occurred once, two practices occurred twice and one practice occurred three 
times. All practices recorded more than once are all local to BCH. 
 
Respondents were asked to record details of their usual community pharmacy. From the 54 
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responses received a total of 46 different CPs were identified. One pharmacy was recorded 3 times. 
All other pharmacies were recorded once only. There were 6 occasions when the description of the 
pharmacy was non-specific (e.g. Boots). 
 
Respondents were cared for by 19 different PCTs (see methods page 49) and details are shown in 
the table below. Five PCTs are from outside the West Midlands. 
 
Table 34 Patient’s PCT and frequency 
 
Patient's PCT Frequency Patient's PCT Frequency 
BEN-PCT 11 NORTHAMPTONSHIRE PCT 1 
SOUTH B‘HAM-PCT 11 DERBY CITY PCT 1 
HEART OF B‘HAM-PCT 9 HEREFORD PCT 1 
DUDLEY PCT 5 NORTH STAFFS PCT 1 
SANDWELL PCT 4 SHROPSHIRE PCT 1 
SOUTH STAFFS PCT 3 WARWICKSHIRE PCT 1 
SOLIHULL PCT 3 WEST BERKSHIRE PCT 1 
WORCESTERSHIRE PCT 2 WOLVERHAMPTON PCT 1 
WALSALL PCT 2 NORTHERN HEALTH SCB – NI 1 
NORTH SOMERSET PCT 1 Total specific responses 60 
 
11.2.2. Attendance by respondents 
 
The number of days since the last attendance at BCH by the respondents was determined. Where 
exact dates were specified for both the date of completion of the survey and the date of any 
previous attendance (n = 47) the number of days ranged from 0 to 98. Mean = 19.3 days. Mode = 0 
days (n = 11).  
 
The number of days since the patient last consulted their GP was similarly determined. Where exact 
dates were specified (n = 31) the number of days ranged from 0 to 252 days. Mean = 39.4 days. 
Mode = 1 day (n = 4). 
 
Over two-thirds of respondents (67.8%, n=40) confirmed that they made a special trip to BCH 
Pharmacy to obtain the medicines they need. The total round trip distance (if coming from patient‘s 
home) for these 40 occurrences = 1070 miles (mean = 26.8 miles). 
Respondents were asked if they obtained advice from a healthcare professional before their 
attendance. 60% (n=36) confirmed that they did so, consulting a range of sources summarised 
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below:  
 PHARMACY / PHARMACIST  n = 9 (15%) 
 GP     n = 9 (15%) 
 HOSPITAL DOCTOR   n = 9 (15%) 
 NURSE    n = 5 (8.3%) 
 A+E     n = 1 (1.7%) 
 NONSPECIFIC   n = 3 (8.3%) 
 
A total of 25 (43%) of the respondents confirmed they had used the rescue-medicines service 
before. Of the 24 patients who did not get advice before coming to BCH, 14 had obtained rescue-
medicines from BCH previously. 
 
11.2.3. Usual medication supply arrangements 
 
Almost half of the respondents confirmed that the patient‘s prescriptions were normally issued by 
their GP (46.3%, n=25) and exactly the same number had prescriptions normal issued by the 
hospital. A small number (7.4%, n=4) had prescriptions issued by both sectors. As expected for this 
study of home-patients, a large majority confirmed that their prescriptions were dispensed by their 
CP (80.9%, n=38) although 6 respondents stated that the hospital usually dispensed their 
medicines. 
 
Over 30% of respondents confirmed that they had problems getting their medicines either often or 
very often. The table below shows a summary of responses to the question: ‗How often do you 
have problems getting medicines for this patient?‘ 
 
Table 35 Recurrence of problems and frequency 
 
 Frequency 
Valid 
Percent 
Never 18 32.7 
Very rarely 8 14.5 
Sometimes 12 21.8 
Often 6 10.9 
Very Often 11 20.0 
Total specific 
responses 
55 100.0 
Missing 
responses 
5  
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58% of respondents (n=35) recorded the medicine(s) that they had difficulty in obtaining, naming 39 
different medicines, with captopril being named five times and sodium chloride, potassium chloride 
and sodium bicarbonate each being named twice. See table below. Of these 39 medicines, one 
was unidentified in clinical practice (triazapan). BCH routinely uses unlicensed products for 25 
(66%) of the 38 identified drugs. 
 
Table 36 Medicines named by respondents requesting urgent supplies (rescue-medicines) 
 
Acetazolamide DNAse Nitrazepam 
Acidophilus Extra 4 
Caps Electrolyte solution G Oxandralone 
Amiodarone Sodium resonium Oxybutinin 
Azathioprine liquid Fucidin (Fucidic Acid) Phosphate sandoz 
Betadine solution 
Joulies phosphate 
solution Promixin 
Captopril Loperamide Amphoterin 
Potassium chloride Sodium bicarbonate Rifampacin 
Domperidone Omeprazole 
Pyridoxal 
phosphate 
Chlorothiazide Madopar 62.5 
Sildenafil 
Suspension 
Clobazam 
Magnesium Oral 
Solution Minoxodil 
Chloral hydrate Mycophenolate Sodium chloride 
Colecalciferol Neorecormon Atrovit 
Desmospray Enalapril Triazapan 
 
 
Forty-nine of the respondents answered the question: Has the patient missed any doses as a 
consequence of not getting the medicine(s)? Of this cohort 13 (26.5%) confirmed that the patient 
had missed dose(s).  
 
11.2.4. Causation 
 
Respondents were asked to express their opinion as to why they had difficulty in obtaining their 
medicines. Free text answers (n=42) were coded and a summary of the results is shown below. 
 
Codes were: 
CARER – Carer-Parent issue 
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COMMUNICATION - Information transfer issue 
COST – cost of item / dispensing 
CP – Community Pharmacy issue 
GP – General practitioner issue 
SUPPLY – problem with the CP obtaining the medicine 
UNCLASSIFIED – Answer is not included in other codes 
UNK – Don‘t know 
 
The code most frequently assigned to answers was ‗Supply – problem with the CP obtaining the 
medicine‘. Over half of respondents (54.8%) expressed the opinion that the cause of the problem 
was either supply, or community pharmacy, or both. Further details of free text answers and 
assigned codes can be found in Appendix 9, Table 55. 
 
Table 37 Summary of ‘reason’ codes assigned to free text comments 
 
 Frequency 
Valid 
Percent 
Supply 11 26.2 
Unclassified 7 16.7 
Community pharmacy 6 14.3 
Supply / comm pharm 6 14.3 
GP 4 9.5 
Unknown 3 7.1 
Carer 1 2.4 
Communication 1 2.4 
Cost / GP 1 2.4 
Cost / supply 1 2.4 
GP / comm pharm 1 2.4 
   
Total specific 
responses 
42 100.0 
   
Missing responses 18  
 
 
11.2.5. Service changes 
 
Respondents were asked to express their opinion as to how existing arrangements could be 
improved. Free text answers (n=29) were coded and a summary of the results is shown below. 
 
Codes were: 
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PROCUREMENT – improve procurement of medicines for CP 
COMMUNICATION – improve communication 
CP – community pharmacy improvement 
PLANNING – improve planning 
GP – general practice improvement 
HOSP – hospital improvement 
 
The codes most frequently assigned to answers were ‗communication – improve communication‘ 
and ‗procurement – improve procurement of medicines for CPs‘. Further details of free text answers 
and assigned codes can be found in Appendix 9, Table 56.  
 
Table 38 Summary of ‘improve’ codes assigned to free text comments 
 
 Frequency 
Valid 
Percent 
Communication 6 20.7 
Procurement 6 20.7 
Unknown 6 20.7 
Community 
Pharmacy 
4 13.8 
GP 2 6.9 
Hospital 2 6.9 
Planning 2 6.9 
Communication / 
planning 
1 3.4 
   
Total specific 
responses 
29 100.0 
   
Missing responses 31  
 
 
 
11.3. Discussion 
 
11.3.1. Main findings 
 
This study demonstrates that access to medicines for children treated by the NHS in their domestic 
setting is not always assured and that caregivers may seek urgent help from hospitals to obtain 
medicines. Caregivers used this hospital service even when the expected route of supply is through 
primary care. Almost 1 in 3 respondents, who came to BCH Pharmacy for help, reported that they 
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had experienced problems getting medicines for the patient either often or very often. This has 
potential consequences for poor medicines adherence, which is contrary to recent national 
initiatives.(84)  
 
Most respondents (68%) confirmed that they made a special (specific) trip to the hospital in order to 
obtain rescue-medication. The mean road distance between the patient‘s home and BCH for these 
patients was 13.4 miles (one way). Of the 24 respondents who did not request advice from a 
healthcare professional before coming to BCH, 58% had used this service previously. It seems 
likely that having used this service before they were sufficiently confident to do so again without the 
need for further advice. This large return rate, without taking further professional advice, indicates 
that this service provided adequately for the needs of this cohort. The data obtained also suggests 
that caregivers used the rescue-medication service whatever the origin of the FP10 prescription (i.e. 
either a GP prescription or hospital prescription). 
 
Six respondents recorded that they would normally get their medicines dispensed by BCH. If this 
were the confirmed route of supply then this episode of care would not actually be part of the 
rescue-medication service and would therefore be ineligible for entry into this study. However, in 
these instances, experienced hospital pharmacy staff, familiar with medicines‘ supply 
arrangements, had confirmed their expectation of a primary care supply. One of the respondents 
confirmed that they had not used this service before and that the medicines were ‗hospital 
medicines‘ and therefore this patient may be a new continuing-care patient and may not be a home-
patient needing urgent rescue-medication. It seems likely that the remaining five respondents found 
it necessary to come to the hospital sufficiently frequently for them to now consider BCH as the 
primary source of supply for the medicines needed. Four of these five respondents confirmed that 
they use the rescue-medication service often or very often. 
 
This study adds to the work of others (68, 146, 147) in demonstrating that obtaining unlicensed 
medicines from community pharmacies can be problematic. However, 34% of the medicines 
mentioned by respondents were licensed in the UK, indicating that problems are not limited to 
unlicensed medicines. This is an important finding since this is not found in any previously 
published work. If confirmed by larger, multisite studies, this has implications for identifying suitable 
service changes. In this present study a total of 16 respondents attended BCH for rescue-
medication supplies of UK licensed drugs. This cohort is more than 1 in 4 of all respondents and 
almost 1 in 2 of those who named identifiable drugs. There is no statistical difference between the 
licensed-drug cohort and the unlicensed-drug cohort in respect to the distance they travelled to 
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BCH. This finding suggests that those needing licensed drugs did not simply attend BCH for 
convenience. Use of the rescue-medication service for licensed drugs was an unexpected finding. 
Further work will be required to understand the reasons that prompt this action by caregivers and 
whether this is found only in the paediatric population or in other patient groups. The difficulties 
associated with different institutions using different formulations of unlicensed captopril for children 
have been described by other researchers.(67) 
 
More than a quarter of respondents (26.5%, n=13) reported that the patient had missed doses of 
their medicine(s) as a consequence of not being able to obtain the medicine(s) required. Further 
work will be needed to determine the clinical significance of this finding, although it is likely that 
some clinical risk to the patient would result from missed doses (e.g. electrolyte solution G can be 
life saving for children with a predisposition for hyperkalaemia).  
 
More than half of respondents (55%, n=23) indicated that the reason for their difficulties in obtaining 
medicines was either a supply issue (at their community pharmacy) or a community pharmacy issue 
or both. Suggestions for improvement focused on improving ‗procurement‘ (21%) and 
‗communication‘ (21%). By indicating a need to improve procurement it seems likely that the 
respondents believe that the medication concerned should be more readily available (on the shelf) 
in community pharmacies. However, there are practical issues in trying to make some paediatric 
medicines immediately available at community pharmacies, especially if they are ‗specials‘, which 
are manufactured to order and may have short expiry dates.  
 
Communication between healthcare professionals and communication between healthcare 
professionals and caregivers may be improved in a number of ways, including: removing delays in 
providing hospital discharge letters or clinic letters to GPs; including nominated community 
pharmacists within the communication arrangements; and electronic or personal transmission of  
patient medication details. The delivery of improved communication about medication has been 
recently called for by the Care Quality Commission.(14) Until 19
th
 August 2010 (150) ‗specials‘ 
manufacturers were not permitted to advertise their products and could only describe the drugs they 
make and their costs when specifically asked to do so. This arrangement may have added to 
communication difficulties for community pharmacists trying to identify a manufacturer of a suitable 
unlicensed medicine. Relaxing advertising of unlicensed medicines may be beneficial in supporting 
the supply of these items.  
 
By definition the provision of rescue-medication to home-patients by secondary care can be 
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described as a support to primary care services. Any Acute Trust providing this service is likely to 
do so outside of existing contractual arrangements and would be out-of-pocket unless costs were 
claimed. BCH claims the costs of this service on an individual patient basis by adding both drug and 
service costs to section E monthly claims to PCTs. Section E includes all claims outside of agreed 
tariff costs. All PCTs have reimbursed BCH for the costs claimed of all rescue-medication provided 
to patients to date (February 2011). By definition all recipients were home-patients who would 
usually expect to obtain continuing medication via primary care services. 
 
11.3.2. Strengths of this study 
 
As far as can be determined this study identifies for the first time the reasons caregivers of children 
treated at home turn to hospitals to support access to medicines. 
 
The study methodology involves non-healthcare professionals (caregivers), completing a self-
completion study instrument unaided. The questionnaire requires mostly free-text (un-coded) 
answers to the survey questions. See Appendix 9. The development of this instrument included 
piloting the questionnaire with three caregivers. All three indicated that the instrument questions 
were suitable and no changes or improvements were suggested. Cognitive testing of the questions 
for this type of survey may be expected. However this was not undertaken and therefore the 
reliability of the questions may be a concern and whether the survey provides internally consistent 
results challenged. Whilst cognitive testing would have been useful and would support the reliability 
of results, answers to the survey questions appear to be sufficiently consistent to provide a usable 
output. Validity, the extent to which the questions are answered accurately, is of less concern since 
few of the questions require quantitative answers. 
 
11.3.3. Limitations of this study 
 
The study methods did not identify the total number of caregivers requesting rescue-medication 
during the data collection period. In practice up to 60 members of the Pharmacy staff may deal with 
carers making these requests. In particular, staff working at weekends may be expected to provide 
core services (e.g. dispensary duties) that are not within their usual job roles. Consistent recording 
of requests for rescue-medications was considered unobtainable in this setting. In this respect the 
study cohort may be considered a convenience sample. Therefore the proportion of caregivers 
completing the survey from within the total population making such requests has not been 
estimated. 
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This study was conducted at one single study site and repeating this study in other areas is 
necessary to identify with confidence which aspects are generalisable. However this present study 
indicates that supply issues of this type are widespread, since 53 different GP practices were 
identified from 19 different PCTs, with dispensing provided by at least 46 different community 
pharmacies, including branches of large multiples, small chains and independent pharmacies. 
Caregivers of children needing continuing medication may turn to other paediatric hospital 
pharmacy departments for similar support to obtain urgent medication. [Personal communication S. 
Conroy to D Terry, September 2010. Used with permission] A multisite extension of this study will 
be needed to determine if these issues are reflected nationally. 
 
On average respondents reported that they last attended BCH approximately 19 days prior to 
completing the study. The questionnaire does not distinguish whether this was as an out-patient or 
as an in-patient. Since BCH provides 3 weeks supply of unlicensed medicines on discharge these 
patients may be running out of their TTO supply. Six respondents (10%) used the rescue-medicines 
service between 14 and 28 days after last attending BCH. Of these patients who recorded the name 
of their medicine(s) (n=4) all were using unlicensed medicines and one comments about information 
on discharge. It seems likely that between one and four respondents were returning to BCH and 
using the rescue-medicines service because their TTO unlicensed medicines were running out and 
further supplies had not been arranged via primary care. There appears to be evidence that this 
problem of inadequate supply of unlicensed medicines on discharge occurs, but only for a small 
percentage of patients using the rescue-medicines service, less than 7%. 
 
11.3.4. Comparisons with other studies 
 
Literature searches were undertaken to identify relevant published studies but none were identified. 
 
 
 
11.4. Conclusions 
 
In conclusion, caregivers of children who are expected to get their medicines from a primary care 
source can find it necessary to use the Pharmacy Department at BCH to maintain their medication 
supply. They do so for both licensed and unlicensed drugs and regardless of the origin of the 
prescription. Respondents indicate that they believe problems could be reduced by improved 
 Page 149 
procurement strategies by community pharmacies and by better communication between the 
parties involved.  
 
Preliminary reports of this study have been published.(151, 152) 
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12. Hospital prescriptions dispensed by UK community 
pharmacists: problems & solutions 
 
12.1. Introduction 
 
Over 5.5 million hospital generated FP10s are dispensed in community pharmacies in England 
each year [personal communication NHSBSA to D Terry used with permission. Copyright NHSBSA. 
23
rd
 July 2009]. The figure below shows the number of hospital generated FP10s dispensed by 
community pharmacies in England each quarter since quarter 1 (Apr-Jun) 2006. 
 
Figure 12 Number of hospital generated FP10s dispensed by community pharmacies in 
England by quarter Copyright NHSBSA. 
 
 
 
On average these represent only 0.6% of all prescriptions dispensed by community pharmacies 
with the vast majority being GP prescribed FP10s. During the period April 2008 to March 2009 a 
total of 852,482,281 prescription items were dispensed in England (all prescribers) at a cost of 
£8.37 billion; an average cost of £9.83 per item (net ingredient cost). The average cost of a hospital 
generated item dispensed in the community during the same period is more than three times 
greater at £33.57. 
 
Computer printed prescription forms were introduced in England in 1998 when the form FP10C was 
made available.(153) Accredited hospitals with approved computer systems can use the current 
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computer printed form FP10SS, but this is not the norm with only 41 hospitals authorised to do so in 
2010. In an audit conducted by the NHSBSA approximately 2% of hospital generated prescriptions 
dispensed in the community were on computer generated forms. [Personal communication 
NHSBSA to D Terry used with permission. Copyright NHSBSA. 23
rd
 July 2009]. 
 
It is clear that hospital generated prescriptions are therefore different from the much more familiar 
GP prescription in at least two respects. Firstly most GP prescriptions are computer generated and 
printed, where as hospital prescriptions are mostly hand-written. Since community pharmacists and 
their staff now have a 12 year history of mostly dispensing printed prescriptions, having to process 
an occasional hand-written script may present additional problems of both legibility and 
completeness. Secondly, on average, a hospital prescription is more than 3 times as costly as a GP 
prescription, implying that items on hospital prescriptions differ from GP prescriptions in terms of 
what is prescribed or the quantity requested, or both. In paediatrics these differences are 
compounded by the number of unlicensed medicines used, and licensed medicines used off-label. 
A hypothesis that community pharmacists have additional problems when dispensing hospital 
generated prescriptions is readily identified and is supported by anecdotal feedback from CPs. 
However, these concerns have generated few published reports. A literature search of community 
pharmacy surveys since 2003 identified over 200 papers but only one citation has been found 
relating to community pharmacy dispensing hospital prescriptions.(154) This report of an audit 
conducted in 2008 within a single PCT concludes that 16.4% of hospital prescriptions required 
action to be taken by the dispensing pharmacist to resolve issues. The survey of caregivers, 
described in Chapter 11, provides evidence that community pharmacy / supply was the main area 
of difficulty for patients and their carers (see page 146). 
 
Other chapters of this study programme highlight problems in maintaining the supply of long-term 
medication for children and the role hospital staff play in supporting this process. Possible solutions 
to accessing long-term medication for children may include making greater use of community 
pharmacies to dispense hospital generated prescriptions. If this solution is to be considered then an 
in depth understanding of the issues CPs may have in dispensing hospital prescriptions is required. 
 
This study aims to identify the experiences and opinions of CPs when dispensing hospital 
prescriptions. This blended study includes both quantitative and qualitative aspects and seeks to 
identify CP recommended actions to minimize any problems identified. 
 
12.2. Results 
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A total of 1,282 surveys were sent to community pharmacies known to have dispensed hospital 
generated FP10s within a 12 month period. 607 were completed (47.3%) and returned for analysis. 
One respondent declined to return a completed questionnaire. The first mailing (second class post) 
was sent on 22
nd
 September 2010. If necessary reminders were sent at + 3 weeks  
(13
th
 October 2010) and + 6 weeks (5
th
 November 2010). The figure below shows the pattern of 
returned questionnaires during the data collection period. 
 
Figure 13 Accumulated frequency of returned community pharmacy surveys by date 
returned 
 
 
12.2.1. Demographics 
 
The respondents had typically many years post registration experience as a pharmacist (median = 
13 years, range 0 to 50 years). A large majority completed their pre-registration experience in 
community pharmacy (81.1%, n=490), although some did so in hospital (15.2%, n=92). The figure 
below shows the number of years experience the respondents had in hospital and community 
pharmacy. A large majority had no hospital experience (84%, n=501). In contrast most respondents 
had more than 5 years experience in community pharmacy (71.7%, n=434). 
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Figure 14 Community Pharmacy Survey. Years experience of respondents in hospital and 
community pharmacy 
 
 
 
Respondents were asked to express the extent of their own personal experience of dispensing 
hospital prescriptions in the community, using the scale: very little; little; moderate; high; very high. 
Responses are shown in Table 39. A majority of respondents (n=347, 58%) considered their own 
experience to be moderate, although almost a quarter (n=147, 24%) considered their experience to 
be high. 
 
 
 
 
 
 
 
 
0
100
200
300
400
500
600
0 0.1 - 5 5.1 - 10 10.1 - 20 20.1 - 30 30.1 - 40 40.1 - 50 
Hospital
Community
Years of experience
N
o
. o
f 
re
sp
o
n
d
en
ts
 Page 154 
 
Table 39 Community Pharmacy Survey. Response to: To what extent have you personal 
experience of dispensing hospital prescriptions in the community? 
 
  
Frequency Valid 
Percent 
Very little 9 1.5% 
Little 50 8.3% 
Moderate 347 57.5% 
High 147 24.4% 
Very high 50 8.3% 
Total specific 
responses 
603 100.0% 
      
Missing responses 4   
 
12.2.2. Prescription handling 
The respondents were asked to estimate the number of prescription items that they personally 
dispense or supervise, from all sources, in one calendar month. The pattern of results is shown in 
Figure 15 below. 75% of respondents dispensed between 3,000 and 12,000 items per month.  
In contrast the respondents dispensed relatively few hospital generated prescription items. 
 
 
Figure 15. Community pharmacy survey. Number of prescription items dispensed in 1 
calendar month by respondents 
 
 
 
Table 40 shows the number of hospital prescription items dispensed by respondents in 1 year. The 
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most frequent response selected (36.1%) was the range 101 to 500: approximately between 2 and 
10 hospital prescriptions per week. A cross-tabulation of the number of hospital items dispensed 
with the total number of prescription items dispensed was undertaken. Analysis of this comparison 
using the Pearson Chi-squared test shows a linear relationship between these two variables (p < 
0.001). In general terms, the number of hospital prescriptions dispensed is in proportion to the 
overall dispensing workload of the CP. 
 
 
Table 40 Number of hospital items dispensed per YEAR by respondents  
 
 Frequency Valid Percent 
None 49 8.3% 
1-25 64 10.8% 
26-100 197 33.2% 
101-500 214 36.1% 
501-1,000 46 7.8% 
>1,000 23 3.9% 
Total specific responses 593 100.0% 
Missing responses 14   
 
 
 
The respondents were asked to estimate the average time it takes to dispense a single item on: a) 
a hospital prescription and b) a GP prescription.  
 
 
Figure 16 shows the pattern of results. The mean time to dispense a hospital prescription is 
calculated as 8.15 minutes, compared with 3.37 minutes for a GP prescription. These results 
indicate that hospital prescriptions take more than twice as long to dispense in comparison with GP 
prescriptions.  
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Figure 16 The time respondents take on average to dispense a single item on hospital and 
GP prescriptions 
 
 
Table 41 below shows the comparative statistics for the time reported by the respondents to 
dispense hospital and GP prescriptions. Analysis confirms that there is a statistically significant 
difference between these two variables (paired samples, p< 0.001). 
 
Table 41 Time to dispense hospital or GP prescriptions (mins). Comparative statistics 
 
Descriptive Statistics 
 
N Minimum Maximum Mean Std. Deviation 
Hosp Rx time 556 1.0 120.0 8.150 9.8648 
GP Rx time 560 0.5 30.0 3.367 2.8553 
 
Differences in time (paired samples) reported by respondents between hospital and GP 
prescriptions are shown in Figure 17 below. Two-thirds of respondents (n=357) report that on 
average hospital prescriptions take between 0 and 4 minutes longer to dispense. Interestingly 2% of 
respondents (n=11) report that hospital prescriptions take less time to dispense than GP 
prescriptions. 
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Figure 17 Community Pharmacy Survey. Histogram of differences in time reported by 
respondents (paired samples) between HP and GP prescriptions (HP minus GP) 
 
 
 
 
The relationships between the time difference it takes to dispense hospital prescriptions in 
comparison with GP prescriptions (Th-g) and a number of other variables has been examined. 
These are: 
 Th-g vs community pharmacy experience Figure 18 
 Th-g vs hospital pharmacy experience Figure 19 
 Th-g vs number of hospital prescriptions dispensed Figure 20 
 Th-g vs personal experience of hospital prescriptions  Figure 21 
 Th-g vs confidence in identifying problems on hospital prescriptions Figure 24 & Figure 25 
 Th-g vs relative likelihood of problems on hospital prescriptions Figure 26 
 Th-g vs relative complexity of hospital prescriptions Figure 27 
 
The relationship between the number of years community pharmacy experience of the respondents, 
with Th-g, has been analysed. A scatter plot of these two variables is shown in  
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Figure 18. 
 
 
Figure 18 Scatter plot of years experience as a community pharmacist verses difference 
between the time to dispense hospital prescriptions and GP prescriptions (minutes). 
 
 
 
Selecting two sub-cohorts based on community pharmacy experience of less than 10 years and 
more than 10 years and applying the Mann-Whitney statistical test confirms a highly significant 
difference (p < 0.001) for Th-g between the two groups. The median Th-g in the less than (or equal to) 
10 years experience group was found to be 3 minutes; Th-g in the more than 10 years experience 
group was found to be 2 minutes. 
 
Similarly, the relationship between the number of years hospital pharmacy experience of the 
respondents, with Th-g, was also analysed. A scatter plot of these two variables is shown in Figure 
19. 
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Figure 19 Scatter plot of years experience as a hospital pharmacist verses difference 
between the time to dispense hospital prescriptions and GP prescriptions (minutes). 
 
 
 
Dividing the respondents into two groups according to hospital experience of less than or equal to 
10 years and greater than 10 years and applying the Mann-Whitney statistical test confirms that 
there is no significant difference (p > 0.05) for Th-g between the two groups. Since this lack of 
significance may be due to too few cases in the greater than 10 years hospital pharmacy sub-cohort 
the variable was re-grouped into less than or equal to 5 years hospital pharmacy experience and 
greater than 5 years hospital experience. Again no significance is identified between the groups (p 
= 0.068). 
 
Other relationships between variables indicating experience of the respondents and Th-g were 
analysed. For example it may be supposed that respondents dispensing more hospital prescriptions 
may report a reduced time difference. A box plot of these two variables failed to identify any trends 
and no further exploration of this relationship was undertaken. See Figure 20. 
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Figure 20 Box plot of number of HP prescriptions dispensed in 1 year verses difference 
between the time to dispense hospital prescriptions and GP prescriptions. 
 
 
 
 
 
The relationship between the variables, personal experience of dispensing hospital prescriptions in 
community pharmacy with Th-g was analysed. A box plot of this relationship was created to identify 
any trends. See Figure 21.  The box plot shows a mostly linear relationship between these two 
variables. 
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Figure 21 Box plot of personal experience of dispensing hospital prescriptions in community 
pharmacy with time difference to dispense hospital and GP prescriptions 
 
 
Analysis of the data with the Jonckheere-Terpstra test shows a highly significant trend across the 
groups (p = 0.002). That is, the more personal experience the respondents have in dispensing 
hospital prescriptions the longer they take to dispense them relative to GP prescriptions (increasing 
Th-g). 
 
 
12.2.3. Hospital prescriptions - general 
 
 
Respondents were asked: In comparison to an average GP (FP10) prescription what is the 
likelihood of problems when dispensing a HP (FP10HP) prescription in a community pharmacy. 
Responses are shown in Figure 22 below. A large majority (87%, n=528) stated that problems were 
either more or much more likely on hospital prescriptions. 
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Figure 22 In comparison to an average GP (FP10) prescription what is the likelihood of 
problems when dispensing a HP (FP10HP) prescription in a community pharmacy. 
 
 
Respondents were given four statements and asked to indicate the extent to which they agreed or 
disagreed. Tabulated results are shown in Table 42. In summary: 
 75.4% agreed or strongly agreed that hospital prescriptions were generally more complex 
than GP prescriptions. 
 52.8% disagreed or strongly disagreed that they were less likely to challenge an unfamiliar 
dose on a hospital prescription compared with a GP prescription. 
 70.1% disagreed or strongly disagreed that hospitals should NOT be allowed to issue 
prescriptions to be dispensed by community pharmacies. 
 Respondents were equivocal as to whether hospitals should ensure that all out-patient 
prescriptions are issued to patients so that they can be dispensed by community 
pharmacies (40% neutral). 
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Table 42 Statements relating to hospital prescriptions. Extent of agreement or disagreement 
by respondents 
 
  
Strongly 
disagree Disagree Neutral Agree 
Strongly 
agree Total 
HP prescriptions are generally more 
complex to dispense than GP 
prescriptions 14 (2%) 31 (5%) 103 (17%) 346 (58%) 108 (18%) 602 
I am less likely to challenge an 
unfamiliar dose on a hospital 
prescription compared with a GP 
prescription 87 (14%) 
232 
(38%) 142 (24%) 127 (21%) 16 (3%) 604 
Hospitals should NOT be allowed to 
issue prescriptions to be dispensed by 
community pharmacies 
159 
(26%) 
265 
(44%) 110 (18%) 49 (8%) 22 (4%) 605 
Hospitals should ensure that all out-
patient prescriptions are issued to 
patients so that they can be dispensed 
by community pharmacies 25 (4%) 
102 
(17%) 244 (40%) 162 (27%) 71 (12%) 604 
 
 
 
The relationship between a) the likelihood of problems on hospital prescriptions in the opinion of 
respondents and b) their own hospital pharmacy experience was analysed. Responses to this latter 
variable were split into two groups; those with 1 year or less hospital experience and those with 
more than 1 year experience. The pattern of results is shown in Figure 23. 
 
There is a statistically significant difference between these two groups (p=0.002, Pearson Chi-
squared). Those with more than 1 year hospital experience believe that the relative problems with 
hospital prescriptions are less than their colleagues with less hospital experience. 
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Figure 23 Respondents opinion of the relative likelihood of problems on hospital 
prescriptions according to their own experience of hospital pharmacy 
 
 
12.2.4. Hospital prescriptions - problems 
 
Respondents were given a list of five possible problems on prescriptions. They were asked to 
indicate the likely occurrence of these problems on hospital prescriptions in comparison with GP 
prescriptions. Responses are shown in Table 43. In summary: 
 
 89.1% considered it more or much more likely that they cannot read hospital prescriptions 
 67% considered it more or much more likely that the hospital prescription will request an 
unfamiliar drug 
 84.7% considered it more or much more likely that the hospital prescription will request an 
unfamiliar drug regimen 
 89.1% considered it more or much more likely that there will be information missing on the 
hospital prescription 
 52% considered that there were no additional problems in obtaining items on hospital 
prescriptions, although 1 in 3 respondents expressed the view that there were more 
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problems obtaining hospital prescription items 
 
Table 43 Problems on prescriptions - the likely occurrence on hospital prescriptions in 
comparison with GP prescriptions. 
 
  
Much 
more More Same Less 
Much 
less TOTAL 
Cannot read the prescription 
264 
(44%) 
273 
(45%) 
63 
(10%) 
2 
(0%) 
1 
(0%) 603 
Unfamiliar drug 
74 
(12%) 
330 
(55%) 
191 
(32%) 
5 
(1%) 
3 
(1%) 603 
Unfamiliar dose regimen 
118 
(20%) 
393 
(65%) 
89 
(15%) 
2 
(0%) 
1 
(0%) 603 
Information on Rx is missing 
361 
(60%) 
177 
(29%) 
58 
(10%)  
7 
(1%) 
1 
(0%) 604 
Problems with obtaining the product 
66 
(11%) 
216 
(36%) 
310 
(52%) 
7 
(1%) 
2 
(0%) 601 
 
 
Respondents were given the opportunity to provide free text comments relating to problems on 
hospital prescriptions. Responses were received from 418 respondents and were coded. The codes 
assigned with the highest frequency were: poor legibility (21.8%); quantity (missing) (19.1%); 
missing information – general (17.2%); communication issues (9.1%); and missing contact details 
(6.7%). 
 
Respondents were asked: In comparison to an average GP (FP10) prescription how confident are 
YOU that you will be able to identify any prescribing errors when dispensing a hospital (FP10HP) 
prescription in a community pharmacy? (scale: much less – less – same – more – much more). 
Two-thirds of respondents (n=398, 66%) expressed the view that they had the same confidence 
when dispensing hospital or GP prescriptions, although a quarter of respondents (n=150, 24.9%) 
stated they had less confidence when dispensing hospital prescriptions. The relationship between 
the relative confidence of respondents in identifying prescribing errors on hospital prescriptions and 
Th-g was analysed. A box plot of this relationship was created to identify any trends. See Figure 24. 
This v shaped graph shows that respondents who have the ―same confidence‖ (the middle option in 
the scale) in identifying problems on hospital prescriptions as on GP prescriptions report the least 
time difference in dispensing the prescriptions.  
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Figure 24 Relative confidence of respondents in identifying prescribing errors on hospital 
prescriptions with time difference required to dispense hospital and GP prescriptions. 
 
 
 
 
Responses relating to confidence were assigned to two groups for further analysis: 
Group 1 Same confidence: where ―confidence‖ = same 
Group 2 Different confidence: where ―confidence‖ does not equal same (includes groups 
much-less, less, more and much-more). 
These groups were plotted against time difference. 
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Figure 25 Box plot of groups with same or different confidence in identifying prescribing 
errors with time difference to dispense prescriptions 
 
 
 
 
The Mann-Whitney non-parametric test for two independent samples demonstrates that there is a 
highly significant difference between these two groups (p < 0.001). Respondents with ―confidence‖ 
= same having a smaller Th-g than those where ―confidence‖ is not equal to same. 
 
Respondents were asked: As a community pharmacist do you believe that there is more risk of 
error when dispensing a hospital prescription compared to a GP prescription? – in answer to which 
61% (n=368) replied yes. Respondents were also given the opportunity to provide free text 
comments in relation to this question. 268 comments were provided and coded. The codes 
assigned with the highest frequency were: poor legibility (37%); communication issues (10.1%); and 
missing information – general (7.5%). 
 
The relationship between the opinion of respondents on the extent of problems on hospital 
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prescriptions and Th-g was analysed. A box plot of this relationship was created to identify any 
trends. See Figure 26. 
 
Figure 26 Likelihood of problems on HP prescriptions verses difference in the time to 
dispense hospital prescriptions and GP prescriptions. 
 
 
 
The relationship between these two variable was analysed using the  
Jonckheere-Terpstra test, and a significant trend across the groups was found (p<0.001). The 
results indicate that as the likelihood of problems on HP prescriptions rises (in the opinion of 
respondents) the more likely are the respondents to take a significantly longer time to dispense HP 
prescriptions. 
 
Similarly, the relationship between the relative complexity of hospital prescriptions in the opinion of 
the respondents, and Th-g was analysed. A box plot of this relationship was created to identify any 
trends. See Figure 27. 
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Figure 27 Relative complexity of HP prescriptions verses difference between the time to 
dispense hospital prescriptions and GP prescriptions. 
 
 
 
Analysis with the Jonckheere-Terpstra test shows a highly significant trend (p<0.001) across the 
groups. That is, respondents who strongly agree that hospital prescriptions are more complex take 
a significantly longer time to dispense HP prescriptions in comparison to GP prescriptions. 
 
 
12.2.5. Hospital prescriptions – getting advice 
 
The respondents were asked: If you require further advice / information when dispensing a 
HOSPITAL PRESCRIPTION what or whom will you consult? Please indicate how likely you are to 
use the following sources of information? Seven different information sources were provided in the 
survey. The responses to these options are shown in Table 44. In order of frequency, respondents 
were either very likely or quite likely to consult: standard texts – e.g. BNF (84.7%); hospital 
prescriber (84%); hospital prescriber‘s support staff (67.3%); the patient or carer (65.7%); hospital 
pharmacy (39.4%); medicines information department (31.3%); GP, or their staff (19.4%). 
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Table 44 How likely respondents will use 7 different information sources when dispensing 
hospital prescriptions. 
 
  
Very 
likely 
Quite 
likely Sometimes 
Quite 
unlikely 
Very 
unlikely Total 
The patient or carer 
231 
(38%) 
165 
(27%) 177 (29%) 20 (3%) 10 (2%) 603 
Standard text (eg BNF) 
318 
(53%) 
191 
(32%) 84 (14%) 5 (1%) 3 (1%) 601 
GP (or their staff) 
45 
(8%) 
67 
(12%) 166 (29%) 
215 
(37%) 85 (15%) 578 
Hospital Pharmacy 
90 
(15%) 
145 
(24%) 173 (29%) 
132 
(22%) 56 (9%) 596 
Medicines information 
67 
(11%) 
118 
(20%) 209 (35%) 
142 
(24%) 56 (10%) 592 
Hospital Prescriber 
325 
(54%) 
179 
(30%) 65 (11%) 18 (3%) 13 (2%) 600 
Hosp prescriber's 
support staff eg 
registrar 
205 
(34%) 
198 
(33%) 110 (18%) 53 (9%) 33 (6%) 599 
 
 
The respondents were also given the opportunity to provide free text descriptions of any other 
information sources they were likely to use. The 63 responses were coded. The codes assigned 
with the highest frequency to identifiable sources were: NPA (n=9, 14.3%); consultant‘s secretary 
(n=7, 11.1%) and internet (n=6, 9.5%). 
 
 
12.2.6. Resolving problems 
 
A large majority of respondents (n=471, 78.2%) confirmed that they had SoPs that provided 
guidance in resolving prescription problems. When a pharmacist acts to modify a prescription, often 
in consultation with the prescriber, it is usually described as an intervention. Respondents were 
asked how often they record details of when they intervene on prescriptions. Responses are shown 
in Figure 28. A majority of respondents (n=335, 55.3%) stated that they always recorded 
intervention details. 
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Figure 28 How often respondents record prescription intervention details 
 
Respondents were asked: In the last 12 months approximately how often have you or the staff 
under your supervision contacted a) a hospital for advice concerning a hospital prescription and b) 
a GP practice for advice concerning a GP prescription? Responses are shown in Figure 29. A large 
majority of respondents (n=378, 62.8%) made contact concerning hospital prescriptions between 1 
and 12 times per annum. In contrast, there is a more Normal distribution of results for GP 
prescriptions. 
 
Figure 29 Frequency respondents contacted the primary information source for hospital and 
GP prescriptions 
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12.2.7. Beneficial changes 
 
The survey provided respondents with 9 options which may be beneficial in reducing the problems 
associated with dispensing hospital prescriptions in community pharmacy. Respondents were 
asked to assess the benefit of each proposed change using the scale: no benefit; little benefit; 
medium benefit; high benefit; very high benefit.  Table 45 shows the responses. A summary of the 
results, in order of popularity for the combined categories high benefit or very high benefit, is 
provided below: 
 
 Ensure all hospital prescriptions include direct contact details for the prescriber (98.5%) 
 Ensure all hospital prescriptions are computer printed (94.1%) 
 If prescribed dose regimens are not included in standard texts ensure the prescriber 
acknowledges that they have done so knowingly on the prescription (eg endorse as BNF 
crossed-through (72.6%) 
 Ensure prescribers indicate the dose calculation as well as the final dose on hospital 
prescriptions for children (eg state mg per kg as well as calculated dose) (67.3%) 
 Ensure all hospital prescriptions are clinically screened by a hospital clinical pharmacist 
before being issued to the patient. (63.8%) 
 Create an internet site to enable access to the hospital‘s usual formulations and source of 
unlicensed medicines and provide web address on the prescription (51%) 
 Provide a prescription fax back system to the hospital– so that the prescription can be 
faxed to the Pharmacy of the hospital for comment. Provide the fax number on the 
prescription. (46.9%) 
 Create an internet site to enable access to the hospital‘s formulary and provide web 
address on the prescription (45.8%) 
 Create an internet site to enable access to the hospital‘s clinical protocols and provide 
web address on the prescription (37.1%) 
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Table 45 Proposed changes to support dispensing hospital prescriptions by CPs. 
Assessment of benefits 
  
No 
benefit 
Little 
benefit 
Medium 
benefit 
High 
benefit 
Very 
high 
benefit TOTAL 
Ensure all hospital prescriptions are 
computer printed  0 (0%) 2 (0%) 34 (6%) 
205 
(34%) 
366 
(60%) 607 
Ensure all hospital prescriptions 
include direct contact details for the 
prescriber 0 (0%) 0 (0%) 9 (2%) 
126 
(21%) 
471 
(78%) 606 
Create an internet site to enable 
access to the hospital‘s formulary and 
provide web address on the 
prescription 
20 
(3%) 
111 
(18%) 
198 
(33%) 
178 
(29%) 
100 
(17%) 607 
Create an internet site to enable 
access to the hospital‘s clinical 
protocols and provide web address on 
the prescription 
31 
(5%) 
144 
(24%) 
207 
(34%) 
157 
(26%) 
68 
(11%) 607 
Create an internet site to enable 
access to the hospital‘s usual 
formulations and source of unlicensed 
medicines and provide web address on 
the prescription 
15 
(3%) 
91 
(15%) 
191 
(32%) 
206 
(34%) 
103 
(17%) 606 
If prescribed dose regimens are not 
included in standard texts ensure the 
prescriber acknowledges that they 
have done so knowingly on the 
prescription (eg endorse as  7 (1%) 
18 
(3%) 
141 
(23%) 
241 
(40%) 
198 
(33%) 605 
Provide a prescription fax back system 
to the hospital– so that the prescription 
can be faxed to the Pharmacy of the 
hospital for comment. Provide the fax 
number on the prescription. 
13 
(2%) 
95 
(16%) 
213 
(35%) 
176 
(29%) 
107 
(18%) 604 
Ensure all hospital prescriptions are 
clinically screened by a hospital clinical 
pharmacist before being issued to the 
patient. 
11 
(2%) 
50 
(8%) 
158 
(26%) 
227 
(38%) 
159 
(26%) 605 
Ensure prescribers indicate the dose 
calculation as well as the final dose on 
hospital prescriptions for children (eg 
state mg per kg as well as calculated 
dose) 5 (1%) 
35 
(6%) 
158 
(26%) 
218 
(36%) 
189 
(31%) 605 
 
 
Respondents were asked to give their opinion as to which single achievable change would bring 
about the most benefit in relation to dispensing hospital prescriptions in community pharmacy. Free 
text answers were provided by 504 respondents. The codes assigned with the highest frequency 
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were: printed / computer generated prescriptions (n=204, 41%); prescriber contact details (n=140, 
28%); multiple changes suggested by respondents (n=52, 10%); unassigned / undefined change 
(n=38, 7.5%); clinically screened (n=25, 5%). 
 
The survey invited respondents to provide any further comments concerning hospital prescriptions 
dispensed in the community. 151 comments were made and coded. All codes that were assigned 
more than once are shown in Table 46. Up to two codes were assigned to each response. 
Problems relating to legibility were most frequently found in these free text answers. 
 
 
Table 46 Further comments concerning hospital prescriptions dispensed in the community 
by respondents (frequency of coding).  
 
CODE Frequency 
Valid 
Percentage 
Contact details illegible / missing 24 15.9% 
Legibility issues (eg. Handwriting) 15 9.9% 
Missing quantity 12 7.9% 
Training – prescriber 10 6.6% 
Unassigned 9 6.0% 
Computer generated Rx beneficial 8 5.3% 
Hospital Rx only - communication issue 8 5.3% 
Communication problems 3 2.0% 
Contact problems 3 2.0% 
Hosp letter beneficial 3 2.0% 
Missing details 3 2.0% 
Not in BNF useful 3 2.0% 
Website beneficial 3 2.0% 
CD errors 2 1.3% 
Excessive quantities 2 1.3% 
Hospital Rx dispense in CP beneficial 2 1.3% 
Patient address omitted 2 1.3% 
Quantity of eye drops 2 1.3% 
Replacement Rx problems 2 1.3% 
Training – secretary 2 1.3% 
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12.3. Discussion 
 
 
12.3.1. Main findings 
 
A return rate of 47.3% was in keeping with expectations and provided over 600 useful replies to this 
survey. This large number of respondents facilitated statistical analysis of the results. A fourth 
posting (third reminder) may have provided further replies but this was not undertaken. The large 
response to the third mailing may have occurred as a consequence of making it clear to recipients 
that this was the final reminder and sending another reminder may be considered disingenuous. 
 
588 respondents provided the postcode of the pharmacy in which they completed the 
questionnaire, although 73 of these were incomplete. Of the full postcodes provided (n=515) only 
15 were duplicated. A total of 263 postal districts (as represented by the first part of the UK code) 
were represented by the respondents and demonstrates the geographical diversity of the study 
cohort and adds to the confidence that the main findings may be generalisable in England.  
 
At the time of the survey over 80% of respondents had more than 3 years experience as a 
pharmacist since first registration. This level of experience adds to confidence in the validity of 
results, with little concern from possible bias or invalid views or opinions due to inexperience. 
Most respondents (80%) completed their pre-registration year in community pharmacy, with a small 
minority (15.2%) doing so in hospital. As expected, the study cohort had, on average, many years 
experience as community pharmacists, with over 70% having more than 5 years experience. Few 
however had any hospital pharmacy experience with 84% having no experience once registered. 
Only 1 in 10 of respondents had more than one year experience in hospital.  It is clear that few 
respondents were neither trained in nor had suitable experience of the hospital sector to support 
their dispensing of hospital prescriptions. Those with 1 year or more hospital experience believe 
that the likelihood of problems on hospital prescriptions (relative to GP prescriptions) is less than 
their colleagues. See Figure 23. However their greater hospital experience does not influence their 
views on the complexity of hospital prescriptions, their likelihood to challenge hospital prescriptions 
nor their assessment of the relative risk of hospital prescriptions. These results may indicate that 
community pharmacists with more than 1 year experience in hospital pharmacy may consider 
themselves better equipped to manage the problems that dispensing hospital prescriptions in 
community pharmacy presents. Whilst results from this present study points to this conclusion, this 
study is far from conclusive in this respect and further consideration of the training needs of CPs to 
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manage hospital prescriptions is necessary. The opportunity to gain experience of hospital 
prescriptions in community pharmacy is limited and most respondents describe their own 
experience of hospital prescriptions as moderate. 
 
Almost half of respondents report that they dispense or supervise over 6000 prescription items per 
month (all sources of prescriptions); over 200 items on average each working day. In contrast over 
a third of respondents (36.1%, n=214) only dispense between 8 and 40 hospital prescriptions each 
month. Overall approximately 0.3% of prescriptions dispensed or supervised by respondents were 
hospital prescriptions, marginly lower than the national average of 0.6% at the time of the study. 
[NHS Business Services Authority. Hospital prescriptions dispensed in Community Pharmacies in 
England. Personal communication, Used with permission. Received July 23rd 2009.] Whilst the 
estimate of 0.3% is half the expected result relatively small errors in estimations of the number of 
hospital prescriptions may account for this difference and the result may be considered similar in 
magnitude to the accepted national figure. 
The mean time to dispense a hospital prescription was found to be twice as long as that for a GP 
prescription; a statistically significant difference. This present study may quantify this difference for 
the first time and indicates the additional work that a CP must do when dispensing hospital 
prescriptions. There is strong agreement by the respondents that hospital prescriptions are either 
more likely or much more likely to have problems than GP prescriptions (87.4%). They also 
consider hospital prescriptions more complex than those issued by GPs. These two factors are both 
likely to influence the time required to dispense hospital prescriptions and both were found to have 
a statistically significant relationship with the (relative) time taken to dispense hospital prescriptions.  
A majority of respondents confirm that they are just as likely to challenge an unfamiliar dose on 
hospital prescriptions as they are GP prescriptions. The respondents‘ professionalism in managing 
the risk to their patients is supported by this finding and they do so even when problems are more 
likely and contacting the prescriber is hindered. They believe that hospitals should continue to be 
allowed to issue prescriptions for CPs to dispense, indicating, in part at least, that the problems are 
manageable. They are less sure however whether all out-patient prescriptions should be dispensed 
in the community and this may reflect their relative lack of experience with hospital prescriptions. 
They may also be unsure of the prescriptions that hospital pharmacies dispense that they may not 
see in community pharmacy. 
 
This present study suggests that the major problems community pharmacists have when dispensing 
hospital prescriptions relate to legibility of the written prescriptions and missing information on the 
prescriptions, often quantity. Lack of familiarity with drugs used by hospital prescribers may 
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contribute to these problems. The survey explores these issues using direct questions in 
accordance with findings from the focus group. These views are strongly supported by free text 
comments made by the respondents which confirm the reliability and validity of these conclusions. 
The respondents‘ answers frequently draw attention to the poor legibility of hospital prescriptions‘ 
and this may be considered the leading cause of the increased risk relating to hospital 
prescriptions. 
 
 The respondents were equivocal concerning problems in obtaining the products with approx. half 
stating there are more problems with hospital prescribed items and the other half disagreeing. Only 
3.6% (n=13) of respondents mention specialist (‗specials‘) drugs within their free text answers. The 
relationship between these views and whether the respondent is in an independent chemist or 
working for a pharmacy chain is yet to be determined. 
 
Two-thirds of respondents have the same confidence that they will be able to identify any 
prescribing errors when dispensing a hospital prescription as with a GP prescription, yet 61.1% 
(n=368) believe that there is more risk of error when dispensing a hospital prescription compared to 
a GP prescription. It is difficult to interpret these two opposing finding although it is possible the 
former may be considered to be a personal expression of the individual‘s ability and the later as a 
group effect. Or in summary these results may imply … I have confidence personally to identify 
errors but I‘m less confident my community pharmacy colleagues can do likewise. 
 
CPs may consult a number of sources when needing advice concerning hospital prescriptions. The 
likelihood of using 7 possible sources is shown in the results section on page 169. A large majority 
of respondents confirm that they are likely or very likely to consult a standard text (e.g. BNF) or the 
hospital prescriber and this approach is in keeping with expectations. Two-thirds also confirm that 
they are likely or very likely to consult the patient. This may be of practical help when managing 
poor legibility of prescriptions and confirming the required item. However, the reliability of 
descriptions of medication regimens provided by caregivers on admission to hospital has been 
questioned in other studies reported in this thesis. Community pharmacists should be cautious 
when acting on lay descriptions of medication regimens without corroborating information. Fewer 
respondents contact the hospital pharmacy or medicines information when needing advice than 
other key sources of information. This may be an unexpected finding since the medicines 
information service is designed to accommodate these enquiries. Anecdotal comments indicate that 
the speed of reply may not be in keeping with the requirements of the CPs. These options are, of 
course, not mutually exclusive and when seeking advice a pharmacist may consult a number of 
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sources. 
 
A majority of respondents (78.2%) confirm that they have standard operating procedures to resolve 
queries on prescriptions. Solving queries on prescriptions may be considered a core task of a CP 
and therefore this figure may be lower than expected. Organisations monitoring the work of CPs 
should expect operating procedures of this kind to be in place and in use. 
 
Respondents were asked to report the frequency that they, or their staff, call hospital prescribers for 
advice on a prescription. 62.8% (n=378, largest group) stated they did so between 1 to 12 times in 
12 months. Similarly, respondents were asked to report the annual frequency that they, or their 
staff, call GPs. 24.5% (n=147, largest group) did so between 25 to 52 times. By comparing the 
frequency of calls with the estimate number of prescriptions processed by each respondent the calls 
per prescription can be estimated: 
 Calls to GPs – range from 1 call per 31 prescriptions to 1 call per 18,000. Using the 
calculated mid-point method the average is estimated to be 1 in 939 
 Calls to hospital prescribers – range from 1 call per 0.1 prescriptions to 1 call per 166. 
Using the calculated mid-point method the average is estimated to be 1 in 9.7. The highest 
frequency of 10 calls per single hospital prescriptions seems unlikely and the reliability of 
the response from this respondent should be questioned. 
This 100 fold difference illustrates the additional problems CPs have when dispensing hospital 
prescriptions. 
The respondents were asked to consider the benefit of a list of possible service options to reduce 
the problems associated with dispensing hospital prescriptions in community pharmacy. Almost all 
(98.5%) indicted that it would be a high or very high benefit to include the prescriber‘s direct contact 
details on the prescription. A similar number (94.1%) of respondents consider printing hospital 
prescriptions as a high or very high benefit. Respondents support these views within their free text 
answers. Increasing numbers of hospital acute Trusts have been accredited to issue computer 
generated prescriptions since their introduction in 2005 [personal communication NHSBSA to D 
Terry used with permission. Copyright NHSBSA. 23
rd
 July 2009] rising from 32 in 2005 to 41 in 
2010. Whilst GP prescriptions are expected to be stamped with the GP practice address and 
contact details of the individual doctor using that prescription pad, this may not be the case for 
hospital generated prescriptions. Each organisation (e.g. GP practice or acute Trust) has a unique 
code assigned by the PPA: and each unique code can be assigned a maximum of 99 prescriber 
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sub-codes. GP practices are unlikely to exceed this number, however even small acute Trusts will 
have more than 99 prescribers. For example, BCH, a small Trust with 240 beds, has 366 
prescribers (see Chapter 9). As a consequence hospitals assign prescriber sub-codes to clinical 
specialties and all prescribers within that specialty are issued with prescription pads with the same 
printed ID code. Many hospital prescriptions will carry the main hospital switch-board telephone 
number. So when faced with a problem on a hospital prescription, CPs will be able to ring the 
institution that issued the prescription but may not be able to identify the prescriber concerned from 
amongst hundreds of possible prescribers. Respondents clearly find this a problem as evidenced by 
their responses in this present study. Service changes should be considered to address these 
communication issues. 
Two proposed beneficial changes involve actions to be taken by the hospital prescriber. These 
were i) indicate that a regimen outside standard texts is intended (e.g. cross through the letters 
BNF) and ii) include the dosage calculation on the script if relevant for children (e.g. state mg per kg 
as well as calculated dose). Both these proposed changes were considered by more than two-thirds 
of respondents to be a high or very high benefit. These options were included in the study of 
medical staff and on each occasion over 80% of respondents confirmed that they would be 
prepared to take these actions. See page 108. Introducing these service changes appears to be 
achievable and beneficial. 
 
The benefit of hospital pharmacists‘ clinically screening the hospital prescriptions before they are 
issued was included in the survey and over 60% of respondents considered this to be a high or very 
high benefit. Clearly there will be practical problems in effecting this change and this may be 
inappropriate in some settings. However, this may be beneficial where paediatric hospitals are 
using homecare suppliers to provide long-term medicines for continuing-care patients. It is unclear 
why more than a third of respondents do not consider this to be a high benefit. They may consider 
that they are equally capable of clinically screening the prescriptions or that they will need to satisfy 
themselves anyway as to the suitability of the prescription regardless of the opinion of a hospital 
colleague. 
 
In general using the internet to gain access to supporting information was less favoured by the 
respondents although a small majority considered gaining access to the hospital‘s unlicensed drugs 
database as a high or very high benefit. Providing a faxback option whereby hospital staff could 
give an opinion of a prescription was also less favoured by the respondents. All of these options 
may seem a little time consuming and this may explain the respondents‘ reticence for these options. 
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Personal experience of dispensing hospital prescriptions in community pharmacy was measured in 
the survey instrument by a 5 point ordinal scale: very-little; little; moderate; high; or very-high 
experience. See Table 39 . Results obtained show that as personal experience increases so does 
the dispensing time difference reported by respondents between hospital prescriptions and GP 
prescriptions (Th-g). See Figure 21  Analysis with the Jonckheere-Terpstra test shows a highly 
significant trend across the groups (p = 0.002). The respondents who report greater experience of 
dispensing hospital prescriptions also report that they take longer to process them in comparison to 
a GP prescription. That is, the more experience they have of hospital prescriptions the longer they 
take (relatively) to dispense them. This is an important finding since it implies that inexperienced 
pharmacists do not take sufficient time when dispensing a hospital prescription. Training and 
education arrangements may need to be considered to reduce this implied risk. 
 
12.3.2. Strengths of this study 
 
This study harvests data from a large number of community pharmacists who have personal 
experience of dispensing hospital prescriptions in community pharmacy. Whilst the study population 
was identified through dispensing prescriptions issued from BCH the respondents are widely spread 
geographically throughout England and therefore reflect experience across the country. The large 
number of respondents facilitates analysis of sub-groups often enabling statistical significance to be 
identified where groups differ. The validity of the results is supported by the large response and the 
consistency between closed (pre-coded) and open (free-text) answers. 
 
Response rates for surveys of community pharmacists in the UK vary in published work, e.g.  
56.4% (87), 32.1% (86), 22.4% (155). The response rate for this present study of 47.3% seems in 
keeping, sometimes higher, than similar studies. All of the study population was targeted because 
of their recent experience of dispensing hospital prescriptions for paediatric patients. 
 
Almost 1 in 5 respondents provided an email address to facilitate follow-up and summary results will 
be sent directly to them. This resource will be useful to explore related issues via email discussion. 
 
12.3.3. Limitations of this study 
 
Whilst the methodology elicited a large response, manual handling of over 29,000 data points 
introduces practical problems of both time / resources and of data quality control. The use of a self-
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completion computer readable survey instrument would therefore have some advantages. However 
this was an unfunded study and a computerised survey was beyond the resources available. A 
number of actions were taken to ensure the quality of the data from this self-completion manually 
recorded survey – see Methods. 
 
Whilst this study generated over 600 responses it should be recognised that this is less than 5% of 
the total number of community pharmacists registered with the RPSGB.  
 
The study instrument did not focus specifically on paediatric prescriptions nor any differences there 
may be between dispensing hospital prescriptions for adults and those for children, with the 
exception of one question:  
„Please indicate in your opinion how beneficial the following changes would be in reducing 
the problems associated with dispensing hospital prescriptions in community pharmacy: 
Ensure prescribers indicate the dose calculation as well as the final dose on hospital 
prescriptions for children (eg state mg per kg as well as calculated dose).‟ 
 
Interestingly 67.2% of respondents consider this potential service change to be a high or very high 
benefit. Four respondents made free text comments in response to this question concerning 
children, in reference to unlicensed medicines (specials), dosages and prescription interpretation. 
Further work may be usefully focused on hospital prescriptions for unlicensed medicines and 
methods whereby community pharmacists can obtain confirmation of prescribed regimens that are 
not covered in standard texts. 
 
12.3.4. Comparison with other studies 
 
An extensive literature search identified only one other published study looking at the issue of 
hospital prescriptions dispensed by community pharmacists, in the UK. This is: 
 
Community Pharmacy Audit. Report of hospital prescription audit: Gloucester Local 
Pharmaceutical Committee; 2009. 
 
This audit focused on the interventions taken by Gloucester community pharmacists in response to 
hospital prescriptions dispensed during the months October and November 2008. A total of 2129 
prescriptions were audited and prompted interventions in 16.4% of occasions. They found that 
23.3% of hospital prescriptions did not have quantity (19%) or dose (4.3%) information and confirm 
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that CPs take considerable time to resolve such issues with the prescriber. They also found that 
143 (6.7%) prescriptions had no prescriber‘s name and 365 (17.2%) prescriptions had no contact 
details to enable the pharmacist to contact the prescriber to clarify the issues. Information was 
received from 68 pharmacies. This audit records some occasions where the prescribers‘ name is 
illegible but does not identify other legibility issues. The audit provides hospital specific reports of 
problems encountered on the prescriptions but does not make any recommendations for improving 
services. 
 
This present study did not audit prescriptions but rather obtained the opinions of a much larger 
group of CPs (607) when dispensing hospital prescriptions covering a much larger geographical 
area. This work found the CPs call the prescriber in 10.3% of occasions but doesn‘t quantify other 
types of intervention that were included in the Gloucester audit total of 16.4%. These findings seem 
congruent. This present study builds on the work of Gloucester LPC and: 
 
 Confirms problems CPs encounter when dispensing hospital prescriptions 
 Identifies legibility as a major problem 
 Quantifies the additional time taken to dispense hospital prescriptions 
 Identifies training issues for CPs 
 Identifies practical solutions to these problems in the view of CPs  
 
 
12.4. Conclusions 
 
Other chapters within this report describe the frequency with which paediatric caregivers have 
difficulty in obtaining on-going medication through primary care supply arrangements including from 
community pharmacists. If these problems are to be minimised then support must be provided for 
community pharmacists to dispense with confidence hospital generated prescriptions for paediatric 
patients. This presents a challenge since only 0.6% of prescriptions dispensed by CPs are from 
hospitals and therefore maintaining appropriate skills after training may be problematic. Acute 
Trusts that issue FP10s for dispensing by CPs can support this process by adopting computer 
programs that will print prescriptions. The NHSBSA should also consider the unique identifier 
limitations on current prescription forms. Adding a single digit to the ID would change the maximum 
number of unique codes for each organisation from 99 to 999 and this would facilitate prescription 
pads for individual prescribers in many acute hospital Trusts. 
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The present level of concern by CPs in dispensing hospital prescriptions casts doubt on whether 
this is an appropriate route for obtaining hospital prescribed items. If hospitals continue to prescribe 
long-term medicines for children then other routes of supply may need to be considered. Hospital 
dispensing is the obvious alternative but this may also be less than ideal. Hospital departments may 
not have the physical resources to provide such services. Even where dispensing facilities can be 
provided, either by a hospital pharmacy or an on-site contracted community pharmacy, there may 
be problems in the caregiver collecting the medication from the acute Trust. This may be particularly 
an issue for tertiary care centres where patients my come from far afield. Supplying long-term 
medicines via homecare providers offers some advantages. In this arrangement hospital 
prescribers can write prescriptions and have them dispensed by approved homecare providers from 
registered pharmacies. Collection difficulties can be overcome by posting medicines to caregivers 
or by direct delivery. Additional costs of such services may be balanced by reduced access 
problems, improved compliance and managed costs of unlicensed medicines. 
 Page 184 
13. General discussion and programme conclusions ….. 
 
The work presented in this thesis can support process changes that will lead to important patient 
benefits for children whether they are in hospital or being cared for at home. These benefits cover 
key aspects of medicines management essential for children needing long-term medication and 
focuses on the processes that ensure their medicines are accessible, safe and appropriately 
managed as they move from one healthcare sector to the next. These service improvements will 
only be realised if the findings of this research are applied appropriately to the development of 
healthcare services delivered by the NHS, in whichever sector the individual patient is receiving 
their care. The findings and recommendations may therefore be best described within the context of 
NHS service delivery and policy changes. Accessibility of the work is essential if benefits are to be 
realised and this section includes short descriptions of the use and dissemination of the programme 
conclusions so far. 
 
The study comparing medicines management policies or strategies in use and ratified by NHS 
organisations in both major healthcare sectors, primary care and hospital care, reveals important 
differences between these domains. Continuity of patient care is compromised by these differences 
mostly as a consequence of poor communication and information transfer or because of poor 
coordination of medicines management processes. Furthermore there is little evidence that the 
sectors recognise these differences and are seeking to address the consequential issues directly. 
The progress made between the preliminary study in 2007 and the main study in 2009 may be 
explained in the context of national guidance and responses by the sectors to meet their obligations 
directed in these documents. In particular the change concerning medicines management on 
admission to hospital can be traced to binding national guidance during this period. National 
guidance itself, of course, encourages cross-sector collaboration relating to medicines management 
and pre-dates studies reported in this thesis. For example, the development of Area Prescribing 
Committees evolved following the publication of guidance provided by the Department of Health in 
1994 concerning the entry of new drugs into the NHS,(156) although functions of this important 
cross-sector group continued to develop over a number of years as the NHS itself changed.(97) 
Responding to national initiatives is an important driver for change but this may be seen as 
inadequate to ensure joined up services that deliver without interruption or corruption the medicines 
patients‘ need. The harmonisation of medicines management policies of organisations within a 
health economy is a pre-requisite for seamless care. Partnership collaboration when developing 
such policies appears to be lacking as evidenced by the differences identified in this programme of 
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work and needs addressing. The opportunity to present the finding of the present study to regional 
groups of pharmacy managers has been offered and accepted and this may influence the 
development of medicines management policies in the future. This may be particularly timely as 
NHS primary care services moves from PCTs to GP clusters. The research on the actions PCTs 
take to support the provision of essential medication information on admission has led to the 
opportunity to directly influence the development of national policy documents produced by the 
NPC (70) and the CQC.(14) The CQC confirmed that the responsibilities of GPs include providing 
information concerning medicines on admission to hospitals, and also described the monitoring role 
that PCTs must play to ensure this service change is delivered. At the time of the CQC publication 
in October 2009 work described in chapter 8 demonstrated that less than 1 in 4 PCTs were actively 
providing guidance to their GPs to support this process. The CQC guidance was provided on the 
basis of an audit of only 12 PCTs. The study reported in this thesis targeted all English PCTs and 
received responses from 65 PCTs. Clearly PCTs and their successor organisations must ensure 
that these responsibilities are accepted by GPs and leads to the appropriate outcomes for 
information continuity. National and local policies should provide clear guidance to healthcare 
providers who are responsible for patients at the point of transfer to another sector. The ‗sending‘ 
organisation should be required to pass on essential medication information in a timely and 
accurate manner and include all information within the defined critical data set. The ‗receiving‘ 
organisation should not have to fetch it. Ensuring that a named individual is identifiable and 
accountable for this function at the point of transfer may support delivery of this process e.g. the GP 
for admission (from home) to hospital, the nurse in charge of the ward for discharge (to home), etc. 
 
NICE-NPSA guidance concerning medication reconciliation has prompted the delivery of this 
important service to adults when admitted to hospital in the UK. Their advice was evidence based 
and excluded children on the grounds of lack of evidence for this patient group. The study reported 
in this thesis (Chapter 7) concerning medication reconciliation in children was published in full in 
October 2010. This work provides evidence that the clinical benefits evidenced for adults are the 
same for children. This study has been presented at a number of forums including 3 national or 
international conferences and has led to opportunities to input into national bodies, regional policies 
and computer aided learning programs. This work indicates that medication reconciliation is 
essential for children on admission to hospital and it is hoped that this will be reflected in a change 
to national guidance. Service agreements, approved by commissioners of healthcare, should 
include the delivery and monitoring of medication reconciliation for children. Medicines policies in 
use by acute Trust should reflect the importance of this service. However, the most efficient way of 
delivering a medication reconciliation service for children, as well as adults, needs to be 
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determined. The service process needs to confirm when medication reconciliation should be 
performed and determine if a set of criteria can be defined when medication reconciliation is not 
likely to be beneficial. Further work also needs to define who should conduct each aspect of the 
process and which sources of information are the most reliable, accessible and useful to support 
appropriate prescribing on or soon after admission. These issues are being addressed following a 
grant awarded by the Neonatal and Paediatric Pharmacists‘ Group where the study design reported 
in this thesis forms the basis of a national multisite study. 
 
The multisite study of hospital nurses supporting the provision of rescue-medication for paediatric 
home-patients demonstrates for the first time the extent of problems that hinder medication access 
to children needing long-term medicines. This work confirms that this is a national problem and 
indicates a failure of current primary healthcare processes to provide, with suitable reliability, 
essential medication for children. It is noteworthy that the NPSA has recently issued guidance to 
ensure that critical medicines are administered to patients in hospital within a suitable time 
frame.(157) The application of this approach to paediatric home-patients would provide an equity of 
service for patients in primary care. Further studies may usefully identify the frequency with which 
children in primary care do not receive medicines considered to be time critical and the clinical 
outcomes of these delays or omissions should be determined. Managing long-term medicines for 
patients is challenging however they are provided. Difficulties will arise whether medicines are 
provided by primary care (GP-CP), hospitals or via homecare providers. Coordinating supplies must 
take into account, dose and formulation changes, medication expiry dates, lead times for acquisition 
and delivery, and must be able to respond to breakages, errors and unplanned changes in the 
delivery of care. Current repeat medication arrangements may be unsuitable for the provision of 
urgent supplies. In particular this may apply to novel preparations including unlicensed drugs often 
required by children with long-term conditions. There is evidence to suggest this holds true for other 
patient groups e.g. ophthalmology patients needing bespoke eye preparations [Personal 
communication. L Titcombe to D Terry dated 2
nd
 March 2011. Used with permission]. Supporting 
patients and their carers to take more personal responsibility will be beneficial. In particular ensuring 
appropriate contingency supplies, requesting repeat prescriptions in good time and expecting some 
medicines to take up to a week to obtain will help ensure that medicine supplies do not run out. 
Patient and carer training may be necessary in addition to providing essential information.  
 
The survey of medical staff confirms their role in the provision of rescue-medicines. All specialties 
caring for children with long-term conditions appear to need to provide prescriptions for rescue-
medicines. In the study setting these responses to requests for urgent help appear uncoordinated, 
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un-resourced and unplanned, yet happen on a regular basis and at a high frequency. Similarly only 
a small proportion of nurses involved in this service have this acknowledged in their job 
descriptions. Work described in this thesis reveals for the first time the extent of this problem and 
the resources needed to minimise the clinical risk to patients. Paediatric hospitals should 
acknowledge this activity and its clinical importance, should make coordinated provision to help 
patients who are at home and should ensure that commissioning arrangements provide the 
resources to deliver these services. Healthcare professionals involved in dealing with these urgent 
requests should have this activity reflected in their working arrangements. How this support is 
provided outside normal working hours should be identified. The study of caregivers attending the 
hospital pharmacy at BCH to access rescue-medicines adds to the understanding of this 
phenomenon. Many make unplanned trips of significant distance to get urgent help. That they do so 
not only for unlicensed drugs but also for licensed medicines is an important finding and cannot be 
predicted from existing published work. If this finding is confirmed, then why children cannot be 
provided with timely supplies of licensed medicines needs further investigation and has implications 
for other patient populations. Acute Trusts must also consider the time it takes to inform GPs of 
medication changes at discharge and how this matches the length of supply of medicines provided 
as the patient leaves hospital. 
 
The studies concerning rescue-medicines for home-patients demonstrate the inadequacies of the 
current system in providing long-term medicines for children. The current system is primary care 
based. Prescribing and dispensing arrangements default to GPs and CPs. The findings in this 
thesis confirm that when the system breaks down, or the carer has sufficient concerns about 
medication access, they turn to hospitals to resolve the immediate problems. If hospital processes 
can respond successfully to these problems then perhaps they should become the default process 
instead of primary care? This would present both practical and financial challenges. If these 
difficulties can be overcome then it is likely that community pharmacies would need to play a role in 
this process because of the geographical distances between the prescriber (hospital) and the 
patient (at home). It seems unrealistic for patients or carers to travel long distances to either collect 
prescriptions or dispensed medicines from their paediatric hospital. Furthermore, dispensing for 
large numbers of home-patients may be beyond the resources of some hospital pharmacy 
departments, at least at present. Homecare ‗dispense and deliver‘ services may be appropriate for 
some patients, but this may be unnecessary, impractical and too costly for others. CPs may 
therefore be required to dispense hospital generated prescriptions. This line of reasoning led to the 
survey of CPs and their experiences and opinions of dispensing hospital prescriptions. The findings 
confirm that the CPs want prescriptions to be printed and include prescriber contact details. Both 
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these requests seem deliverable. Printing hospital prescribed FP10HPs could be undertaken by the 
hospital electronic prescribing system, where they exist. If these are not available hospitals could 
potentially use the hospital pharmacy system (e.g. Ascribe or JAC) or if necessary install stand 
alone prescribing systems (e.g. EZ e-Script). All these solutions will be able to be configured to 
meet NHSBSA requirements. Direct prescriber contact details should be accommodated within PPA 
arrangements for the allocation of prescriber codes. Moving from a 2 digit prescriber identifier to 
either 3 or 4 digits will increase the number available for each organisation from 99 to 999 or even 
9999. This policy change should be considered by NHSBSA. The changes favoured by CPs in 
respect to prescription writing also seem readily achievable. In the survey of CPs respondents 
wanted prescribers to indicate when the dose regimen was outside BNF recommendations and for 
prescribers to provide dose calculations for children‘s regimens. The respondents to the medical 
survey confirmed that they would be prepared to make both these changes to their prescriptions. Of 
course, if prescriptions are to be printed then these changes could conveniently be added to the 
electronic generation of the script to be printed on the prescription. These changes should be made 
regardless of whether or not there are changes made to the supply arrangements for long-term 
medicines for children.  
 
Many of the studies described in this thesis are linked by a common thread of poor communication 
between healthcare professionals working in different sectors. At the present time a universal 
patient medical or medication record is not usually available or accessible. GP electronic 
prescribing systems are a useful source of essential medication information, but are not generally 
accessible to healthcare workers outside that practice. Similarly many hospital systems are not 
accessible to primary care professionals. The high profile, high cost efforts to provide a common 
electronic communication system for the NHS is outside the scope of this research programme. A 
paper based, patient held record of their current long-term medication may provide a useful interim 
solution. As a patient moves from one healthcare sector to another, either planned or unplanned, or 
when needing emergency care, a list of their long-term medication would be useful to support 
clinical decision making. Providing patients with information about their drugs is nationally 
encouraged (14) and may be supported by a national programme to give patients a record of their 
drugs and include name, dose, its intended purpose and a review date. Ensuring that this is 
provided in lay language, updated (or reprinted) whenever long-term medication is changed and 
including details of who to contact if further information is required, would support information 
continuity. 
 
A summary of the conclusions of this study are shown below in relation to the study aims. 
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Aims and conclusions: 
1. Aim: To identify circumstances where medicines management systems across the interface 
are variable between the healthcare sectors and may compromise patient care. 
Conclusions are: 
a. There are important differences between the healthcare sectors in relation to 
medicines management issues as evidenced by their current and approved 
documents identified in both 2007 and 2009. 
b. There is some evidence that medicines management interface issues for the two 
sectors are changing over time and that these changes are mostly converging. 
c. There are important differences between the sectors in particular regarding i. 
transfer of essential medication information on admission to hospital and ii. access 
to long-term medicines when outside hospital. 
 
2. Aim: To investigate key aspects of medicines management systems across the interface, 
where there are identifiable concerns. 
a.  Transfer of essential medication information on admission to hospital for 
paediatrics is not currently supported by NICE-NPSA guidance for medication 
reconciliation, nor do PCTs generally provide guidance to their contractors 
concerning this issue. However, findings described in this thesis indicate the clinical 
importance of medication reconciliation for children admitted to hospital raising 
concerns that this is not formally supported by either national or local guidance.  
b. Access to long-term medication for paediatric home-patients is frequently 
supported by hospital services in response to failures in the current system 
provided by primary care. These problems are often associated with unlicensed 
medicines or licensed medicines used off-label, but not exclusively. 
 
3. Aim: Based on the programme of investigation to make recommendations for changes to 
medicines management systems across the interface. Recommendations include: 
a. Local health economies should work together to ensure the harmonisation of 
medicines policies in use by NHS organisations. 
b. Recognise in national and local guidance the clinical importance of medication 
reconciliation for children on admission to hospital. 
c. Support medication reconciliation for children by modifying estimated resources to 
deliver this service to include paediatric patients. 
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d. Ensure the continuity of information transfer by conferring this responsibility on the 
‗sending‘ organisation. 
e. Review access systems for children requiring long-term medication.  Consider 
providing these drugs via hospital based systems including the prescribing by 
hospital staff. Dispensing and supply arrangements should be convenient for the 
recipient and may include homecare services, direct delivery or supply via 
approved community pharmacies. 
f. Ensure hospital prescriptions to be dispensed in community are printed and include 
prescriber contact details. Support CPs by indicating when regimens are outside of 
standard texts and include dose calculations for paediatric drug regimens. 
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14. Future studies 
 
Further studies are required to support informed and appropriate service changes. The following 
research questions have been identified during this study programme: 
 
1. Are unintentional changes to medication on admission perpetuated on discharge? 
2. What are the beliefs and opinions of GPs concerning the provision of medication 
information on admission of their patients to hospital? 
3. What are the drug costs of medicines provided by hospital prescribers for home-patients? 
4. What are the beliefs and opinions of GPs concerning why home-patients use hospital 
services to access medicines? 
5. Why do the risk perceptions of nurses providing rescue-medication services in different 
geographical locations in the UK differ? 
6. What are the clinical risks relating to missed doses of long-term medication for paediatric 
home-patients? 
 
The following future studies are planned or under consideration: 
1. National, multisite study of MR for children on admission to hospital to identify the optimal 
service required for children including benefits, costs and service design. [Commenced 
November 2010]. 
 
2. Provision of discharge medication (TTOs) for children requiring long-term medication and 
how this relates to medication access failures post-discharge. 
 
3. National, multisite study of hospital led provision of long-term medication for paediatric 
home-patients.  
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Appendices 
 
Appendix 1 Medicines management documents study 
2009 
 
Email sent to recipients: 
 
Dear Colleague 
I would be very grateful if you would forward to me an electronic copy 
of your Medicines Management Strategy and / or Medicines Management Policy or other 
ratified Medicines Management document. I'm hoping to obtain all current documents of 
this kind from all NHS organisations within the West Midlands region. 
 
The intention is to identify medicines management interface issues 
described within them using qualitative research methodology via NVivo. 
Two years ago I was able to obtained Medicines Management Strategies or Policies from 
17 NHS organisations across the West Midlands. Now, 2 
years on, I want to do the same to identify current themes and recent 
changes. This work is being done in conjunction with Aston University. 
If useful information is obtained anonymised data may be submitted for 
publication. 
 
I would be grateful for your current documents even if revisions or new documents are 
being prepared. 
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Appendix 2 The PCT Survey 2007 (Email) 
 
Figure 30 The PCT survey 2007 - questionnaire schematic 
 
Q1. Does your PCT provide operating 
guidelines to GPs in respect to 
prescribing information to be provided to 
the hospital when a patient is referred or 
admitted to hospital?
2007 HoMM 
PCT SURVEY
Yes /  No
Q2.Y If answer to Q.1 
is yes would you be 
willing to provide a 
copy of that 
guidance?
Q2.N If answer to Q.1 
is no are you aware of 
any plans for your 
PCT to provide such 
guidance?
Q3. If you send 
guidance are you 
willing for your PCT to 
be identified within 
any report?
Q4. If you would like to 
receive aggregated data 
(electronic copy only) 
please indicate the 
recipient below.
 
 
The introduction to the email is shown below. 
To: Head of Medicines Management (or equivalent) in all PCTs in England 
Our hospital receives children from many of the PCTs in the country. The information 
provided to us about their medication varies considerably and we would like to develop 
local policies to ensure that continuity of care is accurate and robust. 
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In February 2007 the BMA published guidelines for GPs entitled Prescribing and the 
primary and secondary care interface. This document principally focused on prescribing 
arrangements after in-patient discharge or out-patient referral.  
 
We are interested in guidance concerning information on admission - and especially in 
guidance provided to GPs to ensure that hospitals receive appropriate information 
concerning the medicines prescribed for a patient on referral / admission.  
 
The questions below are designed to identify guidance provided by PCTs to GPs. We hope 
that you will be willing to answer the questions by return email.  
 
The questions only require a yes or no answer, although longer answers are welcome. 
Please indicate your answer directly in the boxes and return to me by email. 
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Appendix 3 The PCT Survey 2009 (Electronic) 
 
Figure 31 The 2009 PCT Study. Survey schematic. Substantial changes to the 2007 survey 
are shown in red 
 
Q1. Does your PCT provide written 
operating guidelines to GPs in 
respect to prescribing information 
to be provided to the hospital 
when a patient is referred or 
admitted to hospital?
2009 HoMM 
PCT SURVEY
Yes /  No
Q3 (Y) How influential 
was national guidance 
in the preparation or 
revision of your 
guidance?
Q2 (N) Are you aware 
of any plans for your 
PCT to provide such 
guidance?
Q4 (Y) How would you 
describe the expected 
impact of your 
guidance on patient 
care?
Q6. If you would like to 
receive aggregated data 
(electronic copy only) 
please indicate the 
recipient below.
Q5. Are you willing to 
provide a copy of your 
current guidance?
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The invitation email text is shown below: 
 
Two years ago we conducted a survey to identify guidance provided by PCTs to GPs in 
respect to medication information on admission to hospital. [1] This follow-up study is 
designed to identify further development of local guidance and the influence of recently 
published national guidance. [2,3] We are interested in guidance concerning information 
on admission – and especially in guidance provided by PCTs to GPs to ensure that 
hospitals receive appropriate information concerning the medicines prescribed for a patient 
on referral / admission. Should useful information be obtained anonymous aggregate 
results may be published. Thank you again for completing this questionnaire.  If you require 
further information please contact:  David Terry (Birmingham Children‟s Hospital) on 0121-
333-9793 or by email on david.terry@bch.nhs.uk    
 
[1] Terry D, Sinclair A, Marriott J, et al. Guidance provided by English Primary Care Trusts 
to general practitioners concerning medication information on admission to hospital. 
International Journal of Pharmacy Practice. 2009 September;17, Supplement 2:B 39-40.   
[2] PSG001 Technical patient safety solutions for medicines reconciliation on admission of 
adults to hospital: Guidance: National Institute for Health and Clinical Excellence, National 
Patient Safety Agency; 2007 12 Dec 2007.   
[3] Medicines Reconciliation: A guide to implementation: National Prescribing Centre; 2008 
March. 
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Appendix 4 Medication reconciliation study 
 
Table 47 CPMs identified during the medication reconciliation study 
 
PATIENT 
NO. Prescriber Route DRUG PAM 
1 GP Oral HYDROCORTISONE 7.5MG AM 5MG PM 
1 GP Oral LEVOTHYROXINE 150MCG OM 
1 CONS SC GENOTROPIN 1.6MG OD 
2 GP INH BUDESONIDE INH 50MCG 8P OD 
2 GP INH SALBUTAMOL INH 2P MDU 
2 GP Oral SEPTRIN PAED 2.5ML BD 
3 UNK Oral SYTRON 2.5ML OM 
3 UNK Oral OMEPRAZOLE 4MG OM 
3 UNK Oral CALOGEN 3ML QDS 
3 CONS Oral DOMPERIDONE 1.6MG QDS 
3 UNK EYE HYPROMELLOSE 0.3% ED QDS BE 
4 GP INH BECLOMETASONE INH 200MCG BD 
4 GP Oral SENNA SENNOKOT 10ML ON 
4 GP Oral SOD VALPROATE 7ML TDS 
5 GP Oral PHENYTOIN SUSP 20ML BD 
5 GP Oral RITALIN 20MG BD 
5 GP Oral TOPIRAMATE 30MG BD 
6 GP Oral LEVOTHYROXINE 125MCG OD 
6 GP Oral HYDRALAZINE 50MG BD 
6 GP Oral ATENOLOL 100MG OD 
6 GP Oral DESMOTABS 100MCG TDS 
6 GP Oral HYDROCORTISONE 10MG AM, 5MG PM 
7 GP Oral CARBAMAZEPINE 300MG BD 
7 GP Oral TOPIRAMATE 30MG BD 
7 GP Oral LEVETIRACETAM 600MG BD 
8 NONE INH SALBUTAMOL INH 
NOT RX'ED SINCE 
2004 
8 GP INH FLIXOTIDE INH  EVOHALER 50, 2P BD 
9 GP Oral THYROXINE 75 MCG OD 
10 GP Oral CARBAMAZEPINE 80MG OM, 120MG ON 
11 GP Oral RANITIDINE 150MG BD 
11 GP Oral TRIMETHOPRIM 15MG OD 
11 GP EYE LACRILUBE BE ON 
11 GP EYE VISCOTEARS BE PRN 
12 GP Oral PHENYTOIN 150MG BD 
13 GP Oral TRIMETHOPRIM 10MG ON 
14 UNK Oral NITROFURANTOIN   
15 GP Oral OMEPRAZOLE 10MG OD 
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PATIENT 
NO. Prescriber Route DRUG PAM 
15 GP Oral DOMPERIDONE SUSP 3MG TDS 
15 GP Oral FEREDETATE 2.5MLS TDS 
15 GP Oral CO-TRIMOXAZOLE PAED 2.5ML ON 
15 GP EYE LACRILUBE BE ON 
15 GP NEB COLISTIMETHATE NEB BD MDU 
16 GP Oral DESMOPRESSIN 50MCG QDS 
16 GP Oral PREDNISOLONE SOL 5MG ALT DIE 
16 GP Oral COTRIMOXAZOLE PAED 240MG BD SAT + SUN 
16 GP Oral MOVICOL PAED 2 OD 
17 GP Oral EPILIM CHRONO 1.5G ON 
17 GP Oral KEPPRA 750MG BD 
18 GP INH SALBUTAMOL INH 2P QDS PRN 
18 GP INH BECLOMETASONE INH 50MCG BD 
18 GP Oral PIZOTIFEN 500MCG ON 
18 GP Oral PROPRANOLOL 10MG OD 
19 GP INH SALBUTAMOL INH 4P q2-q4h prn 
19 GP INH TERBUTALINE TURBO INH 1p q2h-q4h prn 
19 GP INH SYMBICORT 100/6 TURBO 1p od-bd 
19 GP Oral PREDNISOLONE SOL 20mg od 5/7 
20 GP INH SALBUTAMOL INH 2P Q4H PRN 
20 GP INH BECLOMETASONE INH 50 2P BD 
21 NONE INH BRICANYL INH TAKING MUM'S 
21 GP INH SALBUTAMOL INH 1P MDU 
21 GP INH SYMBICORT 200/6 TURBO 2P BD 
21 GP Oral CHLORPHENAMINE 4MG BD 
21 GP Oral DESMOPRESSIN 400MCG ON 
21 GP Oral MOVICOL PAED 1 ON 
21 GP Oral SENNA 15MG ON 
22 GP Oral LAMOTRIGINE 
AS ADVISED BY 
HOSP 
22 GP Oral TOPIRAMATE 
AS ADVISED BY 
HOSP 
23 GP Oral CLOBAZAM  2MG TDS 
23 GP Oral GLYCOPYRROLATE 1MG MDU 
23 GP Oral LACTULOSE 5-15ML BD 
23 GP Oral SENNA 7.5 MG ON 
23 GP Oral NITRAZEPAM 2.5MG BD 
23 GP Oral OMEPRAZOLE 10MG BD 
23 GP Oral VIGABATRIN 750MG BD 
23 GP Oral COTRIMOXAZOLE PAED 240MG MDU 
24 UNK INH SALBUTAMOL INH UNK 
24 UNK INH BECLOMETASONE INH UNK 
25 CONS Oral CLOBAZAM  2.1ML BD 
25 CONS Oral SOD VALPROATE 300MG BD 
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PATIENT 
NO. Prescriber Route DRUG PAM 
26 CONS Oral CICLOSPORIN 31MG BD 
27 GP Oral TRIMETHOPRIM 20MG ON 
28 CONS Oral SOD VALPROATE 100MG BD 
29 GP Oral ETHINYLOESTRADIOL 10 MCG OD 
29 GP Oral LEVOTHYROXINE 100 MCG OM 
29 GP Oral HYDROCORTISONE 10MG AM, 5MG PM 
29 GP Oral DESMOPRESSIN 100 MCG QDS 
29 CONS SC GH - SAIZEN 1.75MG 
30 CONS Oral STIRIPENTOL 750MG BD 
30 GP Oral CLOBAZAM  5MG BD 
30 GP Oral SOD VALPROATE 400MG BD 
31 CONS Oral MELATONIN No Rx by GP 
31 GP Oral PIZOTIFEN 0.5MG BD 
31 GP Oral OMEPRAZOLE 40mg od 4/7 
32 UNK Oral NO RX No Rx by GP 
32 UNK Oral NO RX No Rx by GP 
33 GP Oral LAMOTRIGINE 15MG BD 
33 GP Oral LEVETIRACETAM 300MG BD 
34 UNK Oral CARBAMAZEPINE UNK 
35 GP Oral GABAPENTIN 300-600MG TDS 
35 GP Oral TOPIRAMATE 25MG MDU 
36 UNK Oral TRIMETHOPRIM No Rx by GP 
37 CONS Oral MELATONIN No Rx by GP 
37 GP Oral PHENOBARBITONE MDU BD 
38 GP INH BECLOMETASONE INH 50MCG BD 
38 GP INH SALBUTAMOL INH 2P PRN 
38 GP NASAL NASONEX 2P OD 
38 GP Oral CARBAMAZEPINE 300MG BD 
38 GP Oral LORATADINE 5MG ON 
38 GP Oral TRIMETHOPRIM 100MG BD 
39 GP Oral PHENYTOIN 87.6MG BD 
 
 Page 211 
Table 48  Medication reconciliation study. PAMs comparison with PODs 
 
PATIENT 
NO. Rx’er ROUTE 
DRUG (REGULAR 
MEDS) PAM POD 
PAM = 
POD 
1 CONS SC GENOTROPIN 1.6MG OD 1.6MG OD YES 
1 GP ORAL 
HYDROCORTISON
E 
7.5MG AM 
5MG PM 
15MG AM 
5MG PM NO 
1 GP ORAL LEVOTHYROXINE 150MCG OM 150MCG OM YES 
3 CONS ORAL DOMPERIDONE 1.6MG QDS 1.6MG QDS YES 
5 GP ORAL PHENYTOIN SUSP 20ML BD 20ML BD YES 
5 GP ORAL RITALIN 20MG BD NO LABEL NO 
5 GP ORAL TOPIRAMATE 30MG BD NO LABEL NO 
6 GP ORAL ATENOLOL 100MG OD 100MG OM YES 
6 GP ORAL DESMOTABS 
100MCG 
TDS NO LABEL NO 
6 GP ORAL HYDRALAZINE 50MG BD 50MG BD YES 
6 GP ORAL 
HYDROCORTISON
E 
10MG AM, 
5MG PM NO LABEL NO 
6 GP ORAL LEVOTHYROXINE 125MCG OD 125MCG OD YES 
7 GP ORAL CARBAMAZEPINE 300MG BD 300MG BD YES 
7 GP ORAL TOPIRAMATE 30MG BD NO LABEL NO 
10 GP ORAL CARBAMAZEPINE 
80MG OM, 
120MG ON 
80MG OM, 
120MG ON YES 
11 GP EYE LACRILUBE BE ON BE ON YES 
11 GP ORAL RANITIDINE 150MG BD 150MG BD YES 
11 GP ORAL TRIMETHOPRIM 15MG OD 15MG ON YES 
11 GP EYE VISCOTEARS BE PRN BE PRN YES 
13 GP ORAL TRIMETHOPRIM 10MG ON 10MG ON YES 
16 GP ORAL 
COTRIMOXAZOLE 
PAED 
240MG BD 
SAT + SUN 
240MG BD 
SAT + SUN YES 
17 GP ORAL EPILIM 
CHRONO 
1.5G ON 
CHRONO 
1.5G ON YES 
17 GP ORAL KEPPRA 750MG BD 750MG BD YES 
18 GP INH 
BECLOMETASONE 
INH 50MCG BD 50MCG BD YES 
18 GP ORAL PIZOTIFEN 500MCG ON 500MCG ON YES 
18 GP ORAL PROPRANOLOL 10MG OD 10MG OD YES 
18 GP INH SALBUTAMOL INH 
2P QDS 
PRN 
2P QDS 
PRN YES 
19 GP ORAL 
PREDNISOLONE 
SOL 20mg od 5/7 
20MG OD 
5/7 YES 
19 GP INH SALBUTAMOL INH 
4P q2-q4h 
prn PRN YES 
19 GP INH 
SYMBICORT 100/6 
TURBO 1p od-bd NO LABEL NO 
19 GP INH 
TERBUTALINE 
TURBO INH 
1p q2h-q4h 
prn NO LABEL NO 
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PATIENT 
NO. Rx’er ROUTE 
DRUG (REGULAR 
MEDS) PAM POD 
PAM = 
POD 
20 GP INH 
BECLOMETASONE 
INH 50 2P BD NO LABEL NO 
20 GP INH SALBUTAMOL INH 2P Q4H PRN NO LABEL NO 
21 GP ORAL CHLORPHENAMINE 4MG BD 
USING 
MUM'S NO 
21 GP INH SALBUTAMOL INH 1P MDU PRN YES 
22 GP ORAL LAMOTRIGINE UNK DOSE 100MG BD 
EXCL
UDED 
22 GP ORAL TOPIRAMATE UNK DOSE 100MG BD 
EXCL
UDED 
23 GP ORAL CLOBAZAM  2MG TDS 2MG TDS YES 
23 GP ORAL 
COTRIMOXAZOLE 
PAED 240MG MDU 240MG MDU YES 
23 GP ORAL 
GLYCOPYRROLAT
E 1MG MDU 1MG MDU YES 
23 GP ORAL LACTULOSE 5-15ML BD 5-15ML TDS NO 
23 GP ORAL NITRAZEPAM 2.5MG BD 2.5MG BD YES 
23 GP ORAL OMEPRAZOLE 10MG BD 10MG BD YES 
23 GP ORAL SENNA 7.5 MG ON 7.5 MG ON YES 
23 GP ORAL VIGABATRIN 750MG BD 750MG BD YES 
26 CONS ORAL CICLOSPORIN 31MG BD 31MG BD YES 
27 GP ORAL TRIMETHOPRIM 20MG ON 20MG ON YES 
28 CONS ORAL SOD VALPROATE 100MG BD 100MG BD YES 
30 GP ORAL CLOBAZAM  5MG BD 5MG TDS NO 
30 GP ORAL SOD VALPROATE 400MG BD 400MG BD YES 
30 CONS ORAL STIRIPENTOL 750MG BD 750MG BD YES 
31 CONS ORAL MELATONIN UNK DOSE 6MG ON 
EXCL
UDED 
31 GP ORAL PIZOTIFEN 0.5MG BD 0.5MG BD YES 
33 GP ORAL LAMOTRIGINE 15MG BD 15MG BD YES 
33 GP ORAL LEVETIRACETAM 300MG BD 300MG BD YES 
35 GP ORAL TOPIRAMATE 25MG MDU 25MG ON YES 
37 GP ORAL PHENOBARBITONE MDU BD MDU BD YES 
38 GP ORAL CARBAMAZEPINE 300MG BD 100 BD YES 
38 GP ORAL LORATADINE 5MG ON 5MG OD YES 
38 GP NASAL NASONEX 2P OD NO LABEL NO 
38 GP ORAL TRIMETHOPRIM 100MG BD NO LABEL NO 
39 GP ORAL PHENYTOIN 87.6MG BD 87.6MG BD YES 
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Table 49 Medication reconciliation study. Comparison of PAM and Caregiver regimens 
 
PATIENT 
NO. Rx'er ROUTE CPM PAM CARER PAM = CARER P-C CLASS 
3 CONS ORAL DOMPERIDONE 1.6MG QDS UNK MISSING DATA NO MENTION 
16 GP ORAL MOVICOL PAED 2 OD UNK MISSING DATA NO MENTION 
18 GP ORAL PROPRANOLOL 10MG OD UNK MISSING DATA NO MENTION 
18 GP INH SALBUTAMOL INH 2P QDS PRN UNK MISSING DATA NO MENTION 
18 GP ORAL PIZOTIFEN 500MCG ON UNK MISSING DATA NO MENTION 
18 GP INH BECLOMETASONE INH 50MCG BD UNK MISSING DATA NO MENTION 
22 GP ORAL LAMOTRIGINE UNK UNK MISSING DATA NO MENTION 
22 GP ORAL TOPIRAMATE UNK UNK MISSING DATA NO MENTION 
26 CONS ORAL CICLOSPORIN 31MG BD UNK MISSING DATA NO MENTION 
2 GP INH 
BUDESONIDE INH 
50MCG 8P OD NOT GIVEN NO NOT GIVEN 
4 GP INH BECLOMETASONE INH 200MCG BD 200MCG OD NO FREQ 
4 GP ORAL SOD VALPROATE 7ML TDS 8ML, 7ML, 8ML NO DOSE 
4 GP ORAL SENNA 
SENNOKOT 
10ML ON 18ML ON NO DOSE 
6 GP ORAL DESMOTABS 100MCG TDS 200MCG TDS NO DOSE 
6 GP ORAL ATENOLOL 100MG OD 50MG BD NO BOTH 
10 GP ORAL CARBAMAZEPINE 
80MG OM, 
120MG ON 100MG BD NO DOSE 
11 GP EYE VISCOTEARS BE PRN BE QDS NO MINOR 
13 GP ORAL TRIMETHOPRIM 10MG ON 20MG ON NO DOSE 
15 GP ORAL FEREDETATE 2.5MLS TDS NOT GIVEN NO NOT GIVEN 
15 GP ORAL DOMPERIDONE 
SUSP 3MG 
TDS 4MG TDS NO DOSE 
16 GP ORAL 
COTRIMOXAZOLE 
PAED 
240MG BD 
SAT + SUN 
480MG OD SAT 
+ SUN NO BOTH 
16 GP ORAL DESMOPRESSIN 50MCG QDS 300MCG DAILY NO BOTH 
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PATIENT 
NO. Rx'er ROUTE CPM PAM CARER PAM = CARER P-C CLASS 
16 GP ORAL PREDNISOLONE SOL 5MG ALT DIE 
ORAL EVERY 
3/52 NO FREQ 
20 GP INH SALBUTAMOL INH 2P Q4H PRN 4P BD NO BOTH 
21 GP ORAL MOVICOL PAED 1 ON NOT GIVEN NO NOT GIVEN 
21 GP ORAL SENNA 15MG ON NOT GIVEN NO NOT GIVEN 
21 GP INH SALBUTAMOL INH 1P MDU NOT GIVEN NO NOT GIVEN 
21 GP ORAL DESMOPRESSIN 400MCG ON NO MENTION NO NOT GIVEN 
23 GP ORAL NITRAZEPAM 2.5MG BD NOT GIVEN NO NOT GIVEN 
23 GP ORAL CLOBAZAM  2MG TDS 
2MG, 3MG, 
4MG NO DOSE 
23 GP ORAL VIGABATRIN 750MG BD 500MG BD NO DOSE 
25 CONS ORAL CLOBAZAM  2.1ML BD 2.1ML TDS NO FREQ 
27 GP ORAL TRIMETHOPRIM 20MG ON 22MG ON NO DOSE 
29 GP ORAL HYDROCORTISONE 
10MG AM, 
5MG PM 
10MG AM, 
7.5MG PM NO DOSE 
30 GP ORAL CLOBAZAM  5MG BD 5MG TDS NO FREQ 
31 GP ORAL PIZOTIFEN 0.5MG BD 0.5MG TDS NO FREQ 
31 GP ORAL OMEPRAZOLE 40mg od 4/7 NOT GIVEN NO NOT GIVEN 
35 GP ORAL GABAPENTIN 
300-600MG 
TDS 600MG BD NO BOTH 
38 GP NASAL NASONEX 2P OD 1P ON NO DOSE 
38 GP INH BECLOMETASONE INH 50MCG BD NOT GIVEN NO NOT GIVEN 
2 GP INH SALBUTAMOL INH 2P MDU NOT GIVEN UNK 
MINOR / NOT 
GIVEN 
21 UNK INH BRICANYL INH 
USING 
PARENT'S UNCERTAIN UNK NO Rx 
31 CONS ORAL MELATONIN UNK 6MG ON UNK UNCLASSIFIED 
37 CONS ORAL MELATONIN UNK 7.5MG ON UNK UNCLASSIFIED 
1 CONS SC GENOTROPIN 1.6MG OD 1.6MG OD YES   
1 GP ORAL HYDROCORTISONE 
7.5MG AM 
5MG PM 
7.5MG AM 5MG 
PM YES   
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PATIENT 
NO. Rx'er ROUTE CPM PAM CARER PAM = CARER P-C CLASS 
1 GP ORAL LEVOTHYROXINE 150MCG OM 150MCG OM YES   
2 GP ORAL SEPTRIN 
PAED 2.5ML 
BD 
PAED 2.5ML 
BD YES   
5 GP ORAL PHENYTOIN SUSP 20ML BD 20ML BD YES   
5 GP ORAL RITALIN 20MG BD 20MG BD YES   
5 GP ORAL TOPIRAMATE 30MG BD 30MG BD YES   
6 GP ORAL HYDRALAZINE 50MG BD 50MG BD YES   
6 GP ORAL HYDROCORTISONE 
10MG AM, 
5MG PM 
10MG AM, 5MG 
PM YES   
6 GP ORAL LEVOTHYROXINE 125MCG OD 125MCG OD YES   
7 GP ORAL LEVETIRACETAM 600MG BD 
SAME BUT 
STOPPED 1/12 
AGO YES   
7 GP ORAL CARBAMAZEPINE 300MG BD 300MG BD YES   
7 GP ORAL TOPIRAMATE 30MG BD 30MG BD YES   
8 GP INH FLIXOTIDE INH  
EVOHALER 
50, 2P BD 100MCG BD YES   
9 GP ORAL THYROXINE 75 MCG OD 75 MCG OD YES   
11 GP EYE LACRILUBE BE ON BE ON YES   
11 GP ORAL RANITIDINE 150MG BD 150MG BD YES   
11 GP ORAL TRIMETHOPRIM 15MG OD 15MG ON YES   
12 GP ORAL PHENYTOIN 150MG BD 150MG BD YES   
15 GP NEB COLISTIMETHATE NEB BD MDU 
500,000 UNITS 
BD NEB YES   
15 GP ORAL CO-TRIMOXAZOLE 
PAED 2.5ML 
ON 
PAED 2.5ML 
OD YES   
15 GP EYE LACRILUBE BE ON BE ON YES   
15 GP ORAL OMEPRAZOLE 10MG OD 10MG OD YES   
17 GP ORAL EPILIM 
CHRONO 
1.5G ON 3 OD YES   
17 GP ORAL KEPPRA 750MG BD 3 BD YES   
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PATIENT 
NO. Rx'er ROUTE CPM PAM CARER PAM = CARER P-C CLASS 
19 GP ORAL PREDNISOLONE SOL 20mg od 5/7 20MG OD YES   
19 GP INH SALBUTAMOL INH 4P q2-q4h prn 3-5 PUFFS PRN YES   
19 GP INH 
SYMBICORT 100/6 
TURBO 1p od-bd 1P OD YES   
19 GP INH 
TERBUTALINE TURBO 
INH 1p q2h-q4h prn 1P PRN YES   
20 GP INH BECLOMETASONE INH 50 2P BD 2P BD YES   
21 GP ORAL CHLORPHENAMINE 4MG BD 4MG OD-BD YES   
21 GP INH 
SYMBICORT 200/6 
TURBO 2P BD 2P BD YES   
23 GP ORAL 
COTRIMOXAZOLE 
PAED 240MG MDU 240MG BD YES   
23 GP ORAL GLYCOPYRROLATE 1MG MDU 2MG TDS YES   
23 GP ORAL LACTULOSE 5-15ML BD 6ML BD YES   
23 GP ORAL OMEPRAZOLE 10MG BD 10MG BD YES   
23 GP ORAL SENNA 7.5 MG ON 7.5MG ON YES   
25 CONS ORAL SOD VALPROATE 300MG BD 300MG BD YES   
28 CONS ORAL SOD VALPROATE 100MG BD 100MG BD YES   
29 GP ORAL DESMOPRESSIN 100 MCG QDS 100 MCG QDS YES   
29 GP ORAL ETHINYLOESTRADIOL 10 MCG OD 10 MCG OD YES   
29 CONS SC GH - SAIZEN 1.75MG 1.75MG YES   
29 GP ORAL LEVOTHYROXINE 100 MCG OM 100 MCG OM YES   
30 GP ORAL SOD VALPROATE 400MG BD 400MG BD YES   
30 CONS ORAL STIRIPENTOL 750MG BD 750MG BD YES   
33 GP ORAL LAMOTRIGINE 15MG BD 15MG BD YES   
33 GP ORAL LEVETIRACETAM 300MG BD 300MG BD YES   
35 GP ORAL TOPIRAMATE 25MG MDU 25MG ON YES   
37 GP ORAL PHENOBARBITONE MDU BD 140MG BD YES   
38 GP ORAL CARBAMAZEPINE 300MG BD 300MG BD YES   
38 GP ORAL LORATADINE 5MG ON 5MG ON YES   
38 GP INH SALBUTAMOL INH 2P PRN PRN YES   
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PATIENT 
NO. Rx'er ROUTE CPM PAM CARER PAM = CARER P-C CLASS 
38 GP ORAL TRIMETHOPRIM 100MG BD 100MG BD YES   
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Appendix 5 Focus group free-nodes (codes) 
 
  
Free nodes – Community Pharmacy focus 
group 
1 Ask the patient 
2 Availability of drug 
3 Competency 
4 Confidence (CPs) 
5 Confirmation of dose 
6 Co-operation between CP and Hosp P 
7 CP Time 
8 Dose calculations or interpretation 
9 Fax back 
10 Force hospital to dispense 
11 Frequency of problems 
12 GP 
13 Hosp Rx more complex 
14 Hosp Rxs are hand-written 
15 Hosp Rxs look different to community 
16 Hospital support for CP 
17 Is there an error on the Rx 
18 IT solutions 
19 Locum community pharmacists 
20 Off-label use 
21 Paediatric Prescribing issues 
22 Patient choice 
23 Patient confidentiality 
24 Patient expectations 
25 Patient relationship 
26 PMRs community 
27 Poor hospital prescribing 
28 Prescriber identity 
29 Prescriber known but cannot contact them 
30 Pressure (extra) because the patient is a child 
31 Quantity on Rx 
32 Reluctance to ask Hospital 
33 Returning Rx to Hosp 
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Free nodes – Community Pharmacy focus 
group 
34 Risk 
35 SoPs 
36 [Specials OR ULM text serach 
37 Specials (products) 
38 Strength missing on Rx 
39 Teaching or training prescribers 
40 Telephone contact with hospitals can be difficult 
41 Travel 
42 Waiting 
 
 
 
  Free nodes - medical focus group 
1 Communication - poor 
2 Competence 
3 CP or GP difficulties in providing paed dose 
4 CP supply problems 
5 Dear GP … if you agree please prescribe … letter 
6 Duration of supply 
7 Electronic communication 
8 Electronic prescribing 
9 Financial implications of problem 
10 Follow ups 
11 Formularies 
12 Formulation problems (e.g. MTX tab strength) 
13 Frequency of occurrence 
14 
GP must see patient before prescribing as advised by 
hospital 
15 GP receptionists 
16 GP refuses to prescribe 
17 GP repeat prescriptions 
18 GP supply too short 
19 Hospital doctors refusals (e.g. other paediatricians) 
20 Inadequate supply from hospital 
21 Instructions to families e.g. don't run out 
22 Interface 'rules' unclear 
23 Interface system failure 
24 Junior (hosp) doctors 
25 Letter to GP 
26 Nurse involvement 
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  Free nodes - medical focus group 
27 Nurse prescribing 
28 OOH access to information 
29 Patient hot line 
30 Patients use us as primary care (not secondary care) 
31 Pharmacists changing prescriptions 
32 Posting out prescriptions 
33 Prescribing responsibility 
34 Prescribing unlicensed medicines 
35 Problem resolution 
36 Problems getting correct prep e.g. oint or cream 
37 Support for CPs (e.g. where to get drug) 
38 Teaching students paediatric prescribing 
39 Urgent requests from patient (run out) 
40 Workload 
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Appendix 6 Medical Staff Survey (Electronic) 
 
Medical Staff BCH - Access to Medicines for patients in Primary 
Care (electronic survey) 
 
 
 
 
Medical Staff 
- BCH  
 
 
All medical staff at BCH  
S-A SECTION A - DEMOGRAPHICS  
The following questions are about you. The questions are designed to be completed by  
hospital MEDICAL STAFF  
 
Q1 In which year did you graduate in medicine? (YYYY)  
 
 
Please write your answer here:  ____________________  
 
Q2 How many years experience do you have as a PAEDIATRICIAN (all sub-
specialities)?  
 
 
If you have worked part-time or as a locum count the years you have worked for at least 3 hours per week on  
average in hospital paediatrics. If you have worked for less than 1 year put 
0.  
 
Please write your answer here: ____________________  
 
Q3 In which specialty do you work mostly at present?  
Select one option from the drop-down box  
 
Please choose *only one* of the following:  
Anaesthetics  
Cardiology  
Dermatology Diabetology  
Emergency (ED)  
Endocrinology  
ENT  
Gastroenterology  
General paediatrics  
Haematology  
 Page 222 
IMD  
ITU (Intensivist)  
Liver  
Nephrology  
Neurology  
Neurosurgery  
Oncology  
Ophthalmology  
Plastics  
Psychiatry  
Renal  
Respiratory  
Rheumatology  
Surgery - General  
Trauma & Orthopaedics  
Other - please specifiy in box below  
Make a comment on your choice here:  
 
Make a comment on your choice here:  
____________________ ____________________ ____________________  
 
Q4 What is your designation?  
 
 
Please choose *only one* of the following:  
SHO  
Registrar  
Staff Grade  
Consultant  
Other - please specify  
Make a comment on your choice here:  
____________________ ____________________ ____________________  
 
S-B SECTION B: FREQUENCY of prescribing for PATIENTS IN PRIMARY CARE  
 
We are interested in your experiences and / or opinions in relation to any problems or  
difficulties that may exist when providing prescriptions for patients  who are largely managed 
in PRIMARY CARE but may receive some prescriptions from BCH.  
 
 
 
 
 
Q5 On average approximately how many FP10HP (community pharmacy) prescriptions do 
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you  personally sign in ONE CALENDAR MONTH (Total - all circumstances)?  
 
 
An FP10HP is similar to a GP prescription but written by hospital prescribers. These prescriptions are u sually  
given to the patient to take to a community 
pharmacy.  
 
Please choose *only one* of the following:  
o NONE  
o 1-5 PER MONTH  
o 6-15 PER MONTH  
o 15-30 PER MONTH  
o 31-100 PER MONTH  
o More than 100 per MONTH  
 
Q6 In the last THREE MONTHS approximately how many prescriptions have you personally 
signed for patients outside the hospital (e.g. at home) requesting an urgent prescription - 
perhaps via a help line or an unplanned attendance.  
 
 
For example: A patient at home has run out of their medication and you have been asked to provide an urgent  
prescription  
 
Please choose *only one* of the following:  
o None  
o 1 to 5  
o 6 to 10  
o 11 to 30  
o 31 to 60  
o 61 to 100  
o More than 100  
 
Q8 In the last THREE MONTHS for approximately HOW MANY PATIENTS have YOU 
personally prescribed prescriptions for patients outside the hospital (e.g. at home) requesting 
an urgent prescription - perhaps via a help line or an unplanned attendance?  
 
 
For example: A patient at home has run out of their medication and you have been asked to provide an urgent  
prescription  
 
Please choose *only one* of the following:  
o NONE  
o 1 to 5 patients  
o 6 to 10 patients  
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o 11 to 30 patients  
o 31 to 60 patients  
o 61 to 100 patients  
o More than 100 patients  
 
Q7 Providing prescriptions for continuing medicines may be the responsibility of either the 
GP or BCH depending on what arrangements have been agreed for that patient.  
 
When writing FP10 HPs: (Tick one option)  
 
 
An FP10HP is similar to a GP prescription but written by hospital  prescribers. These prescriptions are usually  
given to the patient to take to a community pharmacy.  
 
 
Please choose *only one* of the following:  
I never know who holds prescribing responsibility  
I occasionally know who holds prescribing responsibility  
I often know who holds prescribing responsibility  
I always know who holds prescribing responsibility  
Not applicable  
Make a comment on your choice here:  
____________________ ____________________ ____________________  
 
Q9 How would you describe the clinical risk to patients if you did NOT prescribe  
medicines for patients outside the hospital (e.g. at home) requesting an urgent  
prescription - perhaps via a help line or an unplanned attendance?  
 
 
Please choose *only one* of the following:  
o No risk  
o Small risk  
o Moderate risk  
o High risk  
o Very high risk  
o Not applicable  
 
S-C SECTION C: PROBLEMS relating to prescriptions for PATIENTS IN PRIMARY CARE.  
 
 
Q10 In your opinion what is the most common reason why paediatric patients and their  
carers in primary care experience problems in obtaining suitable medication from their  
GP?  
 Page 225 
Please choose *only one* of the following:  
Carer did not obtain a prescription in good time ... CARER issue  
Cannot get medication dispensed ... PHARMACY issue  
Child cannot use the formulation provided ... FORMULATION issue  
GP has not received communication (e.g. clinic / discharge letter) ... COMMUNICATION  
issue  
GP will not prescribe (e.g. because it is an unlicensed medicine) ... GP issue  
Not applicable  
Don't know  
Other - please specify  
Make a comment on your choice here:  
____________________ ____________________ ____________________  
 
Q11 For the statement below please indicate the extent to which you agree or disagree:  
 
GP's ARE RELUCTANT TO PRESCRIBE CONTINUING MEDICATION FOR CHILDREN.  
 
 
Please choose *only one* of the following:  
o Strongly disagree  
o Disagree  
o Neither agree nor disagree  
o Agree  
o Strongly agree  
 
Q12 This question shows a list of possible reasons why GPs may decline to provide repeat 
prescriptions for children. For each reason please indicate how likely you believe it to be.  
 
Tick ONE option per line  
 
1 = VERY UNLIKELY  
 
2 = QUITE UNLIKELY  
 
3 = SOMETIMES  
 
4 = QUITE LIKELY  
 
5 = VERY LIKELY  
Please choose the appropriate response for each item:  
Money / finances   
Clinical concerns about the drug or regimen required   
Communication issues   
Drug not on their computer system  
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Workload    
PCT influence / instruction   
Inadequate supporting information   
 
 
S-D SECTION D: INTERACTION WITH COMMUNITY PHARMACISTS (CPs)  
 
Q13 In the last 12 months approximately how often have you been contacted by a community 
pharmacist concerning a hospital prescription you or a BCH colleague has written?  
 
 
Please choose *only one* of the following:  
o Never  
o 1 - 12  
o 13 - 24  
o 25 - 52  
o 53 - 180  
o 181 - 360  
o More than 360  
 
Q14 Would you be prepared to always add YOUR hospital telephone number to FP10HPs 
you sign?  
 
 
Please choose *only one* of the following:  
o Yes  
o No  
o Don't know  
o Not applicable  
 
Q15 Would you be prepared to use a pre-inked stamp to show your name clearly on 
FP10HPs you sign?  
 
 
Please choose *only one* of the following:  
o Yes  
o No  
o Don't know  
o Not applicable  
 
Q16 If you prescribe dose regimens on FP10HPs which are not included in standard texts  
would you be prepared to acknowledge that you have done so knowingly on the prescription  
(e.g. endorse: NOT-BNF)?  
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Please choose *only one* of the following:  
o Yes  
o No  
o Don't know  
o Not applicable  
 
Q17 Would you be prepared to indicate the dose calculation as well as the final dose on  
FP10HP prescriptions you sign (where applicable)? e.g. state mg per kg as well as  
calculated dose  
 
 
Please choose *only one* of the following:  
o Yes  
o No  
o Don't know  
o Not applicable  
 
S-E SECTION E: IMPROVING CURRENT ARRANGEMENTS  
 
 
Q18 Please indicate in your opinion how beneficial the following changes to national  
guidance would be in reducing the problems associated with prescribing for paediatric 
patients in primary care.  
 
REQUIRE GPs TO PRESCRIBE ALL CONTINUING MEDICINES  
 
 
Please choose *only one* of the following:  
No benefit  
Small benefit  
Moderate benefit  
High benefit  
Very high benefit  
Don't know  
Make a comment on your choice here:  
____________________ ____________________ ____________________  
 
Q19 Please indicate in your opinion how beneficial the following changes to national  
guidance would be in reducing the problems associated with prescribing for paediatric 
patients in primary care.  
 
REQUIRE HOSPITALS TO PRESCRIBE & DISPENSE UNLICENSED / UNCOMMON MEDICINES  
 
 
 
Please choose *only one* of the following:  
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No benefit  
Small benefit  
Moderate benefit  
High benefit  
Very high benefit  
Don't know  
Make a comment on your choice here:  
____________________  
____________________  
 
Q20 Please indicate in your opinion how beneficial the following changes to national  
guidance would be in reducing the problems associated with prescribing for paediatric 
patients in primary care.  
 
ENABLE HOSPITAL PHARMACIES TO DISPENSE GP PRESCRIPTIONS  
 
Please choose *only one* of the following:  
No benefit  
Small benefit  
Moderate benefit  
High benefit  
Very high benefit  
Don't know  
Make a comment on your choice here:  
____________________ ____________________ ____________________  
 
Q21  Please indicate your opinion about the statement below.  
 
In my opinion hospitals should ensure that all out-patient prescriptions are dispensed  
by the hospital pharmacy (i.e. FP10HPs are not required)  
 
 
 
If you would like to add any comments please do so in the text box  
Please choose *only one* of the following:  
Strongly disagree  
Disagree  
Neither agree nor disagree  
Agree  
Strongly agree  
Make a comment on your choice here:  
____________________  
 ____________________   
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Q22    
Please indicate your opinion about the statement below.  
 
I would benefit from further training concerning the writing of prescriptions  
Please choose *only one* of the following:  
o Strongly disagree  
o Disagree  
o Neither agree nor disagree  
o Agree  
o Strongly agree  
 
Q23 In your opinion which single achievable change would bring about the most benefit  
for patients concerning problems associated with interface (primary care - hospital)  
prescribing  
 
 
Please write your answer here:  
____________________  ____________________  
 
Q24 Are you aware that patients in primary care with on-going drug access issues can be  
referred to the BCH Access to Medicines Clinic?  
 
 
Please choose *only one* of the following:  
o Yes  
o No  
 
Q25 We welcome any further comments concerning access to medicines across 
the primary-hospital healthcare interface.  
 
 
Please write your answer here:  
____________________ ____________________ ____________________  
 
Thanks  
 
THANK YOU 
VERY MUCH  
 
We know how busy you are and we much appreciate your time.  
 
Please see the study website (www.access2medicines.co.uk) for summary information 
concerning this study: available March 2010.  
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Submit Your Survey.  
 
Thank you for completing this survey.  
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Appendix 7 Medical staff survey. Results 
 
 
Table 50 Medical staff survey. Frequency of writing rescue-medication prescriptions in a 3 
month period 
 
Rescue-med 
prescriptions 
Frequency 
Valid 
Percent 
None 81 50.0 
1-5 46 28.4 
6-10 18 11.1 
11-30 14 8.6 
31-60 3 1.9 
Total 162 100.0 
Missing 5   
Grand total 167   
 
[Estimated total frequency, using the calculated mid-point method = Sum(46x3, 18x8, 14x21, 3x46) 
= 714 (3 month period)] 
 
Table 51 Medical staff survey. Numbers of patients provided with rescue-medication in a 3 
month period 
 
Patients receiving 
rescue-meds 
Frequency Valid Percent 
None 85 52.5 
1-5 47 29.0 
6-10 17 10.5 
11-30 11 6.8 
31-60 2 1.2 
Total 162 100.0 
Missing 5  
Grand total 167  
 
[Estimated number of patients, using the calculated mid-point method, provided with rescue-
medication prescriptions within the 3 month period = Sum(3x47, 8x17, 21x11, 46x2, = 600)] 
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Table 52 Medical staff survey. Knowledge of prescribing responsibility by respondents 
 
Prescribing 
responsibility 
Frequency 
Valid 
Percent 
Never 21 16.4 
Occasionally 23 18.0 
Often 55 43.0 
Always 29 22.7 
Total 128 100.0 
Missing 5   
Not 
applicable 
34   
Grand total 167   
 
Table 53 Medical staff survey. Risk to patients if the rescue-medication service was not 
provided 
 
RISK Frequency 
Valid 
Percent 
No risk 5 4.0 
Small risk 20 16.1 
Moderate risk 56 45.2 
High risk 35 28.2 
Very High risk 8 6.5 
Total 124 100.0 
Missing 9   
Not applicable 34   
Grand total 167   
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Table 54 Medication reconciliation study. Sensitivity of data sources against validated continuing medication (vCM) 
 
PATIENT 
NO. route CPM PAM 
PAM 
SPEC POD 
POD 
SPEC CARER 
CARER 
SPEC vCM 
1 ORAL HYDROCORTISONE 7.5MG AM 5MG PM TP 
15MG AM 5MG 
PM FN 7.5MG AM 5MG PM TP 
7.5MG AM 
5MG PM 
1 SC GENOTROPIN 1.6MG OD TP 1.6MG OD TP 1.6MG OD TP 1.6MG OD 
1 ORAL LEVOTHYROXINE 150MCG OM TP 150MCG OM TP 150MCG OM TP 150MCG OM 
2 ORAL SEPTRIN PAED 2.5ML BD TP 99 FN PAED 2.5ML BD TP 
PAED 2.5ML 
BD 
2 INH 
BUDESONIDE INH 
50MCG 8P OD U 99 U NO MENTION U UNCERTAIN 
2 INH SALBUTAMOL INH 2P MDU TP 99 FN NOT GIVEN FN 2P PRN 
3 ORAL DOMPERIDONE 1.6MG QDS U 1.6MG QDS U UNK U UNCERTAIN 
3 ORAL SYTRON 2.5ML OM TP 99 FN UNK FN 2.5ML OM 
3 ORAL OMEPRAZOLE 4MG OM TP 99 FN UNK FN 4MG OM 
3 ORAL CALOGEN 3ML QDS TP 99 FN UNK FN 3ML QDS 
3 EYE 
HYPROMELLOSE 
0.3% ED QDS BE TP 99 FN UNK FN QDS BE 
4 INH 
BECLOMETASONE 
INH 200MCG BD TP 99 FN 200MCG OD FN 200MCG BD 
4 ORAL SENNA 
SENNOKOT 10ML 
ON TP 99 FN 18ML ON FN 
SENNOKOT 
10ML ON 
4 ORAL SOD VALPROATE 7ML TDS TP 99 FN 8ML, 7ML, 8ML FN 7ML TDS 
5 ORAL PHENYTOIN SUSP 20ML BD TP 20ML BD TP 20ML BD TP 20ML BD 
5 ORAL RITALIN 20MG BD TP NO LABEL FN 20MG BD TP 20MG BD 
5 ORAL TOPIRAMATE 30MG BD TP NO LABEL FN 30MG BD TP 30MG BD 
6 ORAL LEVOTHYROXINE 125MCG OD TP 125MCG OD TP 125MCG OD TP 125MCG OD 
6 ORAL HYDRALAZINE 50MG BD TP 50MG BD TP 50MG BD TP 50MG BD 
6 ORAL ATENOLOL 100MG OD TP 100MG OM TP 50MG BD FN 100MG OD 
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PATIENT 
NO. route CPM PAM 
PAM 
SPEC POD 
POD 
SPEC CARER 
CARER 
SPEC vCM 
6 ORAL DESMOTABS 100MCG TDS FN NO LABEL FN 200MCG TDS TP 
200MCG 
TDS 
6 ORAL HYDROCORTISONE 10MG AM, 5MG PM TP NO LABEL FN 10MG AM, 5MG PM TP 
10MG AM, 
5MG PM 
7 ORAL CARBAMAZEPINE 300MG BD TP 300MG BD TP 300MG BD TP 300MG BD 
7 ORAL TOPIRAMATE 30MG BD TP NO LABEL FN 30MG BD TP 30MG BD 
7 ORAL LEVETIRACETAM 600MG BD FP 99 FP 
STOPPED 1/12 
AGO TP STOP 
8 INH FLIXOTIDE INH  
EVOHALER 50, 2P 
BD TP 99 FN 100MCG BD TP 
EVOHALER 
50, 2P BD 
8 INH SALBUTAMOL INH 99 FN 99 FN PRN TP PRN 
9 ORAL THYROXINE 75 MCG OD TP 99 FN 75 MCG OD TP 75 MCG OD 
10 ORAL CARBAMAZEPINE 
80MG OM, 120MG 
ON TP 
80MG OM, 
120MG ON FN 100MG BD TP 100MG BD 
11 ORAL RANITIDINE 150MG BD FN 150MG BD TP 150MG BD TP 150MG BD 
11 ORAL TRIMETHOPRIM 15MG OD TP 15MG ON TP 15MG ON TP 15MG OD 
11 EYE LACRILUBE BE ON TP BE ON TP BE ON TP BE ON 
11 EYE VISCOTEARS BE PRN TP BE PRN TP BE QDS FN BE PRN 
12 ORAL PHENYTOIN 150MG BD TP 99 FN 150MG BD TP 150MG BD 
13 ORAL TRIMETHOPRIM 10MG ON FN 10MG ON FN 20MG ON TP 20MG ON 
14 ORAL NITROFURANTOIN 0 FN 5MG ON TP 5MG ON TP 5MG ON 
15 ORAL OMEPRAZOLE 10MG OD TP 99 FN 10MG OD TP 10MG OD 
15 ORAL DOMPERIDONE SUSP 3MG TDS FN 99 FN 4MG TDS TP 4MG TDS 
15 ORAL FEREDETATE 2.5MLS TDS FP 99 U NOT GIVEN U UNCERTAIN 
15 ORAL CO-TRIMOXAZOLE PAED 2.5ML ON TP 99 FN PAED 2.5ML OD TP 
PAED 2.5ML 
ON 
15 EYE LACRILUBE BE ON TP 99 FN BE ON TP BE ON 
15 NEB COLISTIMETHATE NEB BD MDU TP 99 FN 
500,000 UNITS BD 
NEB FN 
NEB BD 
MDU 
16 ORAL DESMOPRESSIN 50MCG QDS TP 99 FN 300MCG DAILY FN 50MCG QDS 
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PATIENT 
NO. route CPM PAM 
PAM 
SPEC POD 
POD 
SPEC CARER 
CARER 
SPEC vCM 
16 ORAL PREDNISOLONE SOL 5MG ALT DIE TP 99 FN ORAL EVERY 3/52 FN 
5MG ALT 
DIE 
16 ORAL 
COTRIMOXAZOLE 
PAED 
240MG BD SAT + 
SUN TP 
240MG BD SAT 
+ SUN TP 
480MG OD SAT + 
SUN FN 
240MG BD 
SAT + SUN 
16 ORAL MOVICOL PAED 2 OD U 99 FN NO MENTION U UNCERTAIN 
17 ORAL EPILIM CHRONO 1.5G ON TP 
CHRONO 1.5G 
ON TP 3 OD TP 
CHRONO 
1.5G ON 
17 ORAL KEPPRA 750MG BD TP 750MG BD TP 3 BD TP 750MG BD 
18 INH SALBUTAMOL INH 2P QDS PRN TP 2P QDS PRN TP NO MENTION FN 2P QDS PRN 
18 INH 
BECLOMETASONE 
INH 50MCG BD TP 50MCG BD TP NO MENTION FN 50MCG BD 
18 ORAL PIZOTIFEN 500MCG ON TP 500MCG ON TP UNK FN 500MCG ON 
18 ORAL PROPRANOLOL 10MG OD TP 10MG OD TP UNK FN 10MG OD 
19 INH SALBUTAMOL INH 4P q2-q4h prn TP PRN TP 3-5 PUFFS PRN TP 
4P q2-q4h 
prn 
19 INH 
TERBUTALINE TURBO 
INH 1p q2h-q4h prn TP NO LABEL FN 1P PRN TP 
1p q2h-q4h 
prn 
19 INH 
SYMBICORT 100/6 
TURBO 1p od-bd TP NO LABEL FN 1P OD TP 1P OD 
19 ORAL PREDNISOLONE SOL 20mg od 5/7 TP 20MG OD 5/7 TP 20MG OD FN 20mg od 5/7 
20 INH SALBUTAMOL INH 2P Q4H PRN TP NO LABEL FN 4P BD FN 2P Q4H PRN 
20 INH 
BECLOMETASONE 
INH 50 2P BD TP NO LABEL FN 2P BD TP 50 2P BD 
21 ORAL CHLORPHENAMINE 4MG BD TP 98 FN 4MG OD-BD TP 4MG BD 
21 ORAL DESMOPRESSIN 400MCG ON U 99 U NO MENTION U UNCERTAIN 
21 ORAL MOVICOL PAED 1 ON U 99 U NOT GIVEN U UNCERTAIN 
21 INH SALBUTAMOL INH 1P MDU TP PRN TP NOT GIVEN FN 1P MDU 
21 ORAL SENNA 15MG ON U 99 U NOT GIVEN U UNCERTAIN 
21 INH 
SYMBICORT 200/6 
TURBO 2P BD TP 99 FN 2P BD TP 2P BD 
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PATIENT 
NO. route CPM PAM 
PAM 
SPEC POD 
POD 
SPEC CARER 
CARER 
SPEC vCM 
21 INH BRICANYL INH 98 U 99 U UNCERTAIN U 
NOT 
APPLICABLE 
22 ORAL LAMOTRIGINE 0 FN 100MG BD TP UNK FN 100MG BD 
22 ORAL TOPIRAMATE 0 FN 100MG BD TP UNK FN 100MG BD 
23 ORAL CLOBAZAM  2MG TDS TP 2MG TDS TP 2MG, 3MG, 4MG TP 2MG TDS 
23 ORAL GLYCOPYRROLATE 1MG MDU U 1MG MDU U 2MG TDS U UNCERTAIN 
23 ORAL LACTULOSE 5-15ML BD TP 5-15ML TDS TP 6ML BD FN 5-15ML BD 
23 ORAL SENNA 7.5 MG ON TP 7.5 MG ON TP 7.5MG ON TP 7.5 MG ON 
23 ORAL NITRAZEPAM 2.5MG BD TP 2.5MG BD TP NO MENTION FN 2.5MG BD 
23 ORAL OMEPRAZOLE 10MG BD TP 10MG BD TP 10MG BD TP 10MG BD 
23 ORAL VIGABATRIN 750MG BD U 750MG BD U 500MG BD U UNCERTAIN 
23 ORAL 
COTRIMOXAZOLE 
PAED 240MG MDU TP 240MG MDU TP 240MG BD TP 240MG MDU 
24 INH SALBUTAMOL INH 99 FN 99 FN PRN TP PRN 
24 INH 
BECLOMETASONE 
INH 99 FN 99 FN PRN FN REG DOSE 
25 ORAL CLOBAZAM  2.1ML BD TP 99 FN 2.1ML TDS FN 2.1ML BD 
25 ORAL SOD VALPROATE 300MG BD TP 99 FN 300MG BD TP 300MG BD 
26 ORAL CICLOSPORIN 31MG BD TP 31MG BD TP NO MENTION FN 31MG BD 
27 ORAL TRIMETHOPRIM 20MG ON TP 20MG ON TP 22MG ON FN 20MG ON 
28 ORAL SOD VALPROATE 100MG BD TP 100MG BD TP 100MG BD TP 100MG BD 
29 ORAL ETHINYLOESTRADIOL 10 MCG OD TP 99 FN 10 MCG OD TP 10 MCG OD 
29 ORAL LEVOTHYROXINE 100 MCG OM TP 99 FN 100 MCG OM TP 
100 MCG 
OM 
29 ORAL HYDROCORTISONE 10MG AM, 5MG PM U 99 U 
10MG AM, 7.5MG 
PM U UNCERTAIN 
29 SC GH - SAIZEN 1.75MG TP 99 FN 1.75MG TP 1.75MG 
29 ORAL DESMOPRESSIN 100 MCG QDS TP 99 FN 100 MCG QDS TP 
100 MCG 
QDS 
30 ORAL CLOBAZAM  5MG BD FN 5MG TDS TP 5MG TDS TP 5MG TDS 
30 ORAL STIRIPENTOL 750MG BD TP 750MG BD TP 750MG BD TP 750MG BD 
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PATIENT 
NO. route CPM PAM 
PAM 
SPEC POD 
POD 
SPEC CARER 
CARER 
SPEC vCM 
30 ORAL SOD VALPROATE 400MG BD TP 400MG BD TP 400MG BD TP 400MG BD 
31 ORAL PIZOTIFEN 0.5MG BD U 0.5MG BD U 0.5MG TDS U UNCERTAIN 
31 ORAL MELATONIN 0 FN 6MG ON TP 6MG ON TP 6MG ON 
31 ORAL OMEPRAZOLE 40mg od 4/7 TP n/a U NOT GIVEN FN 40mg od 4/7 
32 ORAL NO RX 99 U 99 U 
CLARITHROMYCIN 
3ML OD U UNCERTAIN 
32 ORAL NO RX 99 FN 99 FN 
FOLIC ACID 10ML 
OD TP 
FOLIC ACID 
5MG OD 
33 ORAL LAMOTRIGINE 15MG BD TP 15MG BD TP 15MG BD TP 15MG BD 
33 ORAL LEVETIRACETAM 300MG BD TP 300MG BD TP 300MG BD TP 300MG BD 
34 ORAL CARBAMAZEPINE 99 U 99 U 210MG BD U UNCERTAIN 
35 ORAL GABAPENTIN 300-600MG TDS FN 99 FN 600MG BD TP 600MG BD 
35 ORAL TOPIRAMATE 25MG MDU FN 25MG ON TP 25MG ON TP 25MG ON 
36 ORAL TRIMETHOPRIM 99 U 99 U 5ML ON U UNCERTAIN 
37 ORAL PHENOBARBITONE MDU BD FN MDU BD FN 140MG BD TP 140MG BD 
37 ORAL MELATONIN 0 U 99 U 7.5MG ON U UNCERTAIN 
38 INH 
BECLOMETASONE 
INH 50MCG BD TP 99 FN NOT GIVEN FN 50MCG BD 
38 ORAL CARBAMAZEPINE 300MG BD TP 100 BD FN 300MG BD TP 300MG BD 
38 ORAL LORATADINE 5MG ON TP 5MG OD TP 5MG ON TP 5MG ON 
38 NASAL NASONEX 2P OD TP NO LABEL FN 1P ON FN 2P OD 
38 INH SALBUTAMOL INH 2P PRN TP 99 FN PRN TP 2P PRN 
38 ORAL TRIMETHOPRIM 100MG BD TP NO LABEL FN 100MG BD TP 100MG BD 
39 ORAL PHENYTOIN 87.6MG BD TP 87.6MG BD TP 87.6MG BD TP 87.6MG BD 
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   Category - PAM Freq 
Category - 
POD Freq Category - CARER Freq  
   TOTAL TP 77 TOTAL TP 42 TOTAL TP 62  
   TOTAL FN 16 TOTAL FN 51 TOTAL FN 32  
   TOTAL FP 2 TOTAL FP 1 TOTAL FP 0  
   UNCLASSIFIED 15 UNCLASSIFIED 16 UNCLASSIFIED 16  
                
   TOTAL VALID  95 TOTAL VALID  94 TOTAL VALID  94  
   % TP 81% % TP 45% % TP 66%  
   % FN 17% % FN 54% % FN 34%  
   % FP 2% % FP 1% % FP 0%  
                
   Sensitivity 0.83 Sensitivity 0.45 Sensitivity 0.66  
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Appendix 8 Nursing staff questionnaire (electronic) 
 
ACCESS TO MEDICINES:THE EXPERIENCE OF BCH CLINICAL NURSE SPECIALISTS AND 
ADVANCED NURSEPRACTIONERS  
 
This questionnaire is part of a series of studies at BCH looking at the problems children and their 
carers experience in obtaining continuing medicines when they are not in hospital (Access to 
Medicines). Accessing continuing medicines can be problematic for paediatric patients for a number 
of reasons, including:  
 GP may be reluctant to prescribe  
 Community pharmacies may have difficulties in obtaining specialist medicines before 
existing supplies run out  
 Variation in the formulation of unlicensed medicines 
 
The results of this survey may be used to identify beneficial changes to existing processes. If useful 
information is obtained a summary of anonymised results and their significance may be published.  
 
* Q1: In which specialty do you work mostly at [hospital / Trust]?  
Please choose *only one* of the following:  
Cardiology  
Dermatology  
Diabetology  
Endocrinology  
Gastroenterology  
Haematology  
IMD  
Liver  
Neurology  
Oncology  
Plastics  
Renal  
Respiratory  
Other 
 
* Q2: On average how many hours per week are you contracted to work at [hospital / Trust]?  
Please choose *only one* of the following: 
Less than 5 hours 
Between 5.1 and 8 hours  
Between 8.1 and 16 hours  
Between 16.1 and 22 hours  
Between 22.1 and 30 hours  
More than 30.1 hours  
Don't know 
 
 
* Q3: What is your job title?  
Please write your answer here:  
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* Q4: Please tick all that apply to your job or role:  
 
Please choose *all* that apply:  
Independent prescriber  
Supplementary prescriber  
Domicillary Visits  
Work with In-patients  
Work with Out-patients  
Provide advice concerning medication  
Other:  
 
 
* Q5: Do you consider your role mainly clinical or psychosocial?  
Please choose *only one* of the following:  
Mainly Clinical  
Mainly psychosocial  
Other 
 
 
Section B: SECTION B: SUPPORTING PATIENTS GET THEIR MEDICINES  
 
We are interested in your involvement in ensuring patients get the medicines they need. You might 
facilitate getting prescriptions written, or advise on how to get a prescription for an uncommon 
medicine dispensed. You may advise patients on how to take a medicine. Please complete the 
following questions.  
 
* Q6: In the last 3 months how many times have you been called upon to organise repeat 
prescriptions for your patients?  
 
Please choose *only one* of the following:  
Never  
1 to 5 times  
6 to 10 times  
11 to 30 times  
More than 30 times 
 
 
* Q7: In the last 3 months for how many patients have you been asked to organise repeat 
prescriptions?  
 
Please choose *only one* of the following:  
 
None  
1 to 5  
6 to 10  
11 to 30  
More than 30  
 
 
* Q8: Is it in your Job Description to resolve drug access problems?  
 
Please choose *only one* of the following:  
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Yes  
No  
Do not know  
* Q9: How would you describe the risk to patients if you did not help patients access their 
medicines?  
 
Please choose *only one* of the following:  
Not Applicable  
Insignificant (no risk)  
Moderately significant  
Significant  
Highly significant (greatest risk 
 
  
* Q10: In your opinion what is the most common reason why carers experience problems in 
obtaining suitable medications (one that the child can use or take)?  
 
Please choose *only one* of the following:  
Cannot obtain a prescription (in time) ... carer issue  
Cannot get medication dispensed ... pharmacy issue  
Child cannot use the formulation provided … formulation issue  
GP has not received communication (eg. clinic/discharge letter) … communication  
issue  
GP will not prescribe (eg because it is an unlicensed medication) … prescriber issue  
Other 
 
  
* Q11: In what ways can services be better organised to minimise disruption to the child‘s therapy?  
 
Please choose *all* that apply:  
Require GPs to prescribe  
Require hospitals to prescribe and dispense unlicensed / uncommon/medicines  
Enable hospital pharmacy to dispense GP prescriptions  
Don't know  
Other: 
 
 
Thank you for your time and cooperation. If you have any other comments that you  
would like to make about children getting the medicines the need please enter them below.  
 
Additional Comments: 
 
Please write your answer here:  
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Appendix 9 Rescue-Medication Survey (paper) 
2009#5  
 
URGENT MEDICINE REQUEST: PARENT / CARER 
SURVEY 
 
About this survey 
This questionnaire is designed to determine the circumstances that lead parents and carers to 
request urgent medication supplies from the Pharmacy, Birmingham Children‘s Hospital. The 
survey also asks your views on how things can improve which may help us identify service 
changes. 
 
Completing the questionnaire is entirely voluntary  If you decide not to participate it will not 
affect the service we provide to you. Please note that we may publish summary data and use the 
survey within some studies we are conducting with Aston University. Any published data will be 
anonymised. A member of our staff is available to help you complete the questionnaire. 
 
What to do 
Most of the questions require a simple answer in the box provided.  The whole questionnaire can be 
completed in 10 minutes and we hope that you will help us with this important research. 
 
 
We respect your right to decline to complete this survey.  
 
However if you do decide not to complete the survey it would be very helpful for us to understand 
why you made this decision. Please tick all that apply: 
 
 This is not a good time / insufficient time, to complete the survey 
 Concerns about confidentiality 
 I am not the usual carer of the patient 
 other … please describe below. 
 
 
 
 
In the event of queries contact David Terry in the Pharmacy, Birmingham 
Children’s Hospital on 0121-333-9786. 
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SECTION A: ABOUT THE PATIENT AND WHICH HEALTHCARE 
PROFESSIONALS YOU USE. 
 
 
The following questions are about the patient and which GP, community pharmacy 
and PCT provides their care. 
 
Q1) What is the patient‟s home postcode? 
 
 
Q2) Which GP practice does the patient attend (include address if possible)? 
 
 
 
Q3) Which is your usual community pharmacy (chemist) – name and address if possible? 
 
 
 
Q4) Which Primary Care Trust (PCT) does the patient belong to? (If in doubt we can look 
up this information for you). 
 
 
SECTION B: CIRCUMSTANCES OF COMING TO THE PHARMACY 
TODAY 
 
We are interested in the details of why you had to come to us to get urgent 
medicines. 
 
 
Q5) When did the patient last attend Birmingham Children‟s Hospital (date if possible)? 
 
 
 
Q6) When did the patient last consult their GP (date if possible)? 
 
 
 Page 244 
Q7) Have you made a special trip to come to us today? 
(tick ONE box) 
a. YES  
b. NO    
 
 
Q8) Did you get advice from a healthcare professional before you came to us (e.g. GP or 
community pharmacist)? 
(tick ONE box) 
a. YES  - if so who  
b. NO    
 
 
Q9) Have you had to come to us before to obtain medicines urgently?  
(tick ONE box) 
a. YES  - if so when  
b. NO    
 
 
Q10) Who normally prescribes the medicine(s)? 
(tick ONE box) 
a. GP   
b. HOSPITAL    
 
 
Q11) Where do you normally get the medicines dispensed (name & address if possible)? 
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Q12) How often do you have problems getting medicines for this patient? 
TICK ONE ONLY 
Never before Very rarely Sometimes Often Very often 
     
 
 
Q13) Which medicines do you have difficulty obtaining (please provide the names of the 
medicines concerned? 
 
 
 
 
Q14) Has the patient missed any doses as a consequence of not getting the medicine(s)? 
 
 
 
 
 
SECTION C: YOUR OPINIONS 
 
 
This section explores your opinions on why these problems occur and how the 
current systems can be improved. 
 
Q15) What do you think are the reasons why you have had difficulty in obtaining the 
medicines? 
 
 
 
 
 
 
Q16) How can existing arrangements be improved? 
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 If you have any additional comments please write in the box below. 
 
 
 
 
 
 
 
Date completed 
 
 
 
Do Not Write Below this line – for administrative use only. 
 
 
 
 
UrgentMedsSurveyJan2009#5 
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Table 55 Free text responses for reasons for problems and assigned codes 
 
ID MEDICINES REASONS 
REASON 
CODES 
1 Acetazolamide 
Unusual to get liquid form in this 
particular strength SUPPLY 
3 
Electrolyte solution G & Sodium 
resonium  
Not available at community 
pharmacy, takes time to be 
delivered SUPPLY 
4 Joulies phosphate solution 
The community pharmacy have to 
order supplies in from hospital SUPPLY 
5 0 Manufacturers delay SUPPLY 
7 Azathioprine liquid 50mg/5ml G.P Refusal GP 
9 0 
They are dispensed to pre-order 
to named users in the community 
pharmacists only and takes 28 
days to arrive. SUPPLY 
11 Phosphate sandoz Not stocked at pharmacy's SUPPLY / CP 
12 0 
Because they didn‘t know the 
dose UNCLASSIFIED 
13 Captopril & potassium chloride 
G.p won't prescribe and pharmacy 
cannot get hold of the unlicensed 
medication GP / CP 
14 0 Reffered from A&E UNCLASSIFIED 
15 0 
had difficulties receiving the 
medicine because the chemist 
wouldn't dispense because it 
wasn't available. CP 
16 Clobazam chloral hydrate 
Not kept in stock in community 
pharmacy SUPPLY / CP 
17 Triazapan 
Pharmacy does not have the 
medicine SUPPLY / CP 
18 Nitrazepam 
The pharmacy said there was a 
strength to the medication but 
there is not. CP 
20 
loperamide, sodium bicarbonate, 
Omeprazole 
Boots pharmacy have problems 
getting meds and are very 
unhelpful CP 
21 0 Problems with manufacturers SUPPLY 
23 Captopril 
I wasn't aware that the pharmacy 
would need so much notice to 
obtain the medicine and a 
prescription in place before 
ordering. Even though they had 
the discharge papers. CARER 
24 Betadine solution 
Local pharmacy's have 
discontinued this medicine SUPPLY 
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ID MEDICINES REASONS 
REASON 
CODES 
25 Neorecormon & enalapril Cost of dispensing, availability COST / SUPPLY 
26 The ones that are prescribed now Really don't know UNK 
27 0 
Because they are specialised 
drugs SUPPLY 
28 Captopril 
Medicine has a short expiry date 
and the chemist have to put it 
through as a specail order which 
in this case will take a week. SUPPLY 
34 
Sodium Bicarbonate tablets 
Minoxodil 
Community pharmacy access to 
specialist drugs SUPPLY / CP 
39 0 Not in stock, have to order SUPPLY / CP 
43 Madopar 62.5 The doctors would not prescribe it GP 
44 Loperamide and 1 other 
GP said he hasn‘t received any 
info from hospital Communication 
47 0 Manufacturers UNCLASSIFIED 
48 MMF 
Pharmacy told us that medicine is 
out of stock with us please buy 
from other pharmacy. But could 
not find any where CP 
51 Promixin 
GP refused to prescribe, money 
being the issue here COST / GP 
54 Catopril 
We were told that it has a short 
shelf life and it had to be ordered 
in advance SUPPLY / CP 
60 0 Unlicenced drug UNCLASSIFIED 
61 0 Hospital medicines UNCLASSIFIED 
62 Desmospray 
We have been told it is due to 
dosage UNCLASSIFIED 
69 Chlorothiazide Don‘t Know UNK 
70 Acidophilus Extra 4 Capsules 
I have been told by the chemist 
they do not prescribe this drug. I 
have tried a few pharmacies CP 
75 Fucidin (Fucidic Acid) 
No, Knowing it would take upto !0 
days to obtain, not getting enough 
to see through the week. Gp 
unaware that hospital discharge 
included regular top-ups.  UNCLASSIFIED 
76 0 No, not yet UNK 
79 
Potassium, 
Magnesium,Amphoterin, 
Rifampacin etc 
I have been told that they are 
special medicines and have to be 
made up. Not all staff know how to 
order them. I have to take bottles 
to show them in order for them to 
order the right medicine. CP 
81 
Magnesium Oral Solution 
sometimes 
Supplier to our local pharmacist 
sometimes doesn‘t have supply SUPPLY 
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ID MEDICINES REASONS 
REASON 
CODES 
82 Pyridoxal phosphate 
GP cannot presribe as he had no 
communication from consultant GP 
84 Sildenafil Suspension 
Because they have to be orderd in 
and sometimes takes longer SUPPLY 
88 DNAse Dr Unwilling to supply GP 
 
 
Table 56 Free text answers to how things can be improved and assigned codes 
 
ID HOW CAN EXISTING ARRANGEMENTS BE IMPROVED? 
IMPROVE 
CODES 
1 
For the chemist to be able to get them without questioning myself, 
GP and the manufacturers COMMUNICATION 
3 For medication to be available monthly when required PLANNING 
9 
To be made aware of the delay when first given the prescription, 
and to be issued with a 28 day supply 
COMMUNICATION / 
PLANNING 
11 
Pharmacy could stock wider variety of medicines or get them 
urgently the same day PROCUREMENT 
13 
If the G.P would prescribe and I was able to get hold of all 
medicines from local pharmacy GP 
15 
Being able to get from the chemist with correct  information being 
given to the parents COMMUNICATION 
16 
For pharmacy to have names of where to obtain specific 
medication from PROCUREMENT 
17 Pharmacy stock the medicine you need to have PROCUREMENT 
18 
That other pharmacy's read up on all medication so there wont be 
an issue again CP 
20 Boots pharmacy need to improve and staff need to be more helpful CP 
23 
Better explanation on discharge to parents and the pharmacy 
anticipating when the next prescription would be due COMMUNICATION 
25 Make more widely available PROCUREMENT 
26 The hospital faxing information to the doctor urgently COMMUNICATION 
27 Maybe if we could be sent straight to the hospital to get them HOSP 
28 Special orders abtained quicker or longer expiry dates PROCUREMENT 
43 They should provide all medicine UNK 
44 Communicate with GP about where to get medicine from COMMUNICATION 
47 Stock PROCUREMENT 
48 I have no idea UNK 
51 break the link between cost and need GP 
62 By our own pharmacy liasing with BCH more CP 
69 There hasn‘t been any UNK 
74 MCS UNK 
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ID HOW CAN EXISTING ARRANGEMENTS BE IMPROVED? 
IMPROVE 
CODES 
75 
Hospital to give required medication (if only to last a few weeks on 
discharge). Parents to be made aware that it could take upto a few 
days for pharmacy to get medication. HOSP 
76 Information not being passed on from healthcare departments. COMMUNICATION 
79 
Chemist to find the manufacturer and make sure they put it in their 
system. Not all the staff know how to order them, they ask me. 
There is lack of communication between the staff.  CP 
81 Our Pharmacist does try hard to get all medicines requireed  PLANNING 
84 Not sure UNK 
88 So I don‘t have to phone and fetch every month UNK 
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Appendix 10 Community Pharmacy Survey (Paper) 
CP_2009#5  
 
COMMUNITY PHARMACY SURVEY – Dispensing 
Hospital Prescriptions in Community Pharmacies 
 
TO THE PHARMACIST IN CHARGE 
What to do 
Most of the questions require a simple answer in the box provided.  The whole questionnaire can be 
completed in 10 minutes and we very much hope that you will help us with this important research. 
Once complete please return the questionnaire using the pre-paid envelope provided to: 
Prof Keith Wilson, Pharmacy Department, Aston University, Birmingham. B4 7ET.  
 
If you have any questions please send them via email to the study lead David Terry at 
david.terry@nhs.net 
 
About this survey 
Over 30,000 prescriptions are written by prescribers at Birmingham Children‘s Hospital and 
dispensed by community pharmacists each year. This survey has been sent to you since PPA data 
shows that your Pharmacy has dispensed at least one of these prescriptions in recent months.  
 
The questionnaire is designed to identify your experiences and opinions concerning the dispensing 
of hospital prescriptions (FP10HPs) by community pharmacies, and also asks your views on how 
things can improve which may help us identify service changes locally and nationally. 
 
The survey has been developed by hospital and community pharmacists: and by pharmacists with 
experience in dealing with medicines management interface issues and academic pharmacists from 
Aston University. 
 
The survey results will be fully anonymous: no community pharmacy or pharmacist will be identified 
in any report. However if useful information is obtained we will publish summary data and use the 
survey within a series of studies we are conducting with Aston University. 
 
If you are willing to be contacted to provide follow up information please enter your email 
address here: 
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SECTION A: DEMOGRAPHICS. ABOUT YOU AND YOUR 
PHARMACY. 
 
 
The following questions are about you and the community pharmacy to which the 
survey was delivered. The questions are designed to be completed by a community 
PHARMACIST. 
 
Q1) Which year did you register as a pharmacist with the RPSGB?(yyyy) 
 
 
 
Q2) In which sector did you complete your pre-registration experience? (Tick ONE box 
only) 
 [   ] 2.1 Community 
 [   ] 2.2 Hospital 
 [   ] 2.3 Community / Hospital split year 
 [   ] 2.4 Industry or academia with community or hospital  
 [   ] 2.5 Other … Please state 
 
 
Q3) How many years experience do you have as a COMMUNITY pharmacist? (if you have 
worked part-time or as a locum, count the years you have worked for at least 3 hours per 
week on average in community pharmacy) 
 
 
 
Q4) How many years experience do you have as a HOSPITAL pharmacist? (if you have 
worked part-time or as a locum, count the years you have worked for at least 3 hours per 
week on average in hospital pharmacy) 
 
 
 
Questions 5 and 6 relate to Your Personal Dispensing & Supervisory Role in 
community pharmacy: NOT the Pharmacy you work in. 
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Q5) On average approximately how many prescription items (all sources) do you 
personally dispense or directly supervise in 1 calendar month? 
TICK ONE ONLY 
 
Less than 
400 per 
MONTH 
401 – 1,000 
per MONTH 
1,001 – 3,000 
per MONTH 
3,001 – 6,000 
per MONTH 
6,001 – 
12,000 per 
MONTH 
More than 
12,000 per 
MONTH 
      
  
 
Q6) On average approximately how many HOSPITAL prescription items (e.g. FP10HPs) 
do you personally dispense or directly supervise in 1 YEAR?  
TICK ONE ONLY 
 
NONE 1 – 25 per 
YEAR 
26 – 100 per 
YEAR 
101 – 500 per 
YEAR 
501 – 1,000 
per YEAR 
More than 
1,000 per 
YEAR 
      
  
 
Q7) What is the postcode of the community pharmacy where the survey was delivered? 
 
 
 
SECTION B: YOUR EXPERIENCE AND OPINIONS CONCERNING 
PROBLEMS WHEN DISPENSING HOSPITAL PRESCRIPTIONS 
 
We are interested in your experiences and / or opinions in relation to any problems 
or difficulties that may exist when dispensing hospital prescriptions in community 
pharmacy 
 
 
Q8) On average approximately how much of your time does it take to dispense a single 
item on a script? Include any problem solving time: 
 
 
HOSPITAL Rx  
mins 
GP Rx  
mins 
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Q9) In comparison to an average GP (FP10) prescription what is the likelihood of 
problems when dispensing a hospital (FP10HP) prescription in a community pharmacy? 
(Tick one box) 
Hospital prescriptions problems are …  
MUCH 
LESS 
frequent 
LESS frequent About the 
SAME 
frequency 
MORE 
frequent 
MUCH MORE 
frequent 
DON’T 
KNOW 
      
 
 
Q10) For the following statements please indicate the extent to which you agree or 
disagree: 
 
10.1 Hospital prescriptions are generally more complex to dispense than GP     
        prescriptions 
 
TICK ONE ONLY 
Strongly 
disagree 
Disagree Neither agree 
nor disagree 
Agree Strongly agree 
     
 
 
 
 10.2 I am less likely to challenge an unfamiliar dose on a hospital prescription 
compared with a GP prescription 
 
TICK ONE ONLY 
Strongly 
disagree 
Disagree Neither agree 
nor disagree 
Agree Strongly agree 
     
 
 
 
 10.3 Hospitals should NOT be allowed to issue prescriptions to be dispensed by 
community pharmacies 
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TICK ONE ONLY 
Strongly 
disagree 
Disagree Neither agree 
nor disagree 
Agree Strongly agree 
     
 
 
 
 10.4 Hospitals should ensure that all out-patient prescriptions are issued to patients 
so that they can be dispensed by community pharmacies 
 
TICK ONE ONLY 
Strongly 
disagree 
Disagree Neither agree 
nor disagree 
Agree Strongly agree 
     
 
Q11) This question shows a list of possible problems on prescriptions. In comparison to an 
average GP prescription please indicate the likely occurrence on a hospital prescription. 
(Tick ONE box on EACH line) 
 
 
Hospital Rx 
MUCH 
MORE 
frequent 
Hospital Rx 
MORE 
frequent 
Hospital 
SAME as GP 
Hospital Rx 
LESS 
frequent 
Hospital Rx 
MUCH LESS 
frequent 
Cannot read the 
prescription     
Unfamiliar drug     
Unfamiliar dose 
regimen     
Information on 
Rx is missing     
Problems with 
obtaining the 
product 
    
 
 
SECTION C: OBTAINING FURTHER INFORMATION 
 
This section explores your experiences and / or opinions in relation to obtaining 
further information when dispensing hospital prescriptions in community pharmacy 
 
 
Q12) In comparison to an average GP (FP10) prescription how confident are YOU that you 
If you would like to expand on your answers do so in this box: 
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will be able to identify any prescribing errors when dispensing a hospital (FP10HP) 
prescription in a community pharmacy?  
 
TICK ONE ONLY 
Much less 
confident 
Less confident Same More confident Much more 
confident 
     
 
 
Q13) As a community pharmacist do you believe that there is more risk of error when 
dispensing a hospital prescription compared to a GP prescription? (Tick one box) 
[  ] Yes 
[  ] No 
[  ] Don‘t know 
 
Please add any comments here: 
 
 
 
 
 
SECTION C: OBTAINING FURTHER INFORMATION 
 
This section explores your experiences and / or opinions in relation to obtaining 
further information when dispensing hospital prescriptions in community pharmacy 
 
Q14) If you require further advice / information when dispensing a HOSPITAL 
PRESCRIPTION what or whom will you consult? Please indicate how likely you are to use 
the following sources of information? (Tick ONE box on EACH line) 
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VERY 
LIKELY 
QUITE 
LIKELY 
SOMETIMES QUITE 
UNLIKELY 
VERY 
UNLIKELY 
The patient or 
carer     
Standard text 
(eg BNF)     
GP (or their 
staff)     
Hospital 
Pharmacy     
Medicines 
information     
Hospital 
Prescriber     
Hosp 
prescriber's 
support staff eg 
registrar 
    
 
14.8 If you are likely to use another source of information please describe this in the box  
 
 
 
 
 
Q15) Do you have standard operating procedures that provide guidance in resolving 
prescription problems? (Tick ONE box) 
 
[  ] Yes 
[  ] No 
[  ] Don‘t know 
 
 
Q16) Do you record details of when you ‗intervene‘ on a prescription (e.g. change dose or 
regimen after obtaining further information)? (Tick ONE box) 
 
[  ] No 
[  ] Sometimes 
[  ] Always 
[  ] Don‘t know 
 
 
Q17) In the last 12 months approximately how often have you or the staff under your 
supervision contacted a hospital for advice concerning a hospital prescription? (Tick ONE 
box) 
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[  ] Never 
[  ] 1 - 12 
[  ] 13 – 24 
[  ] 25 – 52 
[  ] 53 – 180 
[  ] 181 – 360 
[  ] more than 360 times 
 
 
Q18) In the last 12 months approximately how often have you or the staff under your 
supervision contacted a GP practice for advice concerning a GP prescription? (Tick ONE 
box) 
[  ] Never 
[  ] 1 - 12 
[  ] 13 – 24 
[  ] 25 – 52 
[  ] 53 – 180 
[  ] 181 – 360 
[  ] more than 360 times 
 
 
SECTION D: IMPROVING EXISTING ARRANGEMENTS 
 
This section explores your opinions in relation to improving existing arrangements 
concerning dispensing hospital prescriptions in community pharmacy 
 
Q19) Please indicate in your opinion how beneficial the following changes would be in 
reducing the problems associated with dispensing hospital prescriptions in community 
pharmacy 
 
19.1 Ensure all hospital prescriptions are computer printed  
 
TICK ONE ONLY 
No benefit Little benefit Medium benefit High benefit Very high 
benefit 
     
 
 
19.2 Ensure all hospital prescriptions include direct contact details for the prescriber  
 
TICK ONE ONLY 
No benefit Little benefit Medium benefit High benefit Very high 
benefit 
     
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19.3 Create an internet site to enable access to the hospital‘s formulary and provide web 
address on the prescription 
 
TICK ONE ONLY 
No benefit Little benefit Medium benefit High benefit Very high 
benefit 
     
 
19.4 Create an internet site to enable access to the hospital‘s clinical protocols and 
provide web address on the prescription 
 
TICK ONE ONLY 
No benefit Little benefit Medium benefit High benefit Very high 
benefit 
     
 
19.5 Create an internet site to enable access to the hospital‘s usual formulations and 
source of unlicensed medicines and provide web address on the prescription 
 
TICK ONE ONLY 
No benefit Little benefit Medium benefit High benefit Very high 
benefit 
     
 
 
19.6 If prescribed dose regimens are not included in standard texts ensure the prescriber 
acknowledges that they have done so knowingly on the prescription (eg endorse as  
BNF ) 
 
TICK ONE ONLY 
No benefit Little benefit Medium benefit High benefit Very high 
benefit 
     
 
 
19.7 Provide a prescription fax back system to the hospital– so that the prescription can be 
faxed to the Pharmacy of the hospital for comment. Provide the fax number on the 
prescription. 
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TICK ONE ONLY 
No benefit Little benefit Medium benefit High benefit Very high 
benefit 
     
 
 
19.8 Ensure all hospital prescriptions are clinically screened by a hospital clinical 
pharmacist before being issued to the patient 
 
TICK ONE ONLY 
No benefit Little benefit Medium benefit High benefit Very high 
benefit 
     
 
19.9 Ensure prescribers indicate the dose calculation as well as the final dose on hospital 
prescriptions for children (eg state mg per kg as well as calculated dose) 
 
TICK ONE ONLY 
No benefit Little benefit Medium benefit High benefit Very high 
benefit 
     
 
 
Q20) In your opinion which single achievable change would bring about the most benefit 
(one mentioned in this section or one of your own ideas)? 
 
 
 
 
Q21) To what extent have you personal experience of dispensing hospital prescriptions in 
the community? 
 
TICK ONE ONLY 
Very little 
experience 
Little experience Moderate 
experience 
High experience Very high 
experience 
     
 
We welcome any further comments concerning hospital prescriptions dispensed in the 
community. Please write in the box below. 
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THANK YOU VERY MUCH 
We know how busy community pharmacists are and we much appreciate your time. 
Please now return the whole of the questionnaire using the pre-paid envelope or the address on 
page 1. 
 
Please see the study website for summary results. 
 
Do Not Write below this line – for administrative use only. 
 
 
 
a 
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